Studies on fibrin network structure by Ferguson, Ian Andrew
STUDIES ON FIBRIN NETWORK STRUCTURE 
by 
IAN ANDREW FERGUSON 
A thesis submitted for the degree of Doctor of 
Philosophy of the Australian National University 
January, 1983 
STUDIES ON FIBRIN NETWORK STRUCTURE 
by 
IAN ANDREW FERGUSON 
A thesis submitted for the degree of Doctor of 
Philosophy of the Australian National University 
January, 1983 
STATEMENT 
Except where acknowledged, the investigations 
described in this thesis are my own original work 
/ 
,,. 
I ' 
V ) 
IAN FERGUSON 
January, 1983 
1 1 • 
iii. 
ACKNOWLEDGEMENTS 
My sincere thanks go to my supervisors, Dr. D.P. Dhall 
and Dr. Neville Ardlie, for their endless encouragement, 
advice and tolerance of the past three years. 
I also wish to thank Drs. G.A. Shah and T.Z. Dhall for 
many fruitful discussions and their assistance in studying 
surgical patients; G.A. Shah for his assistance in the 
mathematical treatment of the relationship between mass-
length ratio and fibrin network structure; Gillian 
Thorogood and Maree Gay for typing this thesis; and members 
of the Department of Medicine and Clinical Science, A.N.U., 
the Woden Valley Hospital Pathology Department and the Red 
Cross Blood Bank for their tolerant friendly attitude and 
blood donations. 
Financial support from the Canberra Hospitals Private 
Practice Trust Fund is gratefully acknowledged. 
SYNOPSIS 
Fibrin networks were formed in plasma or in fibrinogen 
solutions under conditions which simulated those in plasma 
and these networks were examined with a battery of methods 
so as to establish whether network structure might vary in 
vivo. Studies indicate that network structure and 
properties in plasma changes following surgery. The 
structure and properties of networks in plasma were found 
to be sensitive to anticoagulant and clotting conditions 
particularly to ionic strength and pH. The post-operative 
increasein fibrinogen concentration appears to decrease the 
average thickness of fibrin fibres. The mechanical 
behaviour of networks in plasma differed from those made 1n 
purified fibrinogen. The structure and properties of 
networks formed in purified fibrinogen, like that in 
plasma, were also sensitive to small changes in clotting 
conditions. In addition, they were sensitive to many 
clinically and physiologically important substances, such 
as, heparin, protamine sulphate, glucose and 
glycosaminoglycans. These studies suggest that changes in 
the kinetics of fibrin generation and changes in the 
solubility of fibrin(ogen) result in changes in network 
structure and hence clot properties. Factor XIII mediated 
cross-linking did not substantially influence fibre 
thickness but it did reduce network permeability. It was 
demonstrated that cross-linking decreased the mass-length 
ratio determined from permeability, but not that de te rmined 
from turbidity. Transmission electron micrographs showed 
this was due to the stabilisation of a previously 
undocumented network structure - the minor network. In 
, 
contrast to the assumption implicit in methods for 
calculating mass-length ratio of fibrin fibres it was shown 
that fibre thickness in fibrin gels is not homogeneous. 
iv. 
The gods did not reveal, from the beginning, 
All things to us, but in the course of time 
Through seeking we may learn and know this better. 
But as for certain truth, no man has known it, 
Nor shall he know it, neither of the gods 
Nor yet of all things of which I speak. 
For even if by chance he were to utter 
The final truth, he would himself not know it: 
For all is but a woven web of guesses. 
Xenophanes 
I i 
STATEMENT 
AC KNOW LE DGEM ENTS 
QUOTATION 
LIST OF FIGURES 
LIST OF TABLES 
ABBREVIATIONS 
CONTENTS 
CHAPTER 1 - GENERAL INTRODUCTION 
1.1 FIBRINOGEN 
1 • 1 • 1 
1 • 1 • 2 
1 • 1 • 3 
Molecular characteristics 
Primary structure 
Tertiary structure 
1.2 FIBRIN FORMATION 
V • 
ii 
111 
iv 
xi 
xiv 
xv 
2 
2 
3 
4 
5 
1 • 2 . 1 Th r om b in and fib r in f o rm at i o n 6 
1.2.2 Fibrin formation in the absence 
of thrombin 6 
1.2.3 Polymerization 7 
1.2.4 Crosslinking 9 
1.3 FIBRIN NETWORK STRUCTURE AND PROPERTIES 10 
1. 3. 1 Normal fibrin network structure 10 
1.3.2 Abnormal fibrin structure 13 
1.4 FIBRINOLYSIS 
1.4.1 Lysis by plasmin 
1.5 PHYSIOLOGICAL ROLE OF FIBRIN 
1 • 5. 1 
1 • 5. 2 
Fibrinopeptides and FDPs 
Physiological roles of fibrin 
1.6 PROBLEMS FOR STUDY 
1 • 6. 1 
1 . 6. 2 
1 • 6. 3 
Methodological problems 
Problems in regulation of fibrin 
network 
Problems of studying fibrin 
networks 1n clinical context 
CHAPTER 2 - MATERIALS AND METHODS 
2.1 MATERIALS 
2. 1 . 1 
2. 1 . 2 
2. 1 . 3 
2. 1 • 4 
2. 1 . 5 
2 . 1 . 6 
General 
Fibrinogen 
Radiolabelled fibrinogen 
Thrombin 
Tris-saline buffer 
Other reagents 
14 
14 
1 6 
17 
17 
23 
24 
25 
26 
29 
29 
29 
30 
30 
30 
30 
2.2 METHODS 
2.2. 1 Fibrin networks 
2.2.2 Turbidimetric studies 
2.2.2. 1 Fibrin network 
iv. 
31 
31 
32 
development 32 
2.2.2.2 Opacity ratio 33 
2.2.2.3 Mass-length ratio using 
one wavelengh 34 
2.2.2.4 Mass-length ratio using 
a range of wavelengths 36 
SECTION I 
2. 2. 3 
2.2.4 
2.2.5 
2.2.6 
2.2.7 
Mass-length ratio from 
permeability 
Fibrin network compaction 
Scanning electron microscopy 
Transmission electron 
microscopy 
Statistical analysis 
STUDIES ON METHODS USED FOR EXAMINING FIBRIN NETWORKS 
CHAPTER 3 - METHODS: REPRODUCIBILITY AND TECHNICAL 
LIMITATIONS 
3.1 INTRODUCTION 
3.2 MATERIALS AND METHODS 
3.3 RESULTS 
3. 3.1 Reproducibility of measurements 
3.3.2 Technical limitations of the 
methods 
3.3.2.1 
3.3.2.2 
3.3.2.3 
3.3.2.4 
3.3.2.5 
3.4 DISCUSSION 
3.5 CONCLUSIONS 
Turbidimetric studies 
Compaction 
Perfusion studies 
Transmission electron 
microscopy 
Scanning electron 
microscopy 
CHAPTER 4 - THE EFFECTS OF FACTOR XIII MEDIATED 
CROSSLINKING ON NETWORK ST~UCTURE AND 
MEASU REMENT OF MASS-LENGTH RATIO 
4. 1 INTRODUCTION 
4.2 MATERIALS AND METHODS 
4.3 RESULTS 
37 
40 
40 
41 
41 
45 
45 
45 
45 
46 
46 
47 
47 
48 
48 
48 
52 
60 
60 
61 
I 
4.4. DISCUSSION 
4.5 CONCLUSIONS 
CHAPTER 5 - A COMPARISON OF METHODS 
5. 1 INTRODUCTION 
5.2 MATERIALS AND METHODS 
5.3 RESULTS 
5. 3. 1 
5.3.2 
5. 3. 3 
Perfusion 
Compaction 
Turbidity 
vii. 
62 
65 
71 
71 
71 
71 
72 
72 
5.3.3. 1 Opacity ratio 72 
5.3.3.2 Lag time and ~OD/sec 72 
5.4 DISCUSSION 
5.5 CONCLUSIONS 
SECTION II 
STUDIES ON FIBRIN NETWORKS FORMED IN 
PURIFIED FIBRINOGEN SOLUTIONS 
CHAPTER 6 - A RE-EXAMINATION OF SOME INFLUENCES 
ON FIBRIN NETWORK DEVELOPMENT, 
PROPERTIES AND STRUCTURE: STUDIES ON 
THE MECHANISM UNDERLYING CHANGES IN 
NETWORK STRUCTURE. 
6.1 INTRODUCTION 
6.2 MATERIALS AND METHODS 
73 
75 
86 
87 
6. 2. 1 
6.2.2 
6. 2. 3 
6.2.4 
6.2.5 
Effect of thrombin concentration 87 
Effect of fibrinogen concentration 88 
6.3 RESULTS 
6. 3. 1 
6. 3. 2 
6.3.3 
6. 3. 4 
6.3.5 
Effect of temperature 88 
Effect of ionic strength and pH 89 
Effect of common ions in plasma 89 
89 
Effect of thrombin concentration 89 
Effect of fibrinogen concentration 90 
Effect of temperature 91 
Effect of ionic strength and pH 92 
Effect of common ions in plasma 92 
6.4 DISCUSSION 
6.5 CONCLUSIONS 
92 
98 
( 
viii. 
page 
CHAPTER 7 - THE EFFECTS OF GLUCOSE, 
GLYCOSAMINOGLYCANS, AND PROTAMINE 
SULPHATE ON FIBRIN NETWORK STRUCTURE: 
7. 1 
7.2 
7.3 
7.4 
7.5 
SECTION III 
FURTHER STUDIES ON THE MECHANISM 
UNDERLYING CHANGES IN NETWORK STRUCTURE 
INTRODUCTION 
MATERIALS AND METHODS 
7. 2. 1 Effect of glucose 
7.2.2 Ef feet of he par in 
7.2.3 Effect of protamine sulphate 
7.2.4 Ef feet of heparan sulphate 
7.2.5 Effect of chrondroitin sulphates 
RESULTS 
7. 3. 1 Effect of glucose 
7. 3. 2 Effect of protamine sulphate 
and heparin 
7.3.3 
7.3.4 
Effect of heparan sulphate 
Effect of chondroitin 
sulphates 
DISCUSSION 
CONCLUSIONS 
112 
11 2 
1 1 3 
11 3 
114 
11 4 
114 
11 5 
11 5 
11 6 
11 7 
1 1 7 
11 8 
1 21 
STUDIES ON NETWORKS FORMED IN PLASMA 
CHAPTER 8 - COMPARISON OF FIBRIN NETWORKS IN PLASMA AND 
FIBRINOGEN SOLUTION AND THE EFFECT OF 
ANTICOAGULANTS AND HANDLING PROCEDURES 
8.1 INTRODUCTION 
8.2 MATERIALS AND METHODS 
136 
136 
136 8.2.1 Preparation of plasma clots 
8.2.1.1 
8.2.1.2 
8.2.1.3 
8.2.1.4 
8.2.1.5 
8.2.1.6 
8.2.1.7 
8.2.1.8 
Blood donors 137 
Plasma 137 
pH measurements 137 
Buffered citrate 138 
Fibrin networks in plasma 138 
Perfusion of networks in 
plasma 138 
Networks in fibrinogen 
solution 139 
Electron microscopy 139 
8.2.2 Networks in serum 139 
8.2.3 Effect of anticoagulant and 
recalcification 140 
8. 2. 3. 1 Effect of citrate 
8.2.4 Effect of anticoagulants, 
temperature and platelet 
release products 
i X • 
pa ge 
1 41 
141 
8. 2. 4. 1 Effect of citrate-
theophylline-PGE 1 
solution 141 
8.2.4.2 Effect of citrate-
phosphate-dextrose 
solution 142 
8.2.4.3 Effect of platelet 
release products 142 
8.3 RESULTS 
8. 3. 1 
142 
Networks formed in plasma and 
8. 3. 2 
8.3.3 
purified solutions 142 
Networks formed in serum 143 
Effect of anticoagulant and 
8. 3. 4 
recalcification 144 
Effect of anticoagulants, 
temperature and platelet release 
products 145 
8.4 DISCUSSION 
8. 5 CONCLUSIONS 
CHAPTER 9 - EFFECT OF OPERATION ON FIBRIN NETWORK 
S TR UCT URE 
9. 1 INTRODUCTION 
9.2 MATERIALS AND METHODS 
9.3 RESULTS 
9.4 DISCUSSION 
9.5 CONCLUSIONS 
CHAPTER 10 - GENERAL DISCUSSION AND CONCLUSIONS 
10.1 GENERAL DISCUSSION 
10.2 CONCLUSIONS 
PERSONNEL PUBLICATIONS 
REFERENCES 
147 
150 
162 
1 62 
163 
165 
167 
172 
1 84 
1 87 
189 
APPENDICIES 
APPENDIX 1 
APPENDIX 2 
APPENDIX 3 
APPENDIX 4 
APPENDIX 5 
APPENDIX 6 
X • 
nage 
REFRACTIVE INDEX MEASUREMENTS 204 
MEASUREMENT OF µTUSING TURBIDITY AT 
608 nm AND TURB!DITIES AT A RANGE OF 
WAVELENGTHS 206 
FLOW RATE AND PERFUSION PRESSURE 210 
FACTOR XIIIa MEDIATED CROSS-LINKING 213 
A MATHEMATICAL TREATMENT OF THE EFFECT 
OF POLYDISPERSION IN FIBRE DIAMETER ON 
Pp AND PT 215 
TABULATED DATA OF THE EFFECTS OF CHANGES 
IN CLOTTING CONDITIONS AND THE EFFECTS 
OF VARIOUS SUBSTANCES ON FIBRIN NETWORK 
STRUCTURE AND PROPERTIES 220 
2. 1 
3. 1 
3.2 
3.3 
3.4 
4. 1 
4.2 
4. 3 
5. 1 
5.2 
5.3 
5.4 
5.5 
5.6 
5.7 
6 • 1 
6.2 
6.3 
LIST OF FIGURES 
The apparatus used for perfusing fibrin 
networks 
The change in Darcy constant with ionic 
strength in networks made with different 
batches of fibrinogen and thrombin 
A typical time rate change in the volume of 
fluid perfused through a fibrin network 
Transmission electron micrographs of two 
fibrin networks of different PT 
Scanning electron micrographs of two 
fibrin networks of different PT 
Correlation between Pp and PT 
where pH is varied 
Distribution of fibre diameter in 
a typical fine fibrin network 
Transmission electron micrographs 
of perfused and unperfused fibrin 
networks 
A plot of network protein concentration 
against clot permeability 
A plot of compaction against Pp 
The relationship between opacity 
ratio measured at 30 minutes and 
at 60 minutes 
A plot of opacity ratio against PT 
A plot of bOD/sec against lag time 
A plot of bOD/sec against Pp 
A plot of Darcy constant against lag 
time 
Effect of thrombin concentration on 
lag time and b0D/sec 
Effect of thrombin concentration on 
µT and Pp and network compaction 
Effect of fibrinogen concentration on 
lag time and 60D/sec 
Xi. 
38 
55 
56 
57 
58 
67 
68 
69 
77 
78 
79 
80 
81 
82 
83 
100 
101 
102 
I 
6.4 Effect of fibrino gen concentration on 
Pr and opacity ratio 
6.5 Effect of fibrinogen concentration on 
µp and network compaction 
6.6 Effect of temperature on lag time and 
-600/sec 
6.7 Effect of temperature on PT and Pp 
6.8 Effect of ionic strength on lag time 
and -600/sec 
6.9 Effect of ionic strength on µT and Pp 
6.10 Effect of pH on µT and µp 
6.11 Effect of ca++ and Mg++ on opacity 
ratio and compaction 
7.1 Effect of glucose on PT and Pp 
7.2 The relationship between Pp of networks 
made with glucose and with NaCl of the 
same osmolarity 
7.3 Effect of protamine sulphate on µT and Pp 
7.4 Effect of heparin on µT and µp (I) 
7.5 Effect of heparin on PT and µP (II) 
7.6 Effect of heparin on network protein 
concentration 
7.7 The relation between fibrinogen 
concentration and PT in the presence 
of heparin and protamine sulphate 
7.8 The effect of heparan sulphate on 
opacity ratio and permeation 
7.9 The effect of chondroitin-4-sulphate 
on µT and µP 
7.10 The effect of chondroitin-6-sulphate 
on µT and µP 
8.1 Transmission electron micrographs of 
fibrin networks formed in plasma 
and in purified fibrinogen solutions 
xi i . 
.ea ge 
103 
104 
105 
106 
107 
108 
109 
11 0 
124 
125 
126 
127 
128 
129 
130 
1 3 1 
132 
133 
153 
8.2 
8.3 
8.4 
8.5 
8.6 
8.7 
Scanning electron micrographs of 
fibrin networks formed in plasma and 
in purified fibrinogen solutions 
The µT and µ0 of networks in PFP 
and reconstituted sera 
The effect of anticoagulant and 
recalcification on opacity ratio 
and compaction 
The effect of citrate on PT and µP 
The effect of anticoagulants and 
temperature on opacity ratio and 
compaction 
The effect of CTP constituents on 
opactiy ratio and permeability 
8.8 The effect of 100 ug/ml of PF4, 
pTG and yTG on µT and µP 
9.1 The changes in compaction and fibrinogen 
concentration following surgery 
9.2 The changes in PT and opacity ratio 
following surgery 
A2.1 The wavelength dependence of the 
turbidity of different networks 
A2.2 Mass-length ratio from turbidity at 
608 nm and from turbidities at a range 
of wavelengths 
A3. 1 The relationship between flow rate and 
perfusion pressure in plasma and purified 
fibrin clots 
A4.1 The polyacrylamide gel electrophoresis 
pattern of crosslinked and non-cross-
linked fibrin 
xiii. 
154 
155 
156 
157 
158 
159 
160 
169 
170 
208 
209 
212 
213 
3. 1 
6. 1 
7. 1 
7.2 
8 . 1 
8.2 
9 . 1 
LIST OF TABLES 
The coefficient of variation of various 
techniques 
The effect of common ions found in plasma 
on compaction and opacity ratio 
The effect of glucose on Darcy constant 
and network protein concentration at 
1.8 U/ml thrombin 
The effect of glucose on network protein 
concentration at 0.15 U/ml thrombin 
Comparison of PT, µ and compaction of 
networks formed in B1asma and in purified 
fibrinogen solution 
The effect of CPD at different pHs on 
opacity ratio, permeability, compaction 
and network protein concentration 
The linear correlations between sets of 
data expressed as correlation coefficient 
and level of significance 
Xi V. 
54 
99 
122 
123 
151 
152 
168 
0 
A 
PTG 
YTG 
CPD 
CTP 
DSK 
FOP 
LiOD/sec 
PGE 1 
PPP 
sos 
SPPS 
Tris 
ABBREVIATIONS 
Angstrom 
Beta-thromboglobulin 
Gamma-thromboglobulin 
Citrate-phosphate-dextrose 
Citrate-theophylline-PGE 1 
Disulphide knot 
Fibrin(ogen) degradation product 
Rate of turbidity increase per second 
Wavelength 
Platelet factor 4 
Platelet free plasma 
Prostaglandin E1 
Platelet poor plasma 
Sodium lauryl sulphate 
Stable plasma protein solution 
Tris (hydroxymethyl) aminomethane 
Mass-length ratio from turbidity 
Mass-length ratio from permeability 
xv . 
CHAPTER 1 
I 
GENERAL INTRODUCTION 
2. 
1.1 FIBRINOGEN 
Coagulation factor I or fibrinogen accounts for 
approximately 5% of the total plasma proteins. It is an 
inactive form of a reactive protein. When fibrinogen is 
activated, it forms fibrin monomers. These react with each 
other in a highly organized fashion to form a three 
dimensional network of fibres. 
The structure of the fibrin network depends critically 
upon the fibrinogen molecule and much is known about the 
molecular structure of fibrinogen (reviews: Mosesson and 
Finlayson, 1976; Doolittle, 1977; 1980). 
1 . 1 . 1 Molecular characteristics 
Fibrinogen is a glycoprotein of molecular weight 
. 
340,000 dal tons (McDonagh et al., 1972). It is a dimeric 
molecule composed of three chain pairs termed Aa, Bp and y 
of molecular weights, 64,000, 56,000, and 48,000 daltons, 
respectively (McDonagh et al., 1972). These chains are 
linked together by 29 disulfide bonds formed from 58 
cysteine amino acids in each fibrinogen molecule (Henschen, 
1964). The location of these disulfide linkages and the 
complete amino acid sequences of all the chains are known 
(Doolittle, 1980). 
Carbohydrate moieties are attached to the penultimate 
amino acid of the BP chain, that is, asparigine , and to an 
3 . 
unknown site on the y chain (Topfer-Petersen et al., 1979). 
There are 23 residues of hexose, 20 residues of hexosamine 
and 6-7 sialic acid residues per human fibrinogen molecule 
( Moses son et al., 1967). These moieties are important 
since removal of sialic acid by neuramidinase alters the 
clottability of fibrinogen and the properties of the 
resultant clot ( Chandrasekhar et al., 1962). 
1 • 1 • 2 Primary structure 
The primary structure of fibrinogen has been examined 
by cleaving human fibrinogen using cyanogen bromide into 
five disulfide containing fragments (Murano, 1978). These 
fragments, termed disulfide knots (DSK), form three groups 
according to their properties: 
Ci) N-DSK - a hydrophilic dimeric structure 
. 
consisting of the amino terminal portions of all 
three chains. It is partially "hidden" in the 
intact fibrinogen structure and is contained 
within the plasmin derived fragment E. 
(ii) Hi2-DSK - a hydrophilic single chain derived from 
C-terminal penultimate portion of Aa chain. It 
contains unusually high proportions of threonine, 
serine, glycine and proline and it seems to 
contain surface orientated hydrated structures. 
(iii) H01-DSK; H02-DSK; H03-DSK - are hydrophobic 
' ' I 
'I 
1 • 1 • 3 
4. 
structures respectively derived from: (a) al 1 
three chains, (b) the C-terminal penultimate 
portion of the B~ chain and (c) the C-terminal 
penultimate portion of the ychain. These 
structures are buried within the protein and are 
contained within the plasmin derived fragment D. 
Tertiary structure 
Many models of the tertiary structure of fibrinogen 
have been proposed (review: Lederer, 1979) varying 
according to the techniques used for analysis and on 
whether the fibrinogen examined was dehydrated or in 
solution. Studies on dehydrated preparations using 
electron microscopic examination of shadow cast, negative 
stained or freeze etched fibrinogen samples tend to support 
a "tri-nodular" model first proposed by Hall and Slayter 
(1959). This mod~l depicts the fibrinogen molecule as 450 
0 
A long with three globular domains; the end ones or D 
0 
domain, being approximately 65A in diameter whereas the 
0 
central one or E domain, is 50A in diameter. Models based 
on light scattering studies of fibrinogen in solution, on 
the other hand, support straight or bent swollen 
0 0 
cylindrical shapes of 90A thickness and 450A length 
(Lederer and Hammel, 1975; Bachmann et al., 1975; Marguerie 
and Struhruman, 1976; Lederer, 1979). 
Since hydrodynamic data portrays fibrinogen as a highly 
hydrated protein containing 4 - 6g H20/g protein compared 
q 
5 . 
with 0.4g H20/g protein estimated for most globular 
proteins (Lederer and Hammel, 1975), the value of studying 
dehydrated samples is questionable. 
1.2 FIBRIN FORMATION 
At least three distinct steps may be identified in the 
process of fibrin formation: 
Ci) The production of monomeric fibrin by proteolytic 
activation of fibrinogen. Under physiological 
conditions this reaction is normally catalysed by 
thrombin (review: Doolittle, 1980). 
(ii) The polymerization of monomeric fibrin by self-
assembly. Monomers first associate end-to-end to 
form long protofibrils, two molecules in diameter 
and then these protofibrils associate laterally to 
form fibrin fibres (review: Hermans and McDonagh, 
1982). 
(iii) The covalent crosslinking of fibrin monomers 
results in a massive proteinaceous structure. 
This reaction is catalysed by the thrombin 
activated enzyme factor XIIIa (review: Folk and 
Finlayson, 1977). 
~-
6. 
1 . 2 . 1 Thrombin and fibrin formation 
Thrombin concentration increases explosively when 
the coagulation cascade is activated (Mann and Downing, 
1976). Thrombin, a serine protease, then specifically 
cleaves the arginyl-glycine bond on the 16-17 position of 
the Aa chain and then a similar bond at the 14-15 position 
on the B~ chain of fibrinogen (Blomback and Blomback, 1972; 
Doolittle, 1973). The peptides released are negatively 
charged and they are termed fibrinopeptides A and B. Their 
molecular weights are 1536 and 1552, respectively (Blomback 
et al., 1966). This thrombin mediated removal of the 
fibrinopeptides converts the fibrinogen molecule into 
fibrin monomer. 
Thrombin cleaves fibrinopeptide A about five times 
faster than fibrinopeptide B (Martinelli and Scheraga, 
1980); the second A peptide is cleaved approximately 40 
fold faster than the first (Landis and Waugh , 1975). An 
increase in ionic strength decreases the rate of 
fib r i nope pt id e release (Blomback, 1958). Unlike 
fibrinopeptide A, fibrinopeptide Bis released fastest when 
the monomer is bound to the network (Blomback et al., 
1978). 
1 . 2. 2 Fibrin formation in the absence of thrombin 
Fibrin can form due to the action of various snake 
venom enzymes such as reptilase (Blomback, 1958; Laurent 
'I 
7. 
and Blomback, 1958), ancrod (Pizzo et al., 1972) and a 
fraction from the southern copperhead (Henzig et al., 
1 970), amongst others ( Bilezikian et al., 1975). These 
thrombin-like enzymes cleave one or both fibrinopeptides. 
These proteases have proved useful in examining fibrinogen 
to fibrin conversion, showing, for example, that fibrin 
will polymerize even if fibrinopeptide Bis not removed and 
that if fibrinopeptide Bis removed before fibrinopeptide 
A, then a network will not form until an appreciable amount 
of fibrinopeptide A has been removed (Henzig et al., 1970; 
Bilezikian et al., 1975). 
Studies with thrombin-like proteases suggest that the 
removal of specific fibrinopeptides is critical for normal 
fibrin formation. However, a "fibrin" network may also 
form if peptides which are different to those cleaved off 
by thrombin are removed. An aortic wall extract termed 
vasculokinase (Murray and Gray, 1964) and staphylocoagulase 
a product of certain strains of staphylococci (King et al., 
1975), coagulates fibrinogen solutions by cleaving peptide 
bonds different to those cleaved by thrombin. Consequently, 
such fibrin is of different character when compared with 
that formed through the action of thrombin. 
1 . 2. 3 Polymerization 
It is widely held that the first fibrin monomers formed 
by the action of thrombin bind not to themselves but to 
fibrinogen (Brass et al., 1976). Fibrinogen appears to mop 
8 . 
up free fibrin monomers and thus act like a buffer. The 
number of fibrinogen molecules required to solubilize one 
fibrin monomer varies with the experimental conditions 
(Land is and Waugh, 1975; Sherman, 1977). The continued 
action of thrombin ultimately converts fibrinogen in the 
fibrinogen-fibrin monomer complexes to free fibrin 
monomers. These monomers then self-assemble in a highly 
ordered fashion. 
Recently the polymerization process has been 
extensively researched (review: Hermans and McDonagh, 
1982). Studies suggest at least three different kinds of 
contacts when fibrin is formed. Two of these, the DE-stag 
and DD-long contacts, hold the fibrin monomers together in 
protofibrils. The DE-stag contact represents the contact 
between a D-domain and an E-domain of neighbouring monomers 
in the protofibril. (The E-domain corresponds, roughly, to 
fibrinolytic fragment E and the cyanogen bromide fragment 
N-DSK while the D-domain corresponds to fibrinolytic 
fragment D - see 1.1.2, 1. 1.3). The DD-long contact is 
formed between two adjacent D-domains associated end-to-
end. Relatively little is known about the third kind of 
contact which is the contact responsible for lateral 
association of protofibrils to fibres. 
The polymerization process first involves the formation 
of protofibrils. Th ey are formed from fibrinogen molecules 
activated to monomeric fibrin by the removal of 
fibrinopeptide A; the mono mers self-associate rapidly to 
9 . 
form polymeric strands, two molecules in diameter. The 
pr o to fib r i 1 ha s a he 1 i c a 1 s ym met r y ( He rm an s , 1 9 7 9 ) ; the 
helical axis is approximately a two-fold screw axis 
(Hantgan et al., 1980). This arrangement of monomers 
accounts for the high specific volume of fibrin in fibres; 
fibrin fibrils and fibres contain 80% solvent and 20% 
protein ( Carr and Hermans, 1978). 
As protofibrils grow longer they associate laterally to 
form fibres. The tendency of the protofibrils to associate 
laterally is enhanced by the removal of fibrinopeptide B. 
Indeed, it is likely that thrombin preferentially removes 
fibrinopeptide B from polymerized, rather than monomeric 
fibrin species. During the process of lateral association 
long protofibrils can participate in the formation of two 
fibres simultaneously and this results in fibre 
interconnections and fibre branchpoints. 
1 • 2. 4 Crosslinking 
Before crosslinking the fibrin polymer consists only of 
an ordered arrangement of individual fibrin monomers and it 
may be re-solubilized by using solutions which break 
hydrogen bonds. The stability of fibrin is ensured through 
the introduction of covalent crosslinkages between the 
polymerization sites on neighbouring monomers. 
Crosslinking welds the numerous individual monomers into 
one massive proteinaceous structure. This reaction is 
catalysed by coagulation factor XIII 8 , a transglutaminase 
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activated by thrombin in the presence of ca++. 
Factor XIIIa introduces isopeptide bonds between the 
£ -amino groups of certain lysine residues on one chain and 
the o-carboxyamide groups of certain glutamine residues on 
the neighbouring chain (review: Folk and Finlayson, 1977). 
In this way y chains are dimerized and a chains are 
polymerized. 
Factor XIIIa crosslinks ychains much faster than 
a chains (McDonagh et al., 1972) but the crosslinking of 
the a chains modulates the properties of the clot. 
Relative to non-crosslinked clots, the crosslinked clot is 
mechanically more elastic and less amenable to fibrinolysis 
(McDonagh et al., 1971). 
1.3 FIBRIN NETWORK STRUCTURE AND PROPERTIES 
The structure of the fibrin network determines the 
properties of the clot as a whole. The number and 
thickness of the fibres in the network and the extent of 
factor XIIIa mediated crosslinking generally dictates the 
clot properties. But when certain fibrin fragments are 
incorporated into the growing fibres, the network structure 
becomes abnormal. 
1 • 3. 1 Normal fibrin network structure 
A network of fibrin fibres is a metastable structure as 
'I 
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the composite fibrin fibres tend to associate laterally 
when closely aligned in parallel (Nelb et al., 1976). This 
tendency would lead to a continued increase in the mean 
network fibre thickness if not for the inhibition of 
rotational diffusion of fibres because of their length and 
interpenetration within the network (Hantgan and Hermans, 
1979). 
After the network of fibrin fibres has formed further 
increases in tensile strength may occur. This may result 
from interfibre connections or network branchpoints forming 
between individual fibres (Hantgan and Hermans, 1979) or 
from loosely packed fibres consolidating into densely 
packed fibres (Hantgan et al., 1980). When the network 1s 
fully developed the clot properties do not change. 
Mechanical properties of fibrin network are related to 
the thickness and number of fibres within the network. 
This was first demonstrated by Ferry and Morrison (1947) 
who showed that in their properties, fibrin clots lie 
between two extreme types - elastic, fragile, non-deforming 
and transparent on the one hand and non-elastic, non-
fragile, plastic and opaque on the other. Ferry and 
Morrison termed the former - "fine" clots and the latter 
"coarse" clots and explained the differences in terms of 
the amount of lateral aggregation. When end-to-end 
polymerization predominated, numerous fine fibres formed 
whereas when side-to-side aggregation was extensive, fewer 
but coarser fibres formed. 
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Numerous thin fibres restrict liquid movement more 
efficiently than scarcer larger fibres and consequently, 
fine clots resist mechanical deformation and permeation 
better than coarser clots. The bundling of slender fibres 
into massive cables enhances the tensile strength of the 
fibres and so coarser clots are less fragile and possess 
greater elastic modulus than fine clots (Kamykowski et al., 
1981). The opacity of the clot reflects the thickness of 
the fibres as thicker fibres scatter more light. 
Originally, fine clots were noted to form at high pH or 
ionic strength, while coarse clots formed at lower pH or 
ionic strength (Ferry and Morrison, 1947). Since then many 
factors capable of influencing fibrin network structure 
have become known. These include: temperature (Ferry and 
Morrison, 1947), fibrinogen concentration (Carr et al., 
1977; Rosser et al., 1977), thrombin concentration (Rosser 
et al., 1977; Carr and Hermans, 1978), certain ions, 
especially ca++ (Edsall and Lever, 1951; Abildgaard, 
1964; Bang, 1967), dextran (Dhall and Bryce, 1970; 
Muzaffar, 1974, Carlin et al., 1976; Carr and Gabriel, 
1980), heparin (Sheppard et al., 1956) and protamine 
sulphate (Carlin et al., 1976). The protease used to 
induce clotting also affects fibrin network structure. 
Reptilase yields finer networks (Hantgan and Hermans, 1979) 
and contortrix leads to coarser networks (Furlan et al., 
1976) than thrombin. 
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1 • 3. 2 Abnormal fibrin structure 
The arrangement of fibrin monomers into fibrin strands 
depends on the normal conformation of the composite 
monomers. It is not surprising, therefore, that slow or 
incomplete polymerization is a characteristic of many 
congenital and acquired dysfibrinogenemias (Beck, 1979). 
Fibrin can also be made to display abnormal network 
structure by simply seeding a normally polymerizing 
fibrinogen solution with certain fibrinogen fragments. For 
example, whereas normal fibrin fibres have pointed tapering 
ends, fibrin fibres formed in the presence of plasmin 
derived fibrin degradation products (FDPs - see 1.4) 
display a "frayed rope" appearance (Bang, 1963). Ultra-
structurally, such defective fibrin networks are 
disorganized tangles of heterogeneous fibres and large non-
fibrous aggregates. Clots made in the presence of FDPs are 
slow to form, mechanically weak and easily solubilized by 
plasmin (Hermans and McDonagh, 1982). 
Fibrin(ogen) derivatives inhibit normal polymerization 
by binding to polymerizing fibrin thus preventing 
lengthening and thickening of the fibre (Bang, 1967; 
Hermans and McDonagh, 1982). The early products of plasmin 
digested fibrinogen, such as fragment X, may be clotted by 
thrombin and incorporated into the growing fibre. Further 
normal linkage at these sites is impossible. More extensive 
plasmin digests yield fragment E, a competitive inhibitor 
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of thrombin (Budzynski et al., 1979), and fragments D and 
DD, the most potent inhibitors of fibrin assembly (Dray-
Attali and Larrieu, 1977). The (DD)E complex does not 
exhibit anticoagulant effects (Budzynski et al., 1979). 
1.4 FIBRINOLYSIS 
Fibrin forms a temporary structure in vivo. Its 
removal is accomplished by proteases from leukocytes (Plow 
and Edgington, 1975), by phagocytosis or by the protease, 
plasmin (review: Gaffney, 1978). It 1s believed that 
plasmin mediates the bulk of fibrinolysis in vivo. 
1 . 4. 1 Lysis by plasmin 
Plasmin is formed when its inactive precursor, 
plasminogen, is activated following stimulation of either 
the intrinsic or extrinsic fibrinolytic pathways (Wiman, 
1978). Plasmin cleaves fibrin at specific peptide bonds 
yielding FDPs with unique properties. 
When plasmin is bound to fibrin it cleaves the a, p 
and y chains in an ordered fashion. It is now widely 
accepted that plasmin degrades both fibrinogen and fibrin 
according to an assymmetric scheme first proposed by Marder 
and co-workers (Marder et al., 1969). According to this 
scheme, plasmin systematically prunes the fibrin(ogen) 
molecule to fragment X, then to fragment Y and finally into 
one fragment E and two fragment Ds (review: Mihalyi, 
1 9 80) . 
/' 
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Plasmin first removes a single polypeptide of 
molecular weight 40,000 to 50,000 from the COOH terminal 
end of the chain (Furlan and Beck, 1972; Mills and 
Karpatkin, 1972). Although, the y chain is initially left 
intact, a NH 2 terminal fragment is cleaved off the p 
chain (Takagi and Doolittle, 1975). Fibrinogen degraded to 
this stage is termed fragment X. It is slightly coagulable 
by the action of thrombin as it still possesses fibrino-
peptides A but not B ( Budzynski et al., 1974). Fragment X 
has a molecular weight in the region of 250,000 and it 
occasionally complexes with itself in the absence of 
thrombin (Marder and Shulman, 1969). This characteristic 
is lost after fragment Y is formed. 
When fragment Xis degraded into fragment Y, (molecular 
weight about 155,000) a fragment containing the D domain, 
fragment D, is released. Fragment D, molecular weight 
94,500, is not degraded further and it retains the y-
polymerization site. 
Plasmin cleaves fragment Y into another fragment D and 
fragment E. Fragment E, molecular weight 55,000, contains 
the N-DSK and, like fragment D, it is not degraded further 
by plasmin. 
Fibrinolysis of crosslinked fibrin differs from that of 
non-crosslinked fibrin in that the covalent bonds 
introduced by factor XIIIa continue to link some of the 
fragments. Thus, when crosslinked fibrin is extensively 
I 
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digested by plasmin a double Dor DD dimer species is 
f o rm e d ( G a f fn e y a n d Br asher , 1 9 7 3 ) . Th e D fr a gm en ts a r e 
dimerized since the y- polymerization sites are cross-
linked (Gaffney and Brasher, 1973). The D dimer is 
commonly found to be non-covalently bonded to fragment E 
(Hudry-Clergeon et al., 1974; Gaffney et al., 1975) and 
this DD(E) complex is the predominant species resulting 
from physiological digestion of crosslinked fibrin (Plow 
et al., 1977; Gaffney and Joe, 1979). 
Crosslinking also affects the rate of lysis. 
Crosslinked fibrin is more resistant to lysis than non-
crosslinked fibrin (McDonagh et al., 1971) and this 
resistance to lysis is attributed to the presence of a 
polymers; y-dimers have little influence on lysis (Gaffney 
and Whitaker, 1979). 
1.5 PHYSIOLOGICAL ROLE OF FIBRIN 
Fibrin serves a variety of functions in vivo. It acts 
as a molecular sieve in selectively trapping certain 
substances within its meshwork. The soluble products 
released during fibrin formation and lysis attract 
phagocytic cells and stimulate vascular changes. In 
addition, the fibrin mesh provides a temporary structural 
support over which cells migrate while they grow and lay 
down connective tissue. In these and other ways, fibrin 
participates in the haemostatic mechanism, the inflammatory 
response, the wound repair process as well as in pregnancy 
and malignancy. 
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1 . 5. 1 Fibrinopeptides and FDPs 
As has been already reviewed, activation of fibrinogen 
results in the release of fibrinopeptides concommitant with 
fibrin formation. It appears that the fibrinopeptides 
regulate and co-ordinate the inflammatory response. 
Fibrinopeptide Bis chemotactic for neutrophils and 
monocytes (Kay et al., 1974). The fibrinopeptides are 
vasoconstr ic ti ve ( Colman et al., 1967; Osbahr, 1975) and 
potentiate bradykinin induced smooth muscle contraction 
( Osbahr et al., 1964; Blomback et al., 1969). 
During the early stages in wound repair, fibrin is 
lysed into FPDs which affect haemostasis. It is known that 
FDPs inhibit coagulation by interfering with platelet 
aggregation (Larrieu, 1981) and normal fibrin poly-
merization (Bang, 1963; 1967). FDPs affect the 
inflammatory response by enhancing the permeability of 
capillaries (Malofiejew, 1971; Barhart et al., 1971) and by 
attracting leukocytes (Stecher and Sorkin, 1972; Richardson 
et al., 1976). FDPs also modulate the vasoactive effects 
of bradykinin, oxytocin, histamine, epinephrine and 
serotonin (Malofiejew, 1971). Furtermore, at least in the 
rat, FDPs potentiate the hypotensive effects of bradykinin 
and the hypertensive effect of angiotensin (Malofiejew, 
1 971 ) . 
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1 • 5. 2 Physiological roles of fibrin 
Characteristically fibrin normally forms only at sites 
of trauma or in regions of cell migration and tissue 
remodelling. This is not surprising because fibrin is a 
structural protein which is relatively rapidly formed and 
resolubilized. Consequently, fibrin serves vital roles in 
haemostasis, inflammation ( Riddle and Bar hart, 1964; 
Charkabarti, 1978), pregnancy (Bonnar, 1978) and in 
malignancy (reviews: Donati and Poggi, 1980; Edgington, 
1980). 
The participation of fibrin in haemostasis is well 
known. Morphologically, fibrin appears to reinforce and 
consolidate the platelet aggregates in the haemostatic plug 
(Wester et al., 1978). In both haemostatic plugs (Sixma 
and Wester, 1977) and thrombi (Gottlob, 1975 ; Hattori 
et al . , 1978; Hisano, 1978) fibrin fibres found associated 
with platelet aggregation are much thicker than those found 
ensnaring erythrocytes. 
Fibrin and platelets interact intimately during 
haemostasis. The plasmatic atmosphere of platelets 1s the 
focus of thrombin production (Walsh, 1977) and fibrin forms 
first on the surface of aggregating platelets (Hattori et 
al . , 1978). Fibrinogen is essential for platelet 
a g g r e g a t i o n ( C a e n e t a 1 . , 1 9 7 7 ) a n d i n d e e d , po 1 ym e r i z i n g 
fibrin aggregates platelets (Niewiarowski et al., 1977). 
Platelets retract and compact the fibrin network when it 
jl 
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has formed and the internal resistance of the fibrin 
network to deformation strongly influences platelet 
mediated clot retraction ( Cohen et al., 1975). 
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Fibrin can also form 1n the absence of platelets 
following an increase in the permeability of blood vessel 
walls and this is seen in inflammation. The inflammatory 
response allows the escape of large molecules including 
fibrinogen into the extracellular fluid. Coagulation of 
oedema fluid results in an extravascular fibrin network 
(Walter and Israel, 1974). 
The mechanism of fibrin formation in the extravascular 
space has not been extensively examined. Coagulation may 
be initiated following release of tissue activator and 
subsequent activation of the extrinsic section of the 
coagulation cascade. Indeed, in delayed type hyper-
sensitivity, macrophages release tissue activator-like 
procoagulant (as do some tumour cell lines - review: 
Donati and Poggi, 1980) which results in an extravascular 
fibrin mesh which temporarily imprisons the macrophage 
(Hopper et al., 1981). 
Fibrin is often found associated with rapidly growing 
tissue. It is deposited at the invading periphery of 
malignant neoplasms (review: Donati and Poggi, 1980; 
Edgington, 1980) and is a prominent feature of the utero-
placental vasculature (Bonnar, 197 8 ). In these areas there 
is both rapid fibrin deposition and lysis. 
I' 
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Fibrin is generally thought to facilitate response to 
injury in a number of ways. In the initial stages, fibrin 
assists by forming a union between severed tissues (Walter 
and Israel, 1974) and this limits the exudative process 
and provides a haemostatic barrier (Astrup, 1968). This 
fibrin mesh also acts as a barrier to bacterial invasion 
and probably facilitates phagocytosis of organisms by the 
invading leukocytes (Walter and Israel, 1974). Likewise, 
the fibrin mesh which surrounds certain malignant tumours 
has been suggested to provide a protective barrier against 
cellular attack by activated macrophages and various types 
of cytolytic cells involved in the cellular immune response 
(Dvorak et al., 1979). 
In addition to providing a barrier which defines and 
localizes the injured or rapidly growing region, fibrin 
also stimulates and supports the growth of certain tissues. 
Fibroblasts (Nozawa, 1977; Pohl and Christophers, 1979) and 
neutrophils (Riddle and Barnhart, 1964), are among the 
first cells which migrate or grow into the fibrin rich 
region, and these cells alter morphology when they come 
into contact with fibrin in cell culture; they adhere to 
and grow along the fibrin fibres. The growth of 
fibroblasts (Pohl et al., 1979), as well as certain tumours 
(O'Meara, 1968), is also stimulated by fibrin. In fact, 
fibrin has been suggested to provide a source of amino 
acids for tumour cell growth (Zanker et al., 1980). 
Similarly, fibrin network is thought to stimulate 
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(Florey, 1970) and structurally support (Banerjee and 
Glynn, 1960; Astrup, 1968) the ingrowth of capillary buds. 
Bonnar (1978) suggests that fibrin maintains the integrity 
of the maternal and foetal circulations by temporarily 
supporting the rapidly growing vessels in the placenta 
deprived of their musculo-elastic content. In malignancy 
the fibrin meshwork is thought to facilitate 
vascularization and hence, rapid growth of tumours 
(O'Meara, 1968). 
Fibrin is steadily formed and lysed in the plasmatic 
zone 1n close proximity to the blood vessel wall (Copley, 
1979). Endothelial fibrin lining is critical to the 
development of atheroma according to two recently 
postulated theories of atherogenesis (Copley, 1979; 
Kandish, 1979). 
A bleeding tendency or defective wound healing is 
associated with congenital dysfibrinogenemias which is 
associated with abnormal fibrin structure and abnormal 
thromboelastic patterns (Crum, 1977). It seems possible 
that the network structure of fibrin is critical to normal 
function in haemostasis, inflammation, wound healing and 
pregnancy. 
Pure fibrin networ ks apparently do not form in vivo. 
It has been c a lcul a ted that the mass of an average plasma 
clot is about 95 % fibrin, 4% fibronectin and 1% a 2 -
antiplasmin ( Mosher, 19 80). Fibronectin, a physiolog ically 
--
22. 
important glycoprotein involved in events such as cell 
attachment and growth (Mosher, 1980), is crossl inked to the 
a chain of fibrin by factor XIIIa (Mosher, 1975; 1976). 
a 2 -antiplasmin is also crosslinked to the a chain of 
fibrin by factor XI-IIa (Sakata and Aoki, 1980). It is 
the most potent physiological inhibitor of plasmin (Wiman 
and Collen, 1978). These network constituents are thought 
to influence inflammation and wound healing (Hermans and 
McDonagh, 1982). 
Haemostasis, inflammation and wound healing may also be 
affected by components adsorbed onto fibrin fibres, for 
example, plasmin(ogen) and tissue plasminogen activator 
(Hisano, 1978). In fact, the rate and extent of plasmin 
degradation in vivo is controlled, at least partly, by both 
non-covalent and covalent interactions of the fibrinolytic 
components with fibrin (Hermans and McDonagh, 1982). 
Fibrin acts as an effective antithrombin as it strongly 
adsorbs free thrombin (Liu et al., 1979). Many other 
plasma proteins such as the immunoglobulins, IgG, IgA and 
I g M, are also trapped within fibrin clots (Regeoczi, 1968). 
Thus, it appears that fibrin gels behave like the gels used 
in affinity chromatography and this behaviour probably also 
influences the physiological function of fibrin. 
As an overview it may be seen that fibrin plays 
important roles in a number of reparative mechanisms in 
vivo and that the function of fibrin in these various roles 
may be dependent on its structure. 
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1.6 PROBLEMS FOR STUDY 
It is apparent that fibrin 1s important in a variety of 
ways in several reparative and pathological processes. 
However, a great deal of research in fibrin formation has 
concentrated on kinetics of fibrin polymerization. Fibrin 
network has not received much attention other than in some 
early studies which showed that fibrin fibre thickness 
within networks may be varied by manipulating conditions of 
clotting in vitro. These early studies were undertaken in 
a pharmacological context and whether fibrin networks 
formed under physiological conditions are open to 
modification by subtle changes in clotting conditions 
remains unexamined . To a great extent research in this 
area has remained hampered by the lack of suitable methods 
for examining fibrin networks . However, more recently a 
number of techniques have become available. These 
techniques are based on one of a number of known 
characteristics of fibrin networks. Thus, the permeability 
method (Carr et al., 1977) relies on perfusion 
characteristics or pore size (Blomback and Okado, 1982b) of 
the network; the turbidity method relies on differential 
light scattering properties by fibres of different 
thicknesses (Carr and Hermans, 1978). 
Detailed quantification in a network requires that for 
a given network information should be available not only on 
the mean pore size, fibre thickness, and fibre density but 
also some idea should be obtained of the range of fibrin 
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diameters and pore sizes, the degree of partial 
transformation of fibrinogen to fibrin as well as the 
tensile behaviour of the network. Early studies by Ferry 
and Morrison (1947) attempted to relate all the various 
characteristics of networks to fibre thickness. However, 
since these early studies the introduction of new 
techniques theoretically allows a re-examination of several 
aspects of the physiology of fibrin network. This is the 
major concern of the studies described in this thesis which 
examines problems in three main areas: 
1 • 6. 1 Methodological problems 
Several methods for measuring network characteristics 
have been introduced in recent years. The methods are 
based on widely different theoretical considerations. A 
detailed comparison of methods is lacking. This requires 
to be undertaken to highlight not only reproducibility of 
the various techniques but also to establish relationships 
between the various properties within a single network 
e.g., fibre thickness and porosity. In addition, a 
detailed examination is needed to establish the 
relationship between the various methods, based as they are 
on distinct characteristics of the network. 
Many of the recently introduced techniques purport to 
measure a single value of mass-length ratio (which is 
proportional to fibre thickness). These methods are all 
based on the assumption that the fibre thickness in fibrin 
,1 
networks has a uniform and homogeneous size. This 
fundamental assumption needs a full and thorough 
investigation. 
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In early studies (Ferry and Morrison, 1947; Dhall and 
Bryce, 1970; Dhall et al., 1976), semi-quantitative methods 
such as opacity ratio and compaction were used to 
characterize fibrin networks. The methods are based on 
theoretical reasoning but experimental verification for 
these techniques is lacking and needs examination. 
1 • 6. 2 Problems in the regulation of fibrin network 
In the past, experimental studies on the structure and 
properties of fibrin networks have been primarily 
undertaken to examine the kinetics of fibrin 
polymerization. These studies have demonstrated that fibrin 
networks are sensitive to extreme changes in clotting 
conditions but it is not known whether networks are 
similarly sensitive to changes in clotting conditions 
within the patho-physiological range. Nor is it known 
whether structural changes are influenced by factor XIIIa 
mediated crosslinking. These areas need examination. 
It has been shown by Ferry and Morrison in 1947 that 
fibrin network properties may be modified by several 
substances. Since then isolated studies have shown that 
defective polymerization leads to a network which is 
ineffective for haemostasis. However, systematic studies 
26. 
on whether fibrin networks are affected by the presence of 
substances used clinically or encountered within the blood 
are lacking. Not only should this area be examined fully 
but mechanisms which underlie any modification should be 
examined, hopefully to provide further therapeutic 
approaches to the management of problems in haemostasis and 
thrombosis. 
1 . 6. 3 Problems of studying fibrin networks in a 
clinical context 
Several methods have been used in the past to examine 
networks formed in fibrinogen solutions in vitro but their 
applicability to sequential study of networks formed in 
plasma in a clinical setting is unclear. When plasma is 
examined it is normally anticoagulated. As a first step, 
the effect of various anticoagulants on fibrin network 
needs examination. Networks in plasma contain several 
substances in addition to those formed from purified 
fibrinogen, for example, fibronectin, a 2-antiplasmin and 
plasminogen. It is not known whether fibrin networks formed 
in plasma are different from those formed from purified 
fibrinogen at the same concentration of the latter. This 
area requires elucidation. 
Abnormal structure and properties of fibrin networks in 
plasma have long been a clinical problem encountered in a 
variety of coagulopathies. However, to date comparative 
studies on fibrin network structure and properties have not 
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been reported in these pathological situations. This 
stems, in part, from a lack of sensitive and suitable 
methods. There is a real need at a clinical level for 
methods which would allow sequential studies on fibrin 
network. The available techniques need to be evaluated at 
this level and gauged for their suitability. Once methods 
have been shown to be applicable to clinical studies a 
variety of clinical and physiological situations need 
examination to establish the role of fibrin network in 
health and disease. 
CHAPTER 2 
MATERIALS AND METHODS 
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General methods used throughout this thesis and 
described in this Chapter. Special methods and techniques 
are described in appropriate chapters. 
2. 1 MATERIALS 
2. 1 . 1 General 
Disposable plastic test tubes were used wherever 
possible. All glassware was cleaned by soaking in Pyroneg 
solution (Diversey, Sydney), then scouring with a bristle 
brush, followed by extensive tap water rinsing and at least 
two rinses with distilled water. Glassware was then oven 
dried at about 80°C. When glass was used (e.g., pasteur 
pipettes), it was pretreated with siliconizing solution 
(Siliclad, Clay Adams, U.S.A). 
2. 1 . 2 Fibrinogen 
4gm of human fibrinogen (Kabi, grade L, Stockholm) was 
dissolved in 120ml of 0.895% NaCl and dialysed at 4°c 
against 4 litres of 0.895% NaCl for 20 hours (3 changes). 
Following dialysis, fibrinogen solutions were centrifuged 
for 1 hour at 50,000g at 4°c to clarify them. 0.5ml 
aliquots of the supernatant were kept frozen in plastic 
tubes at -20°c for periods less than two weeks and at -
77°c for longer periods. Fibrinogen concentration was 
measured using the assay of Ratnoff and Menzie (1951). 
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2. 1 . 3 Radiolabelled fibrinogen 
0.8mg fibrinogen labelled with 1251 (Amersham, U.K.) 
(approximately 110uCi) was dissolved in 500~1 distilled 
water. Duplicate 10µ1 samples were counted for 3 minutes 
in a 1280 Ultragamma counter (LKB, Wallac). 
2. 1 . 4 Thrombin 
Bovine thrombin (Parke, Davis and Co., Detroit) was 
dissolved in distilled water to a concentration of 150U/ml 
and 0.3ml aliquots were kept frozen in plastic tubes at 
-20°c for less than two weeks or at -77°C for longer 
periods. 
2. 1 . 5 Tris-saline buffer 
50mM Tris-HCl buffered saline (pH 7.35 and ionic 
strength 0.153) was used throughout the experiments to wash 
or perfuse clots. 
2. 1 . 6 Other reagents 
Except where otherwise stated, all other chemical 
reagents were of analytical reagent grade and obtained from 
B.D.H. (Melbourne) or Sigma (St. Louis, U.S.A.). Distilled 
water was used throu ghout for makin g solutions. 
'I 
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2.2 METHODS 
Throughout studies in this thesis special care was 
taken to form clots under conditions which mimicked those 
in plasma. Fibrinogen concentration was usually 3.3 mg/ml, 
the mean plasma concentration in health (Diem and Leutner, 
1970). The final thrombin concentration was usually 0.15 
U/ml, which is the concentration of thrombin present at the 
moment clotting of freshly drawn native blood (Shuman and 
Majerus, 1976). 
2. 2. 1 Fibrin networks 
Fibrin networks were formed by adding thrombin to 
fibrinogen dissolved in 50mM Tris-HCl-saline. Preliminary 
experiments showed that 50mM Tris-HCl could buffer 
fibrinogen solutions adequately without influencing the 
opacity ratio. Fibrinogen solutions also contained either 
1.20mM CaC1 2 and 0.82mM MgC1 2 or 2.02mM MgC1 2 or 
neither divalent cation. Unless otherwise stated, NaCl was 
added to adjust the ionic strength to 0.153. The pH of the 
fibrinogen solution was 7.35. 
Ionic strengths were adjusted with NaCl and calculated 
on basis of the molarity of electrolytes. Activity 
coefficients, degree of calcium binding to protein and 
contributions of added macromolecular substances were not 
taken into account. 
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Clotting was initiated at room temperature by mixing 
40pl of thrombin in 960pl of fibrinogen solution. 
Solutions were left to clot for 30 minutes before being 
examined. Thrombin and fibrinogen solutions were used 
within 30 minutes of thawing. Throughout experiments 
thrombin was kept on ice. 
2.2.2 Turbidimetric studies 
Clots were formed in 1ml quartz cuvettes of 1cm 
pathlength. Clots were examined in a Unicam SP1800 
spectrophotometer using unclotted fibrinogen solution as a 
reference. 
2.2.2.1 Fibrin network development 
The development of fibrin network was followed using a 
method adapted from Hantgan and Hermans (1979). The 
increase in optical density at 350nm due to network 
development was recorded with a Unicam AR25 linear recorder 
coupled to the spectrophotometer. A tangent was drawn 
through the 0.25 absorbance unit point on the absorbance 
tracing and extrapolated to O intensity. The slope of this 
line defined the rate of turbidity increase (~OD/sec). The 
distance from the origin to the intercept of this line and 
0 intensity defined the lag time. The lag time is the 
period when fibrin is being formed prior to fibre growth. 
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2.2.2.2 Opacity ratio 
The opacity ratio of fibrin networks has been used as a 
measure of the thickness of fibres in a network (Ferry and 
Morrison, 1947; Dhall and Bryce, 1970; Muzaffar et al., 
1972; Dhall et al., 1976). This is based on the following 
theoretical considerations (Dhall and Bryce, 1970): 
The Rayliegh-Gans equation relates turbidity with size 
of suspended spherical particles according to the following 
equation: 
x10-2 • • • 1 
where T 1s turbidity, C is concentration of particles, K is 
rrD/A, D 1s the diameter of particles, Ais the wavelength 
of incident light, d 12 the density of suspension with 
additives, d 2 is the density of suspension without 
additives, mis n 1/n 0 where n 1 is the refractive 
index of fibrin and n0 that of the medium. 
For a given solution, d 12 , d2 , n 1 and n0 , like rr 
and 10-2 , can be regarded as constants (Muzaffar et al., 
1972) and so the equation may be simplified to: 
T o3 
-= K-4 C A 
For turbidities T1 and T2 of the same suspension at 
two different wavelengths A1 and A2 , the equation may 
be written as: 
•.. 2 
... 3 
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If the size of particles is small as compared with the 
wavelength of incident light, then the ratio of 
turbidities, the opacity ratio, may be predicted from the 
known wavelengths. For A1 = 608nm and A2 = 350nm the 
theoretical turbidity ratio of a solution containing 
particles smaller than the wavelength of incident light 
should be 0.1099. Departures from this ratio depend upon 
different degrees of scattering of transmitted light at the 
two wavelengths by the inhomogeneities. The larger the 
inhomogenieties formed, the larger the opacity ratio. 
It should be noted that opacity ratio has been defined 
in a different way in this thesis to the definition in the 
literature. In this thesis opacity of the fibrin network 
at 608nm was divided by that at 350nm. Thus, that opacity 
ratio is directly related to the size of inhomogeneities in 
the network. In previous studies, (Dhall and Bryce, 1970; 
Muzaffar et al., 1972; Dhall et al., 1976), the opacity 
ratio was defined as the ratio of turbidity of fibrin 
network at 350nm divided by that at 608nm so that opacity 
ratio related inversely to the size of the inhomogeneities. 
2.2.2.3 Mass-length ratio using one wavelength 
The average mass-l ength ratio of fibrin fibres can be 
calculated from measurements of the turbidity at a single 
wavelength. Turbidity (T) is given by the equation (Carr 
and Hermans, 1978): 
T = 44n KcAµ/15 n ... 4 
3 5. 
where c is the concentration of fibrin fibres, A is the 
wavelength, n is the refractive index of the solution andµ 
is the mass length ratio of the fibre in daltons/cm. The 
·con s tan t K i s g iv en by : 
... 5 
where dn/dc is the specific refractive index increment of 
the solute in the solvent and N is Avogadro's number. This 
equation is valid provided the diameter of the fibrin 
fibres is small compared with the wavelength of 
incident light. 
To calculate the average mass-length ratio of fibrin 
fibres from measurements of turbidity at 608 nm (µT) in 
purified fibrin clots, the values of n and dn/dc used were 
1.336 and 1.001, respectively (Appendix 1). Thus, from 
equations 4 and 5: 
1.48 X 10-23 
X 10 2 3 
15.186 xTx 10 12 daltons/cm 
C 
... 6 
... 7 
where c is in mg/ml and where T - 2 . 303 x optical density. 
I 
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To calculate PT in plasma clots different refractive 
indices were used (Appendix 1). 
Except where otherwise stated, PT was preferentially 
calculated from turbidity at 608 nm as it correlated 
linearly with PT from turbidities at a range of wave-
lengths (Appendix 2). 
2.2.2.4 Mass-length ratio from a range of wavelengths 
Hantgan and Hermans (1979) showed that: 
44rrKc>.. 
15Tn ... 8 
and that for cylindrical fibres of radius r, 
r2 
2 ... 9 
where p is the radius of gyration and where equation 8 is 
derived, in part, from equations 4 and 5. Equation 8 may 
be expressed in the linear form Y = A+BX by using equations 
5 and 9 and by neglecting higher order terms: 
_c lssrr3 n(dn/ctc)2J _ 
>..r-r [ ,sn _l s_'! Ii 84 rr2 n2] p + p L ,s4>.. ••• 1 0 
A plot of Cl >,..3T vs 1/ >l can be used to calculate 
mass-length ratio, PT, and the square of fibrin fibre 
radius from the intercept and initial slope, respectively. 
Thus, using values in equation 6 it is found that: 
I 
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daltons/cm • • . 1 1 
r 2 = t/20.9(A/B) 0 A ••• 1 2 
2.2.3 Mass-length ratio from permeability 
This technique is taken from Carr et al. (1977). 
Fibrin networks were formed in pre-etched glass tubes (24 
hours in 1% HF) cut from 2ml pipettes. These tubes were 
approximately 10cm x 0.4cm internal diameter; the 
individual internal dimensions of each tube were accurately 
measured. 
Clots were formed in tubes with one end covered by 
parafilm. Before testing the parafilm was removed, clot 
length recorded with a vernier caliper and a micro-
centrifuge tube fitted to collect perfusate. The tube 
containing the clot was then attached to a horizontally 
mounted 1ml pipette on a retort stand using plastic tubing 
(Figure 2.1). Clots were perfused with Tris-saline. 
The pressure head was increased by 5cm each three 
minutes until a pressure of 15cm of H2o was reached. 
Clots were first perfused for 20 minutes. The transit time 
of an accurately measured volume of perfusate (in the 
region of 0.5ml) was then recorded. 
The first 0.5ml of clot perfusate was collected and 
........... 
Figure 2.1 The apparatus used for perfusing fibrin 
networks 
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radioactivity counted or protein concentration measured. 
In purified fibrinogen solutions, protein concentration was 
determined with a standard curve using the absorbance at 
282nm of 400pl of clot perfusate and 600pl of 40% urea/0.2M 
NaOH. From the initial concentration of fibrinogen was 
subtracted the protein concentration in the perfusate to 
give the network protein concentration. In preliminary 
studies, the network protein concentration determined by 
this method was found to be similar to that calculated from 
centrifuging clots and measuring the protein concentration 
in the supernatant. The network protein concentration 
determined from clot perfusion was used in calculating both 
Pp and PT· Where clots were not perfused, the network 
protein concentration was determined from the protein 
concentration in the supernatant of compacted clots. 
The permeability or the Darcy constant, T, of the fibrin 
clot was calculated from: 
T 
- Q h Tl 
Ftp ••• 1 3 
where Q is the volume flow through the clot in time t; ri is 
the viscosity of the perfusion fluid; his the length of 
the clot; Fits cross-section and p the applied pressure. 
By assuming a value of 10 ( Carr et al., 1977) for the fibre 
packing constant, k, the Darcy constant and fibrin 
concentration, c, can be used to calculate the mass-length 
ratio, Pp' using: 
40. 
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2.2.4 Fibrin network compaction 
The measurement of fibrin network compaction is based 
on a method of Dhall et al. (1976). Fibrin network 1s 
formed in a 1.5ml Eppendorf microcentrifuge tube presprayed 
with lecithin based aerosol (Spray and Cook, Woolworths) 
in order to render the surface non-adhering. Clots are 
then centrifuged at 8000g for 45 seconds in a Eppendorf 
microcentrifuge, Model 3200. The volume of fluid expelled 
from the network is measured with a 1ml syringe and 
expressed as a percentage of initial volume. 
2.2.5 Scanning electron microscopy 
200pl of clotting fibrinogen solution was pipetted 
onto 12mm diameter coverslips and left undisturbed for 30 
minutes. Clots so formed were then immersed for 30 minutes 
in 2.5% glutaraldehyde in Tris-saline buffer. Following 
fixing, they were washed with three changes of Tris-saline 
and distilled water and then either freeze dried or 
critical point dried. For freeze drying, gels were snap 
frozen in liquid nitrogen and freeze dried in a Dynavac 
tissue freeze dryer, Model L140M for 20 hours. For 
critical point drying, clots were dehydrated with a graded 
series of acetone followed by critical point drying using 
CO 2 in a Bomar SPC - 1500 critical point dryer. 
Dehydrated clots were coated with approximately 300nm of 
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gold in a Dynavac vacuum coating unit and examined with a 
Cambridge S 1800 scanning electron microscope at a variety 
of magnifications. 
2. 2. 6 Transmission electron microscopy 
Fibrin gels were formed on carbon coated, parlodion 
film reinforced 400 mesh grids. Thrombin was added to 
fibrinogen solution and a drop of the clotting solution 
immediately placed on the grid. Most of the solution was 
then absorbed with filter paper so that only a very thin 
film remained on the grid. As that gelling film tended to 
dry rapidly, a final thrombin concentration of 1.5U/ml was 
used. The gel was left to develop for 4 minutes and then 
flooded with saturated aqueous uranyl acetate for 15 
minutes. Grids were washed twice with tris-saline then 
with distilled water and finally pir dried. Grids were 
examined under a Phillips EM301 microscope fitted with a 
goniometer stage. An accelerating voltage of 40 kV and an 
objective aperture of 40 µm were used to view the 
specimen. 
2.2.7 Statistical analysis 
Analyses were performed with the aid of a Hewlett 
Packard 9815A bench top calculator and supplied statistical 
packages. Plots were made with a Hewlett Packard 7225A 
plotter. Except where otherwise stated , levels of 
significance p(t) were calculated using students test for 2 
42 . 
tailed distributions. The F probabilities - p(F) - were 
calculated F values derived from data fitted to a linear 
regression model. 
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SECTION I 
STUDIES ON METHODS USED FOR EXAMINING 
FIBRIN NETWORKS 
CHAPTER 3 
METHODS: REPRODUCIBILITY AND TECHNICAL 
LIMITATIONS 
45. 
3.1 INTRODUCTION 
A number of methods have been developed and used to 
study fibrin networks. Methods have been based on 
transmission (Tesch et al., 1979) and scanning electron 
microscopy (Carlin et al., 1976), light scattering and 
turbidimetric techniques (Dhall and Bryce, 1970; Carr 
et al., 1977), permeability (Rosser et al., 1977; Carr 
et al., 1977), compaction (Dhall et al., 1976) and 
viscoelastic properties (review: McIntire, 1980). In this 
Chapter reproducibility and technical limitations of some 
of these methods, particularly of those used in studies on 
fibrin networks described in this thesis will be 
considered. 
3.2 MATERIALS AND METHODS 
Networks were examined using all the methods described 
1n Chapter 2. The networks were formed on different days 
using different batches of fibrinogen and thrombin. The 
coefficient of variation and the reproducibility of the 
methods were compared. 
3.3 RESULTS 
3. 3. 1 Reproducibility of measurements 
Table 3.1 shows that for any one method, the day to day 
variation in the measurements is of similar order of 
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magnitude to the reproducibility on any one day. However, 
although measurements could be reproducibly made from 
single batches of fibrinogen and thrombin, the measurements 
in networks formed using different batches of fibrinogen 
and thrombin were significantly different. Neverthless, 
identical treatments (e.g., changes in ionic strength) 
induced a similar magnitude and direction of changes in the 
measurements in different batches of fibrinogen and 
thrombin (Figure 3.1). 
The coefficient of variation in the turbidimetric 
techniques, · in general, is lower than that in the 
mechanical techniques (Table 3.1). The opacity ratio and 
µTare highly reproducible. The data from compaction and 
permeation, on the other hand, are subject to larger 
intraexperimental variation. 
3. 3. 2 Technical limitations of the methods 
3.3.2.1 Turbidimetric studies 
Turbidity and ~ OD/min could be easily measured. At 
physiological fibrin concentrations turbidity at 608 nm was 
directly proportional to A-3 (Appendix 2) so µT could 
be calculated from turbidity at 608 nm. For good 
theoretical reasons (Carr and Hermans, 1978), this linear 
relationship may breakdown at relatively high fibrin 
concentrations. 
Q 
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3.3.2.2 Compaction 
Compaction method depends upon accurate measurement of 
the expelled volume. In the system used, very small 
volumes of expelled fluid could not be measured accurately. 
The lower limit of accuracy of this method was set at 20 
µl, that is, 2% compaction. 
3.3.2.3 Perfusion studies 
The critical variables in determining mass-length ratio 
in perfusion studies are the flow rate and network protein 
concentration. Initially, the perfusion fluid was coloured 
with Azure A to facilitate the observation of bolus 
movement through the clot ( Carr et al., 1977). With 
experience the addition of dye was omitted because non-
uniform flow could be easily detected from non-constant and 
greatly enhanced flow rates often associated with collapse 
of the clot. A minimum of three identically prepared 
networks were always perfused together. Following an 
initial stabilizing period (usually less than 20 minutes), 
the flow rate through clots remained constant (Figure 3.2). 
The protein concentration could be determined with as 
little as 0.1 ml of perfusate. However, because of slow 
flow rate in some very fine networks, evaporation 
significantly reduced the perfusate volume. Consequently, 
calculations of Pp of very fine clots may be subject to 
small but acceptable errors. 
T 
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3 . 3 . 2 . 4 Transmission electron microscopy 
A fine and coarse fibrin network are shown in Figure 
3 . 3 . It may be seen that the fibres in the coarse network 
are, on the average, thicker than those in the finer 
network . Note also that within both networks the thickness 
of fibres is not uniform. 
As fully described in Chapter 4, the network structure 
may be examined quantitatively in transmission electron 
micrographs using morphometric analysis. However, this 
proved time consuming but it was particularly suited to 
examining the internal structure of fibrin networks. 
3 . 3 . 2.5 Scanning electron microscopy 
As shown in Figure 3 . 4, scanning electron micrographs 
of networks, known to be of different mass-length ratio, 
were not visually distinguishable. The micrographs show 
great depth of field, so it was not possible to use 
morphometric analysis in scanning electron micrographs to 
quantify fibre thickness. 
3 . 4 DISCUSSION 
The reproducibility of methods is of paramount 
importance in the selection of techniques suited to this 
study . The experiments described in this Chapter show that 
the techniques used in this thesis vary little from day to 
q 
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day (Table 3.1). 
Measurements made using the turbidimetric technique can 
be analysed in a variety of ways to give useful 
information. From the ratio of turbidities may be obtained 
the network opacity ratio (Dhall and Bryce, 1970) which is 
indicative of fibre diameter. From the turbidity and 
fibrin concentration the mass-length ratio of network 
fibres may be calculated (Carr and Hermans, 1978). In 
addition, continuous measurements of turbidity may be used 
to determine lag time (Hantgan and Hermans, 1979). The 
technique is simple and highly reproducible. 
The PT may be calculated from the turbidity at 608 nm 
at physiological fibrin concentrations (Appendix 2). At 
higher than physiological fibrin concentrations, turbidity 
at 608 nm may not be directly proportional to ~-3. Since 
the theoretical basis of this method no longer holds, 
calculations of PT 1n the presence of higher fibrin 
concentrations should be made with caution. 
Compaction is a simple technique. However, the 
coefficient of variation of this method is relatively high 
(Table 3.1). This arises from the low volume of fluid 
expelled from purified fibrin clots (often 0.05 - 0.10 
ml/ml clot), the difficulty of collecting all the expelled 
fluid and the accuracy limit on the syringe used to collect 
and measure fluid. As shown in later chapters, lower 
coefficients of variation were obtained in clots which 
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compacted more readily. 
The perfusion method allows an index of network 
permeability, the Darcy constant, to be calculated 
(Appendix 3). The Darcy constant and the network protein 
concentration are then used to derive the mass-length ratio 
of the network fibres assuming a value of 10 for the fibre 
packing constant of the network (Carr et al., 1977). 
Measurement of permeability is technically demanding. It 
was feared that the perfusion of incompletely developed 
networks could lead to changes in flow rate due to 
unclotted fibrinogen affecting the viscosity of the 
perfusion fluid. However, significant changes in flow rate 
with perfusion volume were not observed (Figure 3.2). This 
is al so supported by Carr et al. ( 1 977). Thus, Pp can be 
easily calculated from measurements of network 
permeability. 
Scanning and transmission electron microscopy have been 
previously used to visualize the fibrin network (Carlin 
et al., 1976; Krause and Zimmerman, 1979; Tesch et al., 
1979). However, these techniques are unsuited for the 
routine examination of fibrin network structure. As Carlin 
et al. ( 1976) also found, scanning electron 
photomicrographs of networks made with different ionic 
strength or pH are visually indistinguishable (Figure 3.4). 
Routine use of scanning electron microscopy in early 
studies in the following chapters reinforced this 
conclusion. Consequently, this technique was abandoned. 
C 
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Transmission electron microscopy, on the other hand, may be 
used to measure the individual thickness of fibres in a 
network (Krause and Zimmerman, 1979; Tesch et al., 1979; 
Chapter 4). But, a high thrombin concentration is needed 
to form fibrin networks successfully on grids. This 
thrombin concentration is incompatible with the 
experimental design (Chapter 2) in which the thrombin 
concentration used was similar to that found at the 
clotting moment of whole blood, namely, 0.15 U/ml (Shuman 
and Majerus, 1976). Mainly for this reason, transmission 
electron microscopy was not used for the routine 
examination of fibrin networks. 
Transmission electron micrographs show that the 
diameter of network fibres is not homogeneous (Figure 3.3; 
Krause and Zimmerman, 1979; Tesch et al., 1979). However, 
in turbidity and permeability methods a single value 
purporting to be a measure of fibre thickness is obtained. 
This value must be a mean of many different fibre 
thicknesses within the network. As will be shown later in 
this thesis (Chapter 4) turbidity and permeability 
techniques are influenced in different ways by the 
distribution of fibre diameters within the network. For 
this reason both the mechanical methods (pp and 
compaction) and the turbidimetric techniques CpT and 
opacity ratio) have been used in this thesis to investigate 
fibrin network structure. 
Since factor XIIIa crosslinking modifies the 
4 
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mechanical properties of networks (Gerth et al., 1974) it 
may be expected that crosslinked networks will behave 
differently from non-crosslinked networks. This might 
affect measurements in methods which depend upon mechanical 
properties of networks, namely, permeability and 
compaction. Since only networks formed with added ca++ 
are crosslinked (Appendix 4) fibrin networks were routinely 
formed both with and without ca++ and then investigated . 
Although measurements differ significantly between 
different batches of fibrinogen these differences did not 
affect the direction or magnitude of the way in which 
fibrin network responds to changes in clotting conditions 
(Figure 3.2) . It is, therefore, valid to make observations 
on networks formed with different batches of fibrinogen. 
The results and interpretations will remain unaltered. 
3. 5 CONCLUSIONS 
(1) Fibrin network turbidity and permeability may be 
measured reproducibly. The turbidimetric techniques are 
more reproducible than the mechanical methods. 
(2) Electron microscopy could not be used routinely to 
study fibrin networks. Networks with known differences 
cannot be visually distinguished using scanning electron 
microscopy. 
(3) Transmission electron microscopy shows that fibrin 
network fibre thickness is not homogeneous. 
53 . 
(4) Because of heterogeneous fibre size 1n fibrin networks 
and the assumptions and technical limitations of individual 
methods, a variety of methods should be used to investigate 
network structure which should be examined in the presence 
and absence of ca++. 
r 
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Table 3.1 The day to day variation and the coefficient of 
variation of various techniques 
Method 
TURBIDITY 
Lag time 
(sec) 
Opacity ratio 
PT X 1012 
(dal tons/cm) 
PERMEABILITY 
Fibrin cone. 
(mg/ml) 
Pp X 1012 
(daltons/cm) 
COMPACTION 
Expelled volume 
Day 1 
114+8 
( 7. 0) 
29.1+1.9 
( 6. 5) 
0.419+0.006 
( 1 . 4 ) 
12.0+0.2 
-( 1 . 7) 
2.99+0.02 
-( 0. 7) 
13.0+0.9 
( 6. 9) 
( % ) 5.2+0.8 
-(15.4) 
Day 2 
126+8 
( 6. 3) 
31.7+1.7 
( 5. 4) 
0.434+0.009 
( 2. 1 ) 
12.5+0.4 
-( 3. 2) 
2.98+0.02 
( 0. 7) 
15.4+1.2 
-
C 7. 8) 
4.5+0.5 
-(11.1) 
Pooled Data 
120+12 
(10.0) 
30.4+2.6 
( 8. 6) 
0.426+0.011 
-( 2. 6) 
12.3+0.4 
C 3. 3) 
2.98+0.02 
( 0. 7) 
14.2+1.6 
-(11.3) 
4.8+0.7 
-(14.6) 
Results show the mean of 3 observations+ SD (coefficient 
of variation) for two experiments performed on consecutive 
days and for the pooled data for both days. Networks were 
made without additional divalent cations. Except for 
compaction, the coefficients of variation are typical of 
those obtained throughout this thesis . Lower coefficients 
of variation were obtained for compaction in later studies. 
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The change in Darcy constant with ionic 
strength in networks made with different 
batches of fibrinogen and thrombin. 
0. 17 
Networks were formed in two different ( X and D) fibrinogen 
solutions which contained 1.2 mM CaC1 2 + 0.82 mM MgCl2 
of varying ionic stren gth (Chapter 6). Similar results 
were obtained where networks did not contain divalent 
cations or where networks contained 2.02 mM MgC1 2 . The 
Darcy constants of networks formed from these batches of 
fibrinogen were linearly correlated Cr= 0.9 87, p(F) < 
0.001, n = 15). Results are the mean of 5 determinati o n 
+ SD. 
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A typical time rate change in the volume of 
fluid perfused through a fibrin network 
The network was formed in fibrinogen solution (3.3 mg/ml; 
pH 7.35; ionic strength 0.133) using 0.15 U/ml thrombin and 
perfused at 30 minutes. The data are typical of those 
obtained throughout perfusion studies in fibrin networks. 
.......__ 
Figure 3.3 Transmission electron micrographs of two 
fibrin networks of different µT 
The networks A and B were made in fibrinogen solution (1 .5 
mg/ml) of ionic strengths, 0.17 and 0.13, respectively. 
The mean PT of networks A and Bare 8.0 and 20.7 x 10 12 
daltons/cm, respectively. The magnification is the same in 
both micrographs . 
C 
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Figure 3.4 Scanning electron micrographs of two fibrin 
networks of different µT. 
The networks A and B were made in fibrinogen solution (3.3 
mg/ml) of ionic strengths, 0.17 and 0.13, respectively. The 
mean PT of networks A and Bare 8.0 and 20.7 x 10 12 
daltons/cm, respectively. The scale is 20 pm and the 
magnification is the same in both micrographs . 
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CHAPTER 4 
THE EFFECTS OF FACTOR XIIIa 
MEDIATED CROSSLINKING ON NETWORK 
STRUCTURE AND MEASUREMENT OF MASS-LENGTH RATIO 
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4.1 INTRODUCTION 
The mean mass-length ratio of fibres in fibrin networks 
can be calculated from measurements of either the 
permeability (Carr et al., 1977) or the turbidity (Carr and 
Hermans, 1978). Since the mass-length ratio is 
proportional to the square of the fibre radius, the mean 
fibre diameter can be calculated provided the fibre density 
is known . However, the theoretical background rests on the 
assumption that the diameter of the fibres in a clot 1s 
uniform . But this asssmption is not supported by evidence 
from electron micrographs (Chapter 3). In this Chapter the 
consequences of polydispersion in the diameter of the 
fibres on the mass-length ratios calculated from the 
permeability and the turbidity of fibrin clots are 
investigated . 
4.2 MATERIALS AND METHODS 
Fibrin clots were formed from fibrinogen solutions (3.3 
mg/ml) which did not contain divalent cations or which 
contained 2 . 02 mM MgC1 2 or 1 . 2 mM CaC1 2 + 0.82 mM MgC1 2 , 
as described fully in Chapter 2. The pH of the fibrinogen 
solutions was varied as described in Chapter 6. The mass-
length ratio was determined from permeation and turbidity. 
Transmission electron micrographs were obtained usin g 
the negative staining technique (Raju, 1978) . Freshly 
glow-discharged grids were touched onto the surface of 
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perfused and unperfused clots (from permeation studies). 
After 15 seconds, several drops of aqueous uranyl acetate 
were applied to the grid which was subsequently dried. 
Grids were examined as described in Chapter 2. 
The distribution of fibre diameters was determined 
using transmission electron micrographs at a final 
magnification of 70,000X prepared as described in 
Chapter 2. Grid lines 2 cm apart were drawn and the 
diameters of all fibres intersecting the lines measured. 
4.3 RESULTS 
Figure 4.1 shows a plot of Pp against PT· Although 
µP was higher than Pr, a good linear correlation was 
obtained Cr= 0.994) with networks made in the absence of 
calcium (n = 10). However, in networks made in the 
presence of calcium Pp was lower and the values do not 
lie on this regression line. When data from the latter 
networks was included in a composite regression analysis 
the linear correlation deteriorated (n = 15, r = 0.633) and 
this deterioration was statistically significant (Snedecor 
and Cochran, 1978). Similar results were also obtained 
when the networks were formed with a tenfold increase in 
thrombin concentration (i.e., 1.5 U/ml) and where clotting 
conditions other than pH are varied. 
Figure 4.2 shows the distribution of fibre diameters in 
a typical fine fibrin networ k as determined by morphometric 
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analysis of transmission electron microscopy. The diameters 
are polydisperse and their distribution is bimodal. On the 
basis of their diameters the fibrin strands appear to form 
two relatively distinct networks which have been termed 
major and minor networks. 
Figure 4.3 shows electron micrographs of fibrin clots 
before and after perfusion. The minor network can be seen 
in unperfused clots made in the presence of magnesium ions 
(B) or calcium and magnesium ions (A). However, following 
perfusion, the minor network is no longer seen in the clot 
made in the presence of magnesium ions (D). Clearly, the 
minor network is washed away during permeation studies in 
the clot made 1n the presence of magnesium ions. In 
contrast, the minor network remains relatively intact after 
perfusion in the clot made in the presence of calcium and 
magnesium ions (C). Note that only clots formed in the 
presence of added ca++ are cross-linked by factor XIIIa 
(Appendix 4). 
4.4 DISCUSSION 
Morphometric analysis of electron micrographs show that 
the diameters of the fibrin strands in a clot are 
polydisperse and that the distribution of fibre diameters 
is bimodal (Figure 4.2). Thus, the fibrin strands may be 
separated into two networks according to their fibre 
diameter and these have been called the major and minor 
networks. The fibrin strands in the minor network which 
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correspond to the first peak in the distribution are 
thinner than those in the major network. This finding is 
contrary to the assumption implicit in the methods which 
have been developed to determine the mass-length ratio of 
fibres in fibrin networks. 
The consequences of polydispersity in the diameters of 
fibrin strands on Pp and PT were investigated 
(Appendix 5). As a first approximation, a simplified model 
has been used which considers two superimposed monodisperse 
networks with diameters of fibrin strands which differ by a 
factor of ten. This model has shown that the turbidity of 
the clot will be determined by the major network whilst its 
permeability or Darcy constant will be markedly reduced by 
the strands in the minor network. Consequently, 
corresponding to a given PT, pp should be smaller in 
the presence of the minor network than in its absence. 
The mass-length ratios calculated from the permeability 
of the clots are generally greater than those calculated 
from their turbidity (Chapters 6 and 7). This 1s 
consistent with previous observations (Carr et al., 1977). 
The reasons for this discrepancy are not completely 
understood but may be related at least in part to the 
assumption that the packing constant has a value of 10 
( Carr et al., 1977). However, in clots made without 
calcium ions a good linear correlation was obtained between 
PT and PP· In these clots the minor network did not 
withstand the permeation pressure and was washed away 
'I 
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(Figure 4.3), so that the permeability of the clot would 
have been determined predominantly by the major network. 
Since the contribution of the minor network to turbidity is 
negligible in these clots (Appendix 5) the values of pp 
and PT may be taken to correspond to those of the major 
network only. Thus, 1n the absence of the minor network a 
good linear correlation is obtained between PT and PP· 
The fibrin network is strengthened in clots made 1n the 
presence of calcium ions, by factor XIIIa mediated 
crosslinking (McDonagh et al., 1971 ) . This imparts 
additional strength to the minor network which then s eems 
able to withstand the permeation pressure used in this 
investigation (Figure 4.3). Thus, in these clots the minor 
network offers additional resistance to flow, their 
permeability is lowered and the mass - length ratio 
calculated from the permeability is reduced. In keeping 
with this observation, pp of clots made in the presence 
of calcium was smaller than expected from the corresponding 
mass - length ratio calculated from turbidity (Figure 4 . 1) . 
Although the discussion has been restricted to two 
networks, similar considerations apply in an actual clot 
which may be thought of as a superposition of a series of 
monodisperse networks. In general, as the diameter of the 
strands in a network decreases, its contribution to 
turbidity will decrease while its resistance to flow will 
increase . Thus, calculations of mass-length ratio based on 
measurements of turbidity will give a value greater than 
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the mean value. On the other hand calculations based on 
measurements of permeability will give a mean mass-length 
ratio less than the true mean. The difference between the 
maximum and minimum fibre diameters in a clot may be 
greater or less than that assumed in the two network model 
(Appendix 5) and this will determine the magnitude of the 
error between the calculated and true mean. 
The effect of variation in fibre diameter within the 
major network alone on measurements of mass-length ratio is 
not large and may be negligible because estimates of mass-
length ratio of the fibres based on the two techniques give 
good correlation when the minor network is not stabilized 
by crosslinking. 
It may be that the consequences of polydispersion 
become evident only when the minor network 1s stabilized. 
However, in general, due to polydispersion in the diameters 
of the fibrin strands, an error will be introduced in 
calculations of mass-length ratio whose magnitude will 
depend upon the range of diameters and the shape of the 
distribution. Thus, to overcome pitfalls associated with a 
single technique, more than one technique should be used to 
examine and characterize properties of fibrin network. 
4.5 CONCLUSIONS 
(1) The diameters of the strands in a fibrin network are 
polydisperse and when measured experimentally show a 
bimodal distribution. 
66. 
(2) Turbidity and permeation techniques are sensitive to 
opposite ends of the distribution of fibre thicknesses; 
the thinnest fibres which contribute little to the 
turbidity of a network have a marked influence on its 
permeability when strengthened by crosslinking. 
(3) Crosslinked clots have lower permeability than non-
crosslinked clots. 
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Fibrinogen solutions (3.3 mg/ml) were clotted in the 
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Distribution of fibre diameters in a typical 
fine fibrin network 
Fibre diameters were determined by morphometric analysis of 
transmission electron micrographs. Results are the mean of 
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Figure 4.3 Transmission electron micrographs of perfused 
and unperfused fibrin networks 
Clot made in the presence of 2.02 mM MgC1 2 is shown 
before (B) and after (D) perfusion. Figures A and C 
represent clots made similarly in the presence of 1.20 mM 
Cac1 2 + 0.82 mM MgC1 2 before and after perfusion. The 
minor network is present in clots before perfusion but 1s 
apparently washed away after perfusion in clots made in the 
presence of Mg++ alone (D). In contrast the minor 
network remains visible after perfusion in clots made in 
the presence of ca++ (C) . 
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A COMPARISON OF METHODS 
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5. 1 ItJTRODUCTION 
From theoretical reasoning it has been previously 
argued that opacity ratio (Dhall and Bryce, 1970) and 
compaction (Dhall et al., 1976) reflect the relative 
fineness or coarseness of fibres in fibrin networks. 
However, the theoretical reasoning has not been verified 
by direct studies. Studies described in this Chapter 
examine this and some related problems. 
5.2 MATERIALS AND METHODS 
The data obtained under a variety of clotting 
conditions with the perfusion, the turbidity and the 
compaction techniques in Chapters 4 and 5 are compared and 
critically analysed. 
5. 3 RESULTS 
The changes in lag time, nOD/sec, PT, Pp' opacity 
ratio, permeability, compaction and network protein 
concentration under a variety of clotting conditions have 
been described in Chapters 6 and 7. Data from those 
studies has been used in the following analysis. 
5. 3. 1 Perfusion 
The network protein concentration was found to 
generally decrease slightly but significantly with 
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permeability (Figure 5.1). The network protein 
concentration was significantly greater in network made in 
the presence of ca++. 
5.3.2 Compaction 
Compaction generally correlated linearly with mass-
length ratio (Figure 5.2). This relationship is influenced 
by divalent cations. 
5. 3. 3 Turbidity 
5.3.3.1 Opacity ratio 
The opacity ratio of networks which had developed for 
30 minutes was directly proportional to that of more 
completely developed networks (Figure 5.3). 
Opacity ratio generally correlated linearly with PT 
(Figure 5 . 4) . 
5.3.3 . 2 Lag time and ~OD/sec 
Lag time is inversely proportional to ~ OD/sec over a 
wide range of thrombin concentrations (Figure 5.5) . 
~OD/sec either increased or decreased with PT (Figure 
5.6). It increased linearly with PT when ionic strength 
was reduced but it decreased with PT when thrombin 
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concentration was reduced. 
Lag time likewise increased or decreased with network 
permeability (Figure 5.7). Lag time was directly related 
to Darcy constant where thrombin concentration was altered 
but it was inversely related to Darcy constant where ionic 
strength was altered. 
5.4 DISCUSSION 
These studies support and extend the observations made 
1n earlier Chapters. When experimental conditions are 
manipulated to alter the mass-length ratio the opacity 
ratio, lag time, ~OD/sec and compaction correlate with 
mass-length ratio. However, depending upon the method used 
these correlations breakdown when the concentration of 
fibrin or the kinetics of fibrin generation are altered or 
when networks are crosslinked by factor XIIIa· Each 
method is discussed separately below. 
Network protein concentration determined from perfusion 
studies generally followed network permeability (Figure 
5.1). The protein concentration in the perfusate generally 
depended upon how quickly the network was perfused after 
initiating the clotting. It is interesting that the fibre 
thickness in incompletely developed networks mirrors that 
of more completely developed networks (Figure 5.3). 
Network protein concentration was significantly increased 
in the presence of ca++, presumably due to crosslinked 
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stable minor network (Chapter 4). 
Compaction is greater in coarser than 1n finer networks 
(Dhall et al., 1976). Indeed, Figure 5.2 shows that 
compaction is strongly influenced by mass-length ratio. 
However, compaction is additionally sensitive to factor 
XIIIa mediated crosslinking (Chapter 7) and to fibrin 
concentration (Chapter 6). Thus, compaction is influenced 
by the tensile properties of the network as well as by the 
fibre thickness. 
The claim that opacity ratio is an index of fibre 
thickness (Ferry and Morrison, 1947; Dhall and Bryce, 1970) 
is supported by findings shown in Figure 5.4. However, 
opacity ratio increases while PT decreases when 
fibrinogen concentration is altered (Chapter 6). Thus, the 
opacity ratio reflects mass-length ratio only when fibrin 
concentrations remains unaltered. When fibrin 
concentration is altered opacity ratio is additionally 
sensitive to the density of fibrin fibres. 
Lag time is determined from and inversely related to 
~OD/sec (Figure 5.5). Except where thrombin 
concentration is altered, ~OD/sec increases with PT 
(Figure 5.6) . That is, ~OD/sec and thus lag time, is 
sensitive to both changes in the rate of polymerization as 
well as to the extent of lateral aggregation. 
Clotting time is the period prior to gelation. It rnay 
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vary directly with lag time when the rate of polymerization 
is varied. However, this may not hold when the extent of 
lateral aggregation is varied. Blomback and Okado (1982a) 
determined lag time (termed it clotting time) and found it 
directly proportional to network permeability under 
conditions of varying thrombin or fibrinogen 
concentrations. The data in Figure 5.7 supports, 1n part, 
their findings. In addition it shows that lag time is 
inversely proportional to permeability when ionic strength 
is varied. The direct relationship between lag time and 
permeability postulated by Blomback and Okado (1982a), 
therefore, does not hold under all conditions. 
An increase in fibrin concentration increases 
resistance to permeation and compaction and increases 
turbidity and hence, opacity ratio, lag time and n OD/sec. 
Unlike turbidimetric methods, the permeation and compaction 
methods are sensitive to strengthening of the network by 
factor XIIIa mediated crosslinking. Both mechanical and 
turbidimetric methods should be used simultaneously when 
comparing the structures of crosslink~d and non-crosslinked 
networks. 
5.5 CONCLUSIONS 
(1) Opacity ratio reflects mass-length ratio only when 
fibrin concentration is not altered. 
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(2) The direct relationship between lag time and clot 
permeability postul a ted by Blomback and Okado (1982a) does 
not hold under all conditions. 
(3) Network compaction is influenced by the tensile 
properties of the clot as well as by the thickness of fibrin 
fibres. 
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Networks were formed in fibrinogen solution (3.3 mg/ml) 
which did not contain divalent cations ( D ) or which 
contained 1 . 2 mM Cac1 2 + 0.82 mM MgC1 2 ( X) . Ionic 
strength was varied (Chapter 6). 
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Figure 5.2 A plot of compaction against µP 
Networks were formed in fibrinogen solution (3.3 mg/ml) 
which did not contain divalent cations ( D) or which 
contained 1. 2 mM CaC1 2 + 0. 82 mM MgC1 2 ( X). Thrombin 
concentration was varied (Chapter 6). 
Compaction correlates linearly with up (networks made 
without divalent cations: r= 0.989, p(F) < 0.0015 ; 
networks made with divalent cations : r = 0. 990, p(F) < 
0 . 0012; both sets of data together : r = 0 . 868, p(F) < 
0.0011). 
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The relationship between opacity ratio 
measured at 30 minutes and at 60 minutes 
Netwo rks were formed in fibrino gen solution (3.3 mg/ml) 
which did not contain divalent cations, which contained 
2.02 mM MgC1 2 or which contained 1 . 2 mM CaCl2 + 0 . 82 mM 
MgC1 2 . Temperature was varied (Chapter 6 ) . Opacity 
ratio at 30 minutes correlates linearly with that at 60 
minutes ( r - 0.990, p(F) < 0 . 0001 , n - 24) . - -
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Figure 5.4 A plot of opacity ratio against uT 
Networks were formed in fibrinogen solution (3.3 mg/ml) 
which did not contain divalent cations or which contained 
1.2 mM CaC1 2 + 0.82 mM MgC1 2 . The pH was varied 
(Chapter 6). 
Opacity ratio correlates linearly with PT (r=0.997, 
p(F) < 0.0001, n = 15). 
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A plot of ~OD/sec against lag time 
Networks were formed in fibrinogen solutions (3.3 mg/ml) 
which did not contain divalent cations ( D) or which 
contained 1. 2 mM CaC1 2 + 0. 82 mM MgC1 2 ( X). Thrombin 
concentration was var ied (Chapter 6). 
Lag time is inversely related to ~OD/sec (r= -0.997, p(F) 
< 0.0001, n = 10). 
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Figure 5 . 6 A plot of ~ OD/sec against µ P 
Networks were formed in fibrinogen solution (3 . 3 mg/ml) 
without divalent cations . Ionic strength ( D ) or thrombin 
concentration ( X ) was varied (Chapter 6) . 
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Figure 5.7 A plot of Darcy constant against lag time 
Networks were formed in fibrinogen solution (3.3 mg/ml) 
without divalent cations. Ionic strength ( D) or thrombin 
concentration ( X) was varied (Chapter 6). Darcy constant 
is directly related (r=0.999, p(F) < 0.0001, n = 5) to lag 
time where thrombin concentration is varied and inversely 
related Cr= -0.873, p(F) < 0.05, n = 5) where ionic 
strength is varied. 
SECTION II 
STUDIES ON FIBRIN NETWORKS FORMED IN 
PURIFIED FIBRINOGEN SOLUTIONS 
CHAPTER 6 
A RE-EXAMINATION OF SOME INFLUENCES ON FIBRIN 
NETWORK DEVELOPMENT, PROPERTIES AND STRUCTURE: 
STUDIES ON THE MECHANISM UNDERLYING CHANGES IN 
NETWORK STRUCTURE. 
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6. 1 INTRODUCTION 
Fibrin fibre diameter varies not only in different 
individuals (Chapter 9) in response to trauma and operation 
but even within a single thrombus (Hattori et al., 1978; 
Hisano, 1978) or haemostatic plug (Wester et al., 1978). 
Histological studies show that the variation in fibrin 
diameter within thrombi and haemostatic plugs is determined 
according to the location of fibrin in relationship to 
platelet mass. However, the mechanism underlying variation 
in fibre diameter observed under physiological conditions 
remains to be clarified . 
Hermans and associates (Carr et al., 1977; Rosser 
et al . , 1977, Carr and Hermans, 1978) and Wolfe and Waugh 
(1981) have shown that fibre thickness varies considerably 
in vitro when the ionic strength, pH, thrombin or 
fibrinogen concentrations are altered substantially . In 
these studies, however, the conditions of clotting were 
generally pharmacological rather than physiological. The 
relevance of previous observations to clotting in vivo 
remains unknown. In this Chapter factors already known to 
be of importance under pharmacological conditions of study 
were re-examined under conditions of clotting simulating 
those found in plasma. 
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6.2 MATERIALS AND METHODS 
Unless otherwise indicated, fibrin networks were formed 
in fibrinogen solutions (3.3 mg/ml) which did not contain 
divalent cations or which contained 1.2 mM Cac1 2 + 0.82 
mM MgC1 2 , as described in Chapter 2. In addition, 
networks were made in fibrinogen solutions which contained 
2.02 mM MgC1 2 to examine the effects of changes in ionic 
strength, pH and temperature. Turbidity, permeability and 
compaction were measured and used to calculate lag time, 
~OD/sec, opacity ratio, µT, Pp and compaction (Chapter 
2) • 
The effects of changes in ionic composition, ionic 
strength, pH, temperature and of changes in fibrinogen and 
thrombin concentration were explored as follows: 
6. 2. 1 Effect of thrombin concentration 
Networks were formed in different fibrinogen solutions 
by adding 0.05, 0.10, 0.15, 0.25 or 0.50 U/ml thrombin. To 
allow for the effect of thrombin concentration on the rate 
of fibrinogen conversion to fibrin, networks were left to 
develop for 90, 45, 30, 18 and 9 minutes, respectively. It 
was known from preliminary studies that at these times the 
amount of fibrinogen converted to fibrin was constant at 
the concentrations of thrombin examined. 
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6.2.2 Effect of fibrinogen concentration 
Networks were formed in fibrinogen solutions which 
contained 1.0, 2.0, 3.3, 4.0, 6.0 and 8.0 mg/ml 
fibrinogen using 0. 15 U/ml thrombin. 
6.2.3 Effect of tem2erature 
Networks were formed in fibrinogen solution at 
different temperatures which in each case was maintained 
constant until the networks were examined. 
Fibrinogen solutions in tubes for permeation and 
compaction were pre-heated to 15°, 22°, 30°, 37° 
and 40°C by incubating in a water bath for 3 minutes to 
allow equilibration. Thrombin was then added to fibrinogen 
solutions. Networks were left to develop in the water bath 
at the appropriate temperature for 30 minutes before 
testing at room temperature. 
With the turbidimetric technique, the lag time, 
~OD/sec, opacity ratio and PT were determined at the 
range of temperatures listed above and, in addition, at 
20°, 25° and 35°c. Cuvettes containing fibrinogen 
solutions were placed in a thermostatically controlled 
holder for 4 minutes for equilibration and then thrombin 
was added. Readings of optical density at 350 and 608 nm 
were made at 5 minute intervals for 60 minutes. 
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6.2.4 Effects of ionic strength and pH 
Networks were formed in fibrinogen solutions with ionic 
strengths of 0.133, 0.143, 0.153, 0.163 and 0.173 (ionic 
strength adjusted with NaCl) or in fibrinogen solutions 
with pH 7.15, 7.25, 7.35, 7.45 or 7.55. 
6.2.5 Effect of common ions found 1n plasma 
The effect of physiological concentrations of various 
ions on network opacity ratio and compaction were examined 
by clotting fibrinogen solution (3.3 mg/ml) in the presence 
of either 1.20 mM CaC1 2 , 4.30 mM KCl, 0.82 mM MgC1 2 , 
1.11 mM NaH 2Po 4 , 0.35 mM Na 2so 4 or 29.00 mM 
NaHco 3 (final concentrations). A range of concentrations 
of CaC1 2 and MgC1 2 were also examined. In all 
experiments, the ionic strength and pH of test solutions 
were kept constant. Solutions of NaH 2P04 and NaHco 3 
were adjusted to pH 7.35 immediately before use. These 
solutions were added to fibrinogen solution containing 100 
mM Tris-HCl which provided superior pH control than the 
usual 50 mM Tris-HCl. 
6.3 RESULTS 
6. 3. 1 Effect of thrombin concentration 
An increase in thrombin concentration decreased the lag 
time and enhance d ~ OD /sec (Figure 6. 1). As shown, the lag 
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time correlated inversely with thrombin concentration and 
bOD/sec correlated linearly with thrombin concentration. 
Divalent cations decreased the lag time and increased 
bOD/sec at all thrombin concentrations. 
An increase in thrombin concentration decreased both 
PT and Pp (Figure 6.2). The inverse of thrombin 
concentration correlated linearly with both PT and Pp· 
Divalent cations increased PT and Pp at all thrombin 
concentrations. 
In parallel with PT and Pp, an increase in thrombin 
concentration resulted in a decrease in compaction, opacity 
ratio and permeability (Appendix 6). Network protein 
concentration increased only slightly with thrombin 
concentration. 
6.3.2 Effect of fibrinogen concentration 
An increase in fibrinogen concentration increased the 
lag time and bOD/sec (Figure 6.3). The lag time was 
linearly correlated with fibrinogen concentration. 
Divalent cations decreased the lag time and increased 
bOD/sec at all fibrinogen concentrations. 
An increase in fibrinogen concentration generally 
decreased PT (Figure 6.4) and Pp (Figure 6.5). In 
the absence of divalent cations, PT appeared not to 
change substantially at low concentrations of fibrinogen. 
9 1 • 
An increase in fibrinogen concentration increased 
opacity ratio (Figure 6.4) and decreased network compaction 
and permeability (Figure 6.5). In fact, Darcy constant was 
inversely correlated with the fibrinogen concentration 
(networks made without divalent cations : r = -0.991, p(F) 
< 0.0001; networks made with divalent cations : r = -0.994, 
p(F) < 0.0001). 
6. 3. 3 Effect of temperature 
The effect of temperature on the network growth rate 
was complex (Figure 6.6). The ~OD/sec was maximal while 
the lag time was minimal at temperatures between 25° and 
30°c in the absence of divalent cations. Changes in the 
lag time and ~OD/sec were less distinct in the presence 
of divalent cations; the former increased above 35° while 
the latter decreased below 25°c. 
Fibrinogen solutions which contained ca++ gelled 
slowly when cooled below room temperature, even in the 
absence of thrombin. Gelling was most rapid at 15°c. 
An increase in temperature caused a non-linear increase 
in PT and Pp (Figure 6.7). The changes in PT and Pp 
with temperature paralleled the changes in compaction, 
opacity ratio and permeability (Appendix 6). The network 
protein concentration decreased only slightly with 
temperature. 
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6 .3.4 Effects of ionic strength and pH 
An increase in ionic strength resulted in a decrease in 
~OD/sec and a less distinct increase in the lag time 
(Figure 6.8). Divalent cations (ca++> Mg++) decreased 
the lag time and increased ~OD/sec. 
An increase in ionic strength (Fig. 6.9) or in pH 
(Figure 6.10) decreased PT and Pp· These changes 
paralleled the changes in compaction, opacity ratio and 
permeability (Appendix 6). Network protein concentration 
increased only slightly with ionic strength or pH. 
6. 3. 5 Effect of common plasma ions 
With the exception of ca++ and Mg++, physiological 
concentrations of so 4 =, HPo 4-, Hco 3- and K+ 
did not significantly influence network opacity ratio of 
compaction (Table 6.1) . ca++ and Mg+ + induced similar 
increases in opacity ratio and, at divalent cation 
concentrations below 5.0 mM, both induced similar increases 
in network compaction (Figure 6.11). At higher divalent 
cation concentrations, however, networks made in the 
presence of ca++ showed less compaction than those made 
in the presence of Mg++ . 
6 . 4 DISCUSSION 
Previous studies on the effect of ionic strength, pH, 
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temperature, thrombin and fibrinogen concentration (Carr 
et al., 1977; Rosser et al., 1977; Carr and Hermans, 1978; 
Wolfe and Waugh, 1981) have tended to concentrate on the 
mechanics of polymerization rather than on the effect of 
these variables on fibrin network properties under 
physiological conditions of clotting. As a result often a 
single technique was used. The findings from such studies 
have not provided conclusive evidence that the consistent 
variation seen in fibre thickness in normal haemostatic 
plugs and thrombi (Hattori et al., 1978; Hisano, 1978; 
Wester et al., 1978) has its origins in local clotting 
conditions found in vivo. In the studies described in this 
Chapter particular attention was paid to examine fibrin 
network characteristics under relatively physiological 
conditions of clotting in which fibrinogen and thrombin 
concentrations, pH, ionic strength, ionic composition and 
temperature were varied in the range expected in vivo. 
In addition a variety of techniques were used to 
examine fibrin network characteristics to allow 
methodological difficulties (Chapters 3, 4 and 5) to be 
overcome. By so doing it was possible to make several 
interesting observations. For example, it was observed 
that PT and Pp generally change in parallel. Except 
when fibrinogen concentration is varied, the opacity ratio, 
permeability and compaction generally parallel the mass-
length ratio. 
Opacity ratio and compaction, however, did not change 
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1n parallel where divalent cation concentration was 
increased (Figure 6. 11) and as discussed in Chapter 4, this 
ca++ specific effect on compaction may be attributed to 
stabilization of the minor network caused by factor XIIIa 
mediated crosslinking in the presence of ca++. Although 
minor differences between the effects of ca++ on network 
structure may derive from conformational changes in the 
fibrin(ogen) molecule due its ca++ specific binding sites 
(Marguerie et al., 1977), it is notable that Mg++ and 
ca++ increased opacity ratio in an identical manner 
(Figure 6.11). Furthermore, the presence of divalent 
cations did not influence the response of fibrin networks 
to other changes in clotting conditions. These findings 
indicate, firstly, that ionic charge is important in 
influencing network structure and secondly, that factor 
XIIIa mediated crosslinking does not greatly affect the 
polymerization mechanism and the resultant network 
structure. 
It is not clear how changes 1n clotting conditions lead 
to changes in fibre thickness. Ferry and Morrison (1947) 
suggested that thin fibres form when the solubility of 
fibrin(ogen) is great since an increase in solubility 
reduces the tendency for fibrin monomers to aggregate. 
Consequently, an increase in ionic strength or pH which 
leads to increased solubility (Ferry and Morrison, 1947) 
promotes smaller mass-length ratio · (Figures 6.9 and 6.10, 
respectively). In keeping with this suggestion the lag 
time increases as ionic strength increases (Figure 6.8; 
Q 
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Hantgan and Hermans, 1979). However this mechanism fails 
to explain the relationship between fibre thickness and 
fibrinogen or thrombin concentration described in this 
Chapter. Increase in fibrinogen or thrombin concentration 
reduces the mass-length ratio (Figures 6.2, 6.4 and 6.5) 
without affecting fibrin(ogen) solubility. 
More recently Nelb et al. (1976) have proposed that 
fibrin networks are metastable structures in which fibres 
diffuse through solvent and associate laterally with their 
neighbours, except when movement is prevented by their 
neighbours. According to this suggestion the time 
available for fibril diffusion becomes a critical factor. 
Fibre thickness will be determined by the density and rate 
of development of the network. An increase in the rate of 
fibrin generation induced by increase in thrombin 
concentration induces a lower mass-length ratio (Figure 
6.2) because it reduces the extent of realignment of 
fibrils into thicker fibres. 
An increase in fibrogen concentration results in a 
decrease in mass-length ratio (Figures 6.4 and 6.5) and an 
increase in fibril density. The extent of realignment of 
fibrils into thicker fibres decreases at physiological 
concentrations of fibrinogen but not in dilute fibrin gels 
(below 1 mg/ml) in which PT has previously been reported 
to increase with fibrinogen concentration (Carr et al., 
1977; Hantgan and Hermans, 1979; Wolfe and Waugh, 1981). 
Rosser et al. (1977) suggest that at very low fibrin 
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concentrations the density of fibres in the network does 
not limit the extent of realignment of fibrils into thick 
fibres. 
Temperature influences fibrin fibre thickness in a 
complex way. It affects the kinetics of fibrin generation 
through affecting thrombin activity. It also influences 
solubility of fibrin(ogen) as evidenced by the gelation of 
fibrinogen solution at low temperatures. The combined 
effects of temperature on the kinetics of fibrin generation 
and on the solubility of fibrin(ogen) should account for 
the increase in mass-length ratio with temperature (Figure 
6.7) as well as the changes in the lag time and ~ OD/sec 
(Figure 6.8). 
It has been shown in this Chapter that the thickness of 
fibrin fibres and network properties are sensitive to small 
changes in clotting conditions. Shifts in ionic strength, 
pH and temperature within the ranges normally found in 
plasma result in considerable changes in mass-length ratio 
and in network properties. Substantial differences in 
network properties are also induced by varying fibrinogen 
and thrombin concentrations. These findings suggest that 
if these parameters change in vivo the fibrin network 
structure may be expected to vary. 
The thickness of fibrin fibres in thrombi is known to 
vary consistently and predictably (Hattori et al., 1978; 
Hisano, 1978). But the mechanism underlying this variation 
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remains unclear. It has been suggested that compaction of 
thinner fibres into thicker fibre bundles during platelet 
mediated clot retraction accounts for the variation 
(Szalontai, 1968). The results of this study suggest that 
local differences in the clotting conditions may, in 
addition, be responsible for variation in fibre thickness 
in thrombi. 
In circulating plasma the ionic strength, pH and 
temperature are normally tightly controlled within narrow 
1 i m i t s ( Wh i t e e t a 1 . , 1 9 7 3 ) • Fi b r i n , ho we v er , n o rm a 11 y 
forms at the site of injury where alterations may be 
expected in pH, temperature and possibly ionic strength. 
In such regions, fibre thickness and clot properties will 
probably reflect the local ionic strength, pH and 
temperature. 
Although ionic strength, pH and temperature are tightly 
controlled in plasma, thrombin and fibrinogen concentration 
vary greatly. Thrombin is not present in appreciable 
amounts in plasma but during coagulation its concentration 
may exceed 10 U/ml (Lui et al., 1979). Fibrinogen is an 
acute phase reactant and its plasma concentration can 
increase from 2-4 mg/ml in health to greater than 7 mg/ml 
in some inflammatory states (Johansson, 1976; Chapter 8). 
Further, during local inflammation, oedema fluid contains 
very high concentrations of many plasma proteins including 
fibrinogen; this fluid sometimes clots spontaneously 
(Walter and Israel, 1974). Studies in this Chapter show 
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that fluctuations in thrombin and fibrinogen concentration 
not only affect the intrinsic mass of the clot and how 
quickly it forms, but also the structure and properties of 
the fibrin. Therefore, it might be expected that similar 
fluctuations in thrombin and fibrinogen concentration in 
vivo will also affect fibrin structure and properties. 
6.5 CONCLUSIONS 
(1) Fibrin fibre thickness is sensitive to small changes 
in clotting conditions within the ranges found in plasma. 
(2) Divalent cations and factor XIIIa mediated cross-
linking do not substantially influence the changes in fibre 
thickness induced by any one of a variety of changes in 
clotting conditions. 
(3) Results indicate that small alterations in the ionic 
strength, pH or temperature or in the thrombin or 
fibrinogen concentration of plasma will probably affect 
fibrin network stucture and properties. 
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Table 6.1 The effect of common ions found in plasma on 
compaction and opacity ratio 
Control 
4.30 mM KCl 
0.35 mM Na2S04 
1 . 20 mM CaCl2 
0.82 mM MgC1 2 
Control 
1.11 mM NaH2P04 
29.00 mM NaHCo 3 
OPACITY RATIO 
0.432 + 0.008 
-
0.432 + 0.009 
-
0.436 + 0.007 
-
0.453 + 0.016* 
-
0.454 + 0.009* 
-
0.422 + 0.011 
0.422 + 0.001 
0.412 + 0.010 
% COMPACTION 
7.2 + 0.5 
-
7.0 + 0.9 
-
6.8 + 0.4 
-
8. 1 + 0. 7 * 
-
7.9 + 1 . 0 * 
-
6.8 + 0.8 
6.0 + 1.0 
6.0 + 0.7 
Networks were formed in fibrinogen solution (3.3 mg/ml) to 
which various salts were added. Networks formed in the 
presence of NaH 2P04 and NaHco 3 contained 100 mM Tris-
HCl. Results are the mean of 9 determinations+ SD. * 
indicates valu es significantly different (p(F)<0.01) from 
controls. 
.... 
Figure 6.1 The effect of thrombin concentration on lag 
time and ..6.0D/sec 
The lag time correlated inversely with thrombin 
concentration (networks made without divalent cations : r = 
-0.999, p(F) < 0.0001; networks made with divalent cations 
r = -0.997, p(F) < 0.0001). 
The ..6.0D/sec correlated linearly with thrombin concentration 
(networks made without divalent cations : r = 0.999, p(F) < 
0.0001; networks made with divalent cations 
p(F) < 0.0001). 
r = 0.999, 
Networks were formed in fibrinogen solution (3.3 mg/ml) 
which did not contain divalent cations ( D) or which 
contained 1.2 mM CaC1 2 + 0.82 mM MgC1 2 ( X). Results 
are the mean of 3 determinations . 
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Figure 6.2 The effect of thrombin concentration on µT_ 
and µP 
The inverse of thrombin concentration was correlated 
linearly with PT and µp CpT-networks made without 
divalent cations : r = 0.991, p(F) < 0.0002; networks made 
with divalent cations : r = 0.945, p(F) < 0.0075. Pp-
networks made without divalent cations : r = 0. 985, p(F) < 
0.0006; networks made with divalent cations : r = 0.944; 
p(F) < 0.0075). 
Networks were formed in fibrinogen solution (3. 3. mg/ml) 
which did not contain divalent cations ( D) or which 
contained 1. 2 mM CaC1 2 + 0. 82 mM MgC1 2 ( X). Results 
are the mean of 3 determinations+ SD • 
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Figure 6.3 The effect of fibrinogen concentration on lag 
time and .6.0D/sec 
Lag time was linearly correlated with fibrinogen 
concentration (networks made without divalent cations : r -
0.994, p(F) < 0.0001; networks made with divalent cations 
r = 0.992, p(F) < 0.0001. 
' 
Networks were formed in fibrinogen solutions which did not 
contain divalent cations ( D) and which contained 1.2 mM 
CaC1 2 _:+- 0.82 mM MgC1 2 CX). Results are the mean of 3 
determinations+ SD . 
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The effect of fibrinogen concentration on µT 
and opacity ratio 
Networks were formed in fibrinogen solutions which did not 
contain divalent cations ( 0) and which contained 1.2 mM 
Cac1 2 + 0. 82 mM MgC1 2 ( X). Results are the mean of 3 
determinations+ S.D. 
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The effect of fibrinogen concentration on 
~p and network compaction 
Networks were formed in fibrinogen solutions which did not 
contain divalent cations ( O) and which contained 1.2 mM 
CaCl2 + 0. 82 mM MgC1 2 ( X). Results are the mean of 
3 determinations+ SD. 
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The effect of temperature on lag time and 
~OD/sec 
Networks were formed in fibrinogen solution (3.3 mg/ml) 
which did not contain divalent cations ( O) or which 
contained 1. 2 mM CaC1 2 + 0. 82 mM MgC1 2 ( X). Results 
are the mean of 5 determinations+ SD. For graphic 
simplicity data from networks formed in the presence of 
2.02 mM MgC1 2 is not shown as it falls midway between the 
other two sets of data. 
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Figure 6.7 The effect of temperature on µT and µP 
Networks were formed in fibrinogen solution (3.3 mg/ml) 
which did not contain divalent cations ( O) or which 
contained 1. 2 mM CaC1 2 + 0. 82 mM MgC1 2 ( X). Results 
are the mean of 5 determinations+ SD. For graphic 
simplicity data from networks formed in the presence of 
2.02 mM MgC1 2 is not shown. 
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The effect of ionic strength on lag time and 
6.0D/sec 
Networks were formed in fibrinogen solution (3.3 mg/ml) 
which did not contain divalent cations ( D) or which 
contained 1. 2 mM CaC1 2 + 0. 82 mM MgC1 2 ( X). Results 
are the mean of 5 determinations+ SD. For graphic 
simplicity data from networks formed in the presence of 
2.02 mM MgC1 2 is not shown. It falls midway between the 
other two sets of data. 
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Figure 6.9 The effect of ionic strength on µT and µP 
Networks were formed in fibrinogen solution (3.3 mg/ml) 
which did not contain divalent cations ( D), which 
contained 2.02 mM MgC1 2 (0) or which contained 1.2 mM 
CaCl2 + 0. 82 mM MgC1 2 CX). Results are the mean of 
5 determinations+ SD. 
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Networks were formed in fibrinogen solution (3.3 mg/ml) 
which did not contain divalent cations ( O), which 
contained 2. 02 mM MgC1 2 ( 0) or which contained 1. 2 mM 
CaC1 2 + 0. 82 mM MgC1 2 ( X). Results are the mean of 
5 determinations+ SD. 
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Figure 6.11. The effect of ca++ and Mg++ on opacity 
ratio and compaction 
1 1 0. 
Networks were formed in fibrinogen solution (3.3. mg/ml) 
which contained a range of divalent cation concentrations; 
CaC1 2 ( X), MgC1 2 ( D). Results are the mean of 5 
determinations+ SD. 
I . CHAPTER 7 
THE EFFECTS OF GLUCOSE, GLYCOSAMINOGYLANS AND 
PROTAMINE SULPHATE ON FIBRIN NETWORK STRUCTURE: 
FURTHER STUDIES ON THE MECHANISM UNDERLYING 
CHANGES IN NETWORK STRUCTURE 
11 2. 
7.1 INTRODUCTION 
Plasma is a complex solution which contains many 
solutes besides fibrinogen. Influence on fibrin network 
structure of constituents other than fibrinogen is largely 
unknown. It is known that some substances, such as glucose 
(Ferry and Morrison, 1947), heparin (Sheppard et al., 
1957), protamine sulphate ( Carlin et al., 1976) and dextran 
(Muzaffar, 1974), may modify fibrin network properties 
under pharmacological conditions. It was shown in the last 
Chapter that networks are sensitive to small changes in 
clotting conditions. It seems reasonable to expect that 
these agents may also affect fibrin network structure under 
clotting conditions similar to those in plasma. 
In this Chapter, a variety of physiologically and 
clinically important substances known to be sometimes 
present during fibrin formation in plasma are examined. 
7.2 MATERIALS AND METHODS 
Unless otherwise stated fibrin networks were formed 
in fibrinogen solutions which did not contain any added 
divalent cations or which contained 1.2 mM CaC1 2 + 0.82 
mM MgC1 2 (Chapter 2). Networks were made in the presence 
of a variety of substances as described below. Except 
where otherwise indicated, PT, µP' network protein 
concentration, opacity ratio, compaction and permeability 
were determined as described in Chapter 2. 
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7. 2. 1 Effect of glucose 
Glucose was added to fibrinogen solution (3.3 mg/ml) to 
give final concentrations of 10, 40, 70 and 100 mM. In 
other experiments, either 12.5, 20, 35, or 50 mM NaCl was 
added to fibrinogen solutions to adjust the osmolarity to 
that of the solutions which contained glucose. 
In another set of experiments, either 25, 50, 75 or 100 
mM glucose and 125I-labelled fibrinogen were added to the 
fibrinogen solution (1.5 mg/ml). Clotting was initiated 
with 1.5 U/ml thrombin. Networks were left to develop 
fully for 1 hour and then perfused. The radioactivity and 
absorbance at 282 nm of the perfusate were then determined 
(Chapter 2). 
7.2.2 Effect of heparin 
Mucous sodium heparin (David Bull Laboratories) was 
added to fibrinogen solutions (3.3 mg/ml and 1.5 mg/ml) to 
yield final concentrations of 0.18, 0.90, 1.80, 9.0 or 18.0 
U/ml. Networks formed in these solutions were examined for 
compaction, permeability, network protein concentration and 
Pp· These networks and others formed in the presence of 
0.5 U/ml heparin were also examined for opacity ratio and 
In addition, networks were formed 1n fibrinogen 
I 
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solution (2.50 and 5.0 mg/ml) which contained (i) 0.5 U/ml 
heparin, ( ii) 1 pg/ml protamine sulphate or ( iii) 0. 5 U /ml 
heparin+ 1 pg/ml protamine sulphate. The mass-length 
ratios were calculated from turbidity measurements. 
7.2.3 Effect of protamine sulphate 
Protamine sulphate (Sigma, U.S.A.) alone precipitated 
fibrinogen at concentrations greater than 0.5 ug/ml, so 
protamine sulphate was added to fibrinogen solutions (1.5 
mg/ml) at the same time as thrombin. The final protamine 
sulphate concentrations used were 0.1, 0.25, 0.5, 0.75 and 
1.0 pg/ml. 
7.2.4 Effect of heparan sulphate 
According to the manufacturer, heparan sulphate 
(Upjohn, Kalamazoo) contained 18 U/mg of heparin activity. 
It was dialysed against 2 changes of 4 litres of 
distilled water for 12 hours and added to fibrinogen 
solutions (1.5 mg/ml) to achieve final concentrations of 
0.01, 0.05, 0.1, 0.5, 1 or 10 mg/ml. 
7.2.5 Effect of chondroitin sulphates 
Chondroitin-4-sulphate and chondroitin-6-sulphate 
(Sigma, U.S.A.) were freed of ionic contaminants by 
dialysis against 2 changes of 4 litres of distilled water 
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for 12 hours. Networks were formed in fibrinogen solutions 
( 1. 5 mg/ml) which contained 7, 35, 70, 350 and 700 pg/ml of 
either chondroitin-4-sulphate or chondroitin-6-sulphate. 
7.3 RESULTS 
7. 3. 1 Effect of glucose 
Table 7.1 shows that glucose reduced permeability and 
hence Pp without affecting network protein concentration 
when networks were formed with 1.5 U/ml thrombin. These 
networks were fully formed and no further increase in 
turbidity was recorded after 40 minutes following thrombin 
addition. 
The µT and Pp in networks formed with O. 15 U/ml 
thrombin were reduced in the presence of glucose (Figure 
7.1) as was the network protein concentration (Table 7.2). 
Compaction, opacity ratio and permeability were found 
reduced in parallel with PT and Pp (Appendix 6). These 
changes were apparently not influenced by divalent 
cations. 
The decrease in mass-length ratio caused by glucose was 
similar to that induced by NaCl at a similar molar 
concentration (Figure 7.2). However, the decrease in mass-
length ratio induced by glucose, but not that induced by 
NaCl, was associated with a marked reduction in network 
protein concentration. 
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7. 3. 2 Effect of 2rotamine sul2hate and he2arin 
Protamine sulphate increased PT and Pp (Figure 
7.3) but did not significantly affect the network protein 
concentration. Compaction, opacity ratio and permeability 
increased in parallel with PT and Pp (Appendix 6). 
Divalent cations did not influence these changes. 
At concentrations above 1.8 U/ml heparin significantly 
increased PT and Pp (Figure 7.4) while below 1.8 U/ml, 
Pr, but not Pp, was reduced. These observations were 
confirmed in networks formed in 1.5 mg/ml fibrinogen 
(Figure 7.5). 
The effect of heparin on opacity ratio paralleled the 
change in PT while the effect of heparin on compaction 
and permeability paralleled the changes in Pp (Appendix 
6). These changes were not influenced by divalent cations. 
Heparin reduced the network protein concentration most 
effectively at about 1.8 U/ml (Figure 7.6). That is, the 
effect of heparin on network protein concentration 
paralleled the changes in PT but not the changes in 
Fibrinogen concentration appeared to influence the 
effect of protamine sulphate on network structure (Figure 
7. 7) . 1 pg/ml protamine sulphate caused a greater increase 
1n µTat lower concentrations of fibrinogen. On the 
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other hand, 0.5 U/ml heparin decreased mass-length ratio by 
a similar amount at high and low fibrinogen concentrations. 
1 pg/ml protamine sulphate seemed to neutralize 0.5 u/ml 
heparin in its effect on the mass-length ratio. 
7.3.3 Effect of heparan sulphate 
Fibrin networks formed in the presence of more than 0.5 
mg/ml (0.9 U/ml of heparin activity) of heparan sulphate 
were significantly more permeable and displayed higher 
opacity ratios than controls (Figure 7.8). Compaction 
paralleled permeability (Appendix 6). The PT and Pp 
could not be derived because reliable measurements of the 
fibrin concentration in the network could not be made. 
This was because the protein concentration of perfusates 
could not be calculated on account of contamination of 
heparan sulphate with some material which absorbed strongly 
at 282 nm. 
7. 3. 4 Effect of chondroitin sulphates 
Both chondroitin-4-sulphate (Figure 7.9) and 
chondroitin-6-sulphate (Figure 7. 10) induced similar 
changes in fibrin network properties. At concentrations 
above 7 µg/ml they significantly increased PT and Pp· 
The chondroitin sulphates increased compaction, opacity 
ratio and permeability in parallel with PT and Pp 
(Appendix 6). These changes were apparently not influenced 
by divalent cations. 
I 
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7.4 DISCUSSION 
This study demonstrates that when fibrin is formed 
under conditions which simulate those in plasma, the 
structure and properties of the fibrin network may be 
influenced by a variety of substances, some known to be 
present in the extracellular space and some in blood, 
naturally or under therapeutic conditions. 
The studies in this Chapter support the postulate that 
the solubility of fibrin(ogen) strongly affects the 
structure of fibrin networks (Chapter 6). Protamine 
sulphate reduces fibrinogen solubility and increases mass-
length ratio (Figure 7.3). Positively charged protamine 
sulphate molecules presumably precipitate fibrinogen by 
stoichiometrically reacting with the negatively charged 
fibrinopeptides (Stewart and Niewiarowski, 1969). In 
accordance with this suggestion, protamine sulphate 
increases mass-length ratio more efficiently at low 
concentrations of fibrinogen (Figure 7.7). 
Glucose reduces mass-length ratio as well as the 
amount of fibrin formed by 30 minutes (Figure 7. 1). The 
inhibition of fibrin formation by glucose was not a non-
specific effect of increased osmolarity as a similar 
increase in osmolarity with NaCl did not reduce network 
protein concentration (Figure 7.2). The increased 
solubility of fibrin(ogen) in the presence of glucose has 
been attributed to steric hindrance of polymerization by 
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the cyclic conformation of glucose (Einarsson, 1975). 
High concentrations of glycosaminoglycans, such as 
heparin (Figures 7.4; 7.5), heparan sulphate (Figure 7.8) 
and chondroitin sulphates (Figures 7.9; 7.10), presumably 
increase mass-length ratio as a result of a steric 
exclusion effect. All glycosaminoglycans occupy a large 
volume in solution and hence, they exert a marked steric 
exclusion effect on other macromolecules (Laurent, 1975; 
Obrink, 1975). Steric exclusion results in an effective 
increase in the concentration of fibrin(ogen) in solution 
and therefore a decrease in fibrin(ogen) solubility 
(Rampling et al., 1976). Hence, it is likely that steric 
e'X c 1 us ion increases mas s-1 en gt h ratio by d e c re as in g 
fibrin(ogen) solubility. 
It should be noted as discussed in the preceding 
Chapter that although an increase in fibrinogen 
concentration tends to increase mass-length ratio (Carr 
et al., 1977; Hantgan and Hermans, 1979; Wolfe and Waugh, 
1981) this is only seen at very low fibrinogen 
concentrations. At physiological concentrations, the 
increase in the density of fibrils associated with a 
physical increase in fibrin concentration leads to a 
reduction in the extent of rotational diffusion of growing 
fibrils and hence a reduction in the extent of lateral 
aggregation. It is expected, however, that steric 
exclusion results in an effective increase in fibrinogen 
concentration without an increase in fibril density and 
Q 
120. 
consequently only the tendency for an increased mass-length 
ratio is expressed. 
Glycosaminoglycans and proteoglycans also interact non-
specifically with proteins through electrostatic effects 
(Laurent, 1975; Obrink, 1975). Electrostatically, all 
glycosaminoglycans are polyanions at physiological ionic 
strength and pH and thus react with positively charged 
proteins (Laurent, 1975). Sheppard et al. (1957) proposed 
that heparin inhibits fibrin polymerization 
electrostatically. Presumably, low concentrations of 
heparin increase fibrin(ogen) solubility and lead to a low 
mass-length ratio but at higher heparin concentrations, 
steric exclusion effects over-ride and reduce fibrin(ogen) 
solubility leading to a higher mass-length ratio. 
Although the effect of high and low concentrations of 
heparin on PT can be successfully explained in terms of 
fibrin(ogen) solubility, the influence of heparin on Pp 
is unclear. Low concentrations of heparin reduced µT but 
not Pp (Figures 7.4; 7.5). The heparin induced decrease 
in network protein concentration (Figure 7.6) supports the 
suggestion that heparin inhibits polymerization (Sheppard 
et al., 1957). Perhaps low concentrations of heparin also 
inhibit the development of the minor network (see Chapter 
6) and thereby increase Pp relative to PT· It should 
be noted that antithrombin III is not present in these 
systems and hence, thrombin would not be inhibited by 
heparin as occurs in vivo. 
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It is obvious from this discussion on the mechanism 
underlying changes in network structure that a primary 
cause of major changes in network structure is an 
alteration in fibrin(ogen) solubility. Inhibition of 
fibrin polymerization, that is, an increase in fibrin(ogen) 
solubility causes a relative decrease in mass - length ratio 
while a decrease 1n fibrin(ogen) solubility by virtue of 
charge or steric exclusion effects results in the opposite 
change in network structure. With this realization the 
task of identifying substances which alter network 
structure in vivo and of selecting substances for 
therapeutic control of fibrin network structure might 
become easier. 
7.5 CONCLUSIONS 
(1) The structure and properties of fibrin formed under 
conditions which simulate those in plasma are sensitive to 
a variety of clinically and physiologically important 
substances. 
(2) Studies support the postulate that the solubility of 
fibrin(ogen) greatly influences the structure of fibrin 
networks. 
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Table 7.1 
glucose 
(mM) 
Control 
25 
50 
75 
100 
122. 
The effect of glucose on Darcy constant and 
network 2rotein concentration at 1 .5 U/ml 
thrombin. 
Darcy constant 
x 10 11 ( cm 2) 
180.6 + 2.9 
-
1 66. 0 + 2.0 
-
139.0 + 8.5 
-
130.0 + 9.6 
-
11 8. 9 + 2. 1 
-
network protein concentration 
(mg/dl) 
137.3 + 0.4 
-
137.9 + 0.4 
-
137.4 + 0. 6 
-
137.3 + 0.8 
-
136.5 + 0. 6 
-
Networks were formed with 1.5 U/ml thrombin 1n fibrinogen 
solution (1.5 mg/ml) which contained 1.2 mM Cac1 2 + 0.82 
mM MgC1 2 using 1.5 U/ml thrombin. Networks were fully 
formed when perfused. Results are the mean of 3 
determinations+ SD. Compare these results with those in 
Table 7.2 where thrombin concentration is 10 fold lower. 
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Table 7.2 The effect of glucose on network protein 
concentration at 0.15 U/ml thrombin. 
glucose 
(mM) 
Control 
10 
40 
70 
100 
network protein concentration 
(mg/dl) 
301. 0 + 2. 1 
-
287.2 + 4.5 
-
257.7 + 9.4 
-
214.9 + 1 2. 0 
-
145.8 + 1 0. 0 
-
Networks were formed with 0.15 U/ml thrombin in fibrinogen 
solutions (3.3 mg/ml) which contained 1.2 mM CaC1 2 + 0.82 
mM MgC1 2 . Similar results were obtained when divalent 
cations were not present. Results are the mean of 3 
determinations+ SD. 
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Figure 7.1 The effect of glucose on µ1 and µP. 
Networks were formed in fibrinogen solutions (3.3 mg/ml) 
which did not contain divalent cations ( t]) or which 
contained 1. 2 mM CaC1 2 + 0. 82 mM MgC1 2 ( X). Results 
are the mean of 3 determinations+ SD. 
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Networks were formed in fibrinogen solutions (1.5 mg/ml) 
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contained 1. 2 mM CaC1 2 + 0. 82 mM MgC1 2 ( X). Results 
are the mean of 3 determinations+ SD. 
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The effect of heparin on µT and µP (I). 
Networks were formed in fibrinogen solutions (3.3 mg/ml) 
which did not contain divalent cations. Similar results 
were obtained in the presence of divalent cations. Results 
are the mean of 3 det e rminations+ SD. 
- -
128 . 
Y0 
- 30 5 
~ 
~ 
re 
Ci 
-
20 
N Lr° l ISi 
X 
' I 
::t m 10 ' 
0 3 6 9 12 tk ta 
HEPARfN (U/ML> 
100 
H0 
-b 
~ 
Cl 60 I-
re 
Ci 
-N 
-I Y0 ISi 
-------¢ X 
~ 0 
r,;i,r/ 20 
0 3 6 9 12 1k lB 
HEPARIN <UIML> 
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Networks were formed in fibrinogen solutions (1.5 mg/ml) 
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of 3 determinations+ SD. 
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divalent cations. Results are the mean of 3 determinations 
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Networks were formed in fibrinogen solutions (1.5 mg/ml) 
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are the mean of 3 determinations+ SD. 
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Networks were formed in fibrinogen solutions (1.5 mg/ml) 
which did not contain divalent cations ( D) or which 
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are the mean of 3 determinations+ SD. 
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Figure 7.10 The effect of chondroitin-6-sul2hate on µT 
and µP. 
Networks were formed in fibrinogen solutions (1.5 mg/ml) 
which did not contain divalent cations ( Q) or which 
contained 1. 2 mM CaC1 2 + 0. 82 mM MgC1 2 ( X). Results 
are the mean of 3 determinations+ SD. 
SECTION III 
STUDIES ON NETWORKS FORMED IN PLASMA 
CHAPTER 8 
COMPARISON OF FIBRIN NETWORKS IN 
PLASMA AND FIBRINOGEN SOLUTION 
AND THE EFFECT OF 
ANTICOAGULANTS AND HANDLING PROCEDURES 
136. 
8.1 INTRODUCTION 
Fibrin network formed in plasma differs from that 
formed in purified fibrinogen solutions in two fundamental 
ways. During network development in plasma in the absence 
of anticoagulants, the thrombin concentration increases 
explosively (Liu et al., 1979). In anticoagulated plasma 
and in purified fibrinogen solutions, however, the thrombin 
concentration does not increase during network development. 
Networks formed in plasma also differ from those formed in 
purified solutions in that many plasma components such as 
i mm u no g 1 ob u 1 ins ( Reg e o c z i , 1 9 6 8 ) , fib r one ct in and a 2-
a n tip las min (Mosher, 1980) are incorporated into the 
network matrix. It was not known whether basic differences 
in network development and composition affect the structure 
and properties of fibrin networks and if so, whether these 
differences are affected by the anticoagulant used or by 
the procedure used to prepare the plasma. 
Studies described in this Chapter compare networks 
formed in plasma prepared under different conditions with 
networks formed in serum reconstituted with fibrinogen and 
with networks formed in purified fibrinogen solutions. 
8.2 MATERIALS AND METHODS 
8. 2. 1 Preparation of plasma clots 
137 . 
8.2.1.1 Blood donors 
Donors had fasted overnight and had not taken any drugs 
known to affect platelet function or blood coagulation for 
10 days. All donors were healthy and had normal full blood 
and differential counts as measured with a Technicon 
Hemalog. Blood was drawn by atraumatic venepuncture using 
21 gauge needle, 20 ml plastic syringes and mild 
compression with tourniquet and collected into different 
anticoagulants as described in 8.2.2, 8.2.3 and 8.2.4. 
8.2.1.2 Plasma 
Unless otherwise stated, blood was centrifuged for 15 
minutes at 2500 gin a MSE multex bench centrifuge at room 
temperature . In some studies, a MSE Minstral 6L centrifuge 
was used for centrifuging at 2°c. The resulting 
platelet-poor plasma (PPP), was removed with a siliconized 
pasteur pipette. Platelet-free plasma (PFP) was prepared 
by centifuging PPP for 10 minutes at 10,000 gin a MSE high 
speed 25 at room temperature. 
8.2.1.3 pH measurements 
The pH of blood was measured with a Radiometer ABL-1 
Acid-Base Laboratory. The pH of the anticoagulants was 
measured with a PHM 62 standard pH Meter (Radiometer, 
Copenhagen). 
' I 
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8.2.1.4 Buffered citrate 
A mixture of 0.2M trisodium citrate and 0.2M acid 
citrate of pH 6.80 (hereafter termed buffered citrate) was 
sometimes used as an anticoagulant. Preliminary studies 
showed that blood collected into 0.2M trisodium citrate in 
ratio 19: 1 had a pH of about 7.7, while blood collected 
in the same ratio into 0.2M buffered citrate had a pH of 
7.404 + 0.015 (n=6). 
8.2.1.5 Fibrin networks in plasma 
Fibrin networks were developed in plasma by clotting 
960 ul of plasma with 40 ul of 3.75 U/ml thrombin dissolved 
in either 0.6M CaC1 2 (thrombin /CaC1 2 ) or 0.895% 
saline. Where required, 10 µl (approximately 107 
counts/min) of 125I-labelled fibrinogen was added to 950 
µl of plasma prior to clotting. Radioactivity counts were 
made (Chapter 2). 
8.2.1.6 Perfusion of networks in plasma 
In preliminary studies, networks formed in plasma with 
0.15 U/ml thrombin sometimes collapsed under 15 cm pressure 
head of water. It was therefore decided to perfuse all 
plasma clots at a pressure head of 10 cm of water and to 
precoat the internal surfaces of the perfusion tubes (Carr 
et al., 1977) with a film of purified fibrin 
containing ca++ and Mg++ (Chapter 2) so as to obtain 
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good adherence of plasma clots to perfusion tubes. The 
fibrin film was left for 1 hour before plasma was added and 
clotted. Permeability was measured as otherwise described 
in Chapter 2. 
8.2.1.7 Networks in fibrinogen solution 
Unless otherwise stated, fibrin networks were 
formed with 0.15 U/ml thrombin in fibrinogen solution (3.3 
mg/ml) which either did not contain divalent cations or 
which contained 1.2 mM CaC1 2 + 0.82 mM MgC1 2 
(Chapter 2). Networks were examined using the methods 
described in Chapter 2. 
8.2.1.8 Electron microscopy 
Blood was collected into 0.2M buffered citrate in the 
ratio of 19:1 and PPP prepared. Networks were formed using 
thrombin (1.5 U/ml) and specimens prepared for transmission 
and scanning electron microscopy as described in Chapter 2. 
A similar procedure was followed for forming networks in 
fibrinogen solution containing divalent cations. 
8.2.2 Networks in serum 
9.5 ml of blood was collected into tubes which 
contained 60 µl 125I-fibrinogen and 0.5 ml of 0.2 M 
buffered citrate. Some of the anticoagulated blood was 
processed to yield PFP, and the remainder was clotted with 
14 0 . 
thrombin/Cac1 2 . Some of the PFP was also clotted with 
thrombin/CaC1 2 . The final thrombin concentration was 
O. 15 U/ml. The serum from coagulated blood and plasma 
specimens was removed 2 hours later. The thrombin 
concentration in the serum was determined using a thrombin 
clotting time standard curve prepared with stock PFP 
(collected from 10 blood donors, pooled and stored at 
-77°C), thrombin standards and a fibrometer (BBL,USA). 
Further thrombin was added to the serum to bring the 
thrombin concentration to 1 U/ml. These sera were then 
reconstituted with fibrinogen which was adjusted to the 
same level as in the plasma. PFP was also clotted with 
thrombin/Cac1 2 so that the final concentration was 1 
U/ml. The fibrinogen concentration was determined using 
the heat precipitate determination of Goodwin (1965). All 
clots were left to develop fully for 1 hour before µT 
and µp were determined. 
8.2.3 Effect of anticoagulant and recalcification 
9.5 ml blood was collected into chilled tubes kept on 
ice. These tubes either did not contain any solution or 
contained 0.5 ml of 0.2 M buffered citrate or 0.5 ml of 1.2 
M NaCl. The tubes were immediately centrifuged at 2°c. 
PPP was removed and warmed to room temperature in a water 
bath. The PPP was then clotted with thrombin/CaC1 2 or 
thrombin alone. The opacity ratio and compaction were 
measured 30 mi nutes later (Chapter 2). 
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8.2.3.1 Effect of citrate 
A mixture of acid citrate and trisodium citrate at pH 
7.4 was used to give final citrate concentrations of 2.5, 
5.0, 7.5, 10.0 or 12.9 mM. The ionic strength of these 
solutions was maintained at 0.153. 
8.2.4 Effect of anticoagulants, temperature and 
platelet release products 
9.5 ml of blood was collected into 0.5 ml of 0.2M 
buffered citrate or CTP (see 9.2.4. 1 for final 
concentrations of components). In addition, 9.0 ml of 
blood was mixed with 1 ml of 3.8% trisodium citrate. These 
anticoagulated blood samples were either immediately 
chilled on crushed ice and centrifuged at 2°c to yield 
PPP which was then warmed to room temperature in a water 
bath, or the blood was processed entirely at room 
temperature. The PPP was clotted with either 
thrombin/Cac1 2 or thrombin alone. The opacity ratio and 
compaction were measured 30 minutes later. 
8.2.4.1 Effect of citrate-theophylline-PGE 1 
solution 
Fibrinogen solutions with 10 mM buffered citrate (pH 
7.4) was used as the control. To this was added (final 
concentration) either 10 mM theophylline (Sigma, USA) or 
0. 001% ethanol or 0. 1 µg Prostaglandin E1 (Sigma, USA) 
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dissolved in 0.001% ethanol or both Prostaglandin E1 and 
theophylline. 
8.2.4.2 Effect of citrate-phosphate-dextrose solution 
CPD from unused blood packs (Tuta, Sydney) was added to 
fibrinogen solution or blood in a ratio of 1:6.8. The pH 
was recorded and networks formed. In separate experiments, 
the pH of these solutions was readjusted to 7.4 with HCl 
before clotting. 
8.2.4.3 Effect of platelet release products 
PF 4 , ~TG and yTG were gifts from Dr. F.J. Morgan (St. 
Vincent's School of Meqical Research, St. Vincent's 
Hospital, Melbourne). These were dissolved in distilled 
water and added to fibrinogen solutions to achieve final 
concentrations of 5, 10, 50 and 100 µg/ml. 
8.3 RESULTS 
8. 3. 1 Networks formed in plasma and purified 
solutions 
Table 8.1 shows that networks formed in plasma compact 
more easily than purified fibrin networks. Although both 
µT and Pp of plasma networks are greater than those 
established for purified fibrin networks formed under 
patho-physiological conditions, the Pp of plasma networks 
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is much larger than would be expected from the ratio of 
µp to µT found in purified fibrin networks. 
Under transmission electron microscopy, fibrin networks 
formed in plasma appear identical to networks formed in 
purified fibrinogen solutions (Figure 8.1). Under scanning 
electron microscopy, however, fibrin networks formed in 
plasma were different to those formed from purified 
fibrinogen. The fibrin fibres of plasma clots seemed 
compacted together as if deformed during the freeze-drying 
process (Figure 8.2). 
8. 3. 2 Networks formed in serum 
Figure 8.3 shows that the Pp of networks in plasma is 
substantially higher than that of networks in reconstituted 
sera. The PT of networks in plasma, however, is 
significantly lower than that in reconstituted sera. The 
ratio of PT to µ 0 is much lower in networks in plasma 
• 
than in reconstituted sera. 
The PT of clots formed in PFP serum is not 
significantly different from that of clots formed in serum 
from anticoagulated blood (Figure 8.3). The µP of the 
former, however, is significantly lower (p(F) < 0.0171) 
than that of the latter. 
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8.3.3 Effect of anticoagulant and recalcification 
The effect of anticoagulants and recalcification on 
networks in plasma is shown in Figure 8.4. The opacity 
ratio and compaction of networks in anticoagulated PPP with 
thrombin/Cac1 2 are not significantly different from those 
in native PPP. When anticoagulated plasma was clotted 
without recalcifying the opacity ratio was reduced and 
compaction increased relative to the values in native PPP. 
NaCl of the same ionic strength as 0.01M citrate decreased 
both opacity ratio and compaction. 
Networks made in native PPP or in anticoagulated PPP 
with thrombin/CaC1 2 showed significant retraction and 
sometimes an opacity ratio greater than 1.000. This was 
never observed in networks in PFP or in PPP with thrombin 
alone. 
When PFP (made with 0.2M buffered citrate and 
containing 1251-fibrinogen) was clotted with 
thrombin/CaC1 2 , 92.4 ~ 3.1% of the 125I - fibrinogen was 
converted into network. However when thrombin alone was 
used for clotting only, 42.5 + 4.1% of the label was 
incorporated into the network by 30 minutes (n=10). 
Citrate alone significantly increased PT and Pp in 
purified fibrin at constant ionic strength and pH (Figure 
8.5). Citrate increased compaction, opacity ratio and 
permeability in parallel with PT and Pp · These changes 
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were apparently not influenced by divalent cations. 
8. 3. 4 Effect of anticoagulants, temperature and 
platelet release products 
Opacity ratio and compaction of networks formed in PPP 
(Figure 8.4) is greater than the corresponding value in PFP 
(Figure 8.6). 
The temperature at which PPP 1s prepared and the 
presence of theophylline or PGE 1 does not significantly 
affect opacity ratio or compaction (Figure 8.6). 
Theophylline and PGE 1 , do not significantly affect 
the opacity ratio or permeability of purified fibrin 
networks (Figure 8.7). A very low concentration of ethanol 
increases opacity ratio and permeability slightly. 
The opacity ratio and compaction in networks formed 
using thrombin/CaC1 2 in PFP containing 3.8% trisodium 
citrate were significantly higher (p(F)<0.0008 and 0.0026 
(4°C); p(F)<0.0261 and 0.0002 (22°c), respectively) 
than those in networks formed in PFP containing buffered 
citrate (Figure 8.5). However, these values proved to be 
linearly correlated (p(F)<0.0152 and 0.0001 (4°c); 
p(F)<0.0001 and 0.0001 (22°c), respectively). Further, 
the opacity ratio and compaction in networks formed using 
thrombin alone in PFP containing 3.8% trisodium citrate 
were linearly correlated (p(F)<0.028 and 0.0003 (4°C); 
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p(F)<0.0031 and 0.0071 (22°C), respectively) with those 
in networks formed using thrombin/CaC1 2 in PFP containing 
buffered citrate. 
Three platelet proteins known to be released during 
coagulation were found not to significantly influence the 
mass-length ratio in purified fibrin network (Figure 8.8). 
Blood collected in CPD had a pH of near 6.0. Networks 
formed very slowly in plasma prepared from CPD blood, even 
at pH 7.4. These networks could not withstand pressure 
heads of 5 cm during permeation and collapsed completely 
when examined for compaction. 
As Table 8.2 shows, CPD also dramatically affected 
networks formed in purified fibrinogen. The pH of the 
buffered fibrinogen solution with CPD was about 6.5. These 
networks were not fully formed at 30 minutes as indicated 
by the large perfusate protein concentration. 
Consequently, these networks exhibited large permeability 
and compaction relative to the control. On the other hand, 
when the pH of CPD-fibrinogen solutions was readjusted to 
that of the control, network permeability and compaction 
were much lower than those in the control. They were so 
low, in fact, that perfusate could not be collected nor 
compaction measured. Hence, mass-length ratio could not 
be calculated. 
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8.4 DISCUSSION 
Although networks formed in plasma are similar to those 
formed in purified fibrinogen solution in terms of their 
appearance under the transmission electron microscope 
(Figure 8.1) they differ in their ability to resist 
deformation during freeze drying (Figure 8.2) and 
centrifugation (Table 8.1). Relative to purified fibrin 
networks, networks formed in plasma are considerably more 
permeable than their PT would indicate (Table 8.1). It 
is thus obvious that networks formed in plasma exhibit 
different mechanical properties to purified fibrin 
networks. 
The reason underlying the differences in network 
characteristics in plasma and in fibrinogen solution is not 
known. Networks formed in serum do not display the 
relatively great permeability which seems such a 
characteristic feature of networks in plasma (Figure 8.3) 
The enhanced permeability does not arise from deformation 
under perfusion conditions (Appendix 3). It seems possible 
that some plasma component is responsible for perfusion 
characteristics of networks developed in it. Furthermore, 
because such an enhanced permeability does not feature 
prominently in networks made in reconstituted sera, it may 
be that the responsible plasma component is in some way 
consumed during network development. 
It 1s known that some plasma components which are 
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incorporated into networks may alter their tensile 
properties and hence the ease with which networks deform. 
For example, fibronectin, which comprises 
about 4% of the mass of the network formed in plasma 
(Mosher, 1980), considerably increases the elastic modulus 
of fibrin, presumably by binding fibres together 
(Kamykoski et al., 1981). 
The relative absence of the minor network in plasma 
networks may also explain their relatively great 
permeability and deformability. Networks formed in native 
plasma characteristically contain no fibres of less than 
100nm diameter (Koppel, 1962). Perhaps, unlike networks 
formed in serum and fibrinogen solution, the minor network 
does not develop where thrombin concentration increases 
explosively in native (Shuman and Majerus, 1976) and 
recalcified anticoagulated plasma (Liu et al., 1979). In 
other words, the amount of minor network formed when 
networks are developed with a fixed thrombin concentration 
may be greater than where the thrombin concentration 
increases sharply. 
Unlike networks formed in anticoagulated plasma using 
thrombin alone (0.15 U/ml), the progressive increase in 
thrombin concentration in plasma clotted using 
thrombin/CaC1 2 (Liu et al., 1979) results in almost 
complete conversion of fibrinogen into fibrin network. The 
lower fibrin concentration in networks formed in 
anticoagulated plasma using thrombin alone accounts for 
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their relatively low opacity ratio and high compaction 
(Figures 8.4 and 8.6). 
Differences in thrombin concentration resulting from 
the generation of additional thrombin in recalcified 
plasma can explain the relatively small differences in PT 
of networks formed in plasma and reconstituted serum 
(Figure 8.3). Thus, although platelets contain substances 
which reduce mass-length ratio (Dhall et al., 1982), it 
seems unlikely that cellular elements of blood release 
components which substantially increase mass-length ratio. 
Greater than serum concentrations (Bolton et al., 1976, 
Prowse et al., 1980) of platelet release products do not 
significantly affect mass-length ratio (Figure 8.8), and 
neither does collecting the blood under conditions known 
to inhibit release of platelet products viz collection of 
blood into CT P on ice (Jakubowski, 1980), ( Figure 8. 6). It 
thus seems likely that the very thick fibrin fibres found 
associated with platelets in thrombi (Gottlub, 1975; 
Hattori et al., 1978; Hisano, 1978) and haemostatic plugs 
(Sixma and Wester, 1977) are not caused by enhanced lateral 
polymerization due to platelet release products, but rather 
they may be simply thinner fibrin fibres which have been 
drawn together during platelet mediated clot retraction 
(James et a 1 . , 1 9 6 0; 1 9 6 2; S z a 1 on ta i , 1 9 6 8) • 
It is apparent that the structure of networks formed in 
plasma is sensitive to the anticoagulant used. 
Anticoagulant concentration (Figure 8.5), pH (Table 8.2) 
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and ionic strength (Figure 8.4), all influence the network 
characteristics. But to a large extent, the effect of 
anticoagulant on the fibrin content of networks formed in 
plasma appears to be neutralized by recalcification (Figure 
8. 4) • 
This might suggest that the anticoagulant in transfused 
blood will not affect fibrin network structure and 
properties provided enough ca++ is available in the 
circulation to neutralize the citrate load. This may not 
be the case where large volumes of blood are administered 
clinically. In such cases, circulating high concentrations 
of citrate, glucose and phosphate may affect the 
development of fibrin network structure in vivo. This is 
an area which will require full examination in the future. 
8.5 CONCLUSIONS 
(1) The networks formed in plasma are more permeable and 
deform more readily than networks formed in purified 
fibrinogen solutions. 
(2) The networks formed in plasma are sensitive to 
anticoagulants, ionic strength and pH but, to a large 
extent, the effect of anticoagulants is neutralized by 
recalcification. 
(3) The cellular elements of blood do not release stable 
serum soluble factors which increase the mass-length 
ratio. 
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Table 8.1 Comparison of µT~p and compaction of 
networks formed in plasma and in purified 
fibrinogen solutions. 
NETWORKS FORMED IN 
PLASMA PURIFIED FIBRINOGEN SOLUTIONS 
PT X 1012 24.6 + 3 . 1 1 5. 1 + 4.2 
- -(dal tons/cm) 
Pp X 1012 83. 4 + 34.9 20. 1 + 8.8 
- -(daltons/cm) 
Compaction 67.8 + 5.4 1 0. 0 + 4.6 
- -( % ) 
Networks were formed either in PFP using buffered citrate 
and thrombin/CaC1 2 (results expressed as the mean of at 
least 5 observations+ SD) or in purified fibrinogen 
solution containing 1.2 mM CaC1 2 + 0.82 mM MgC1 2 where 
ionic strength, pH, temperature thrombin and fibrinogen 
concentrations were varied within physiological ranges 
(results from Chapter 6 expressed as the mean of at least 
26 observations+ SD). 
Table 8.2 
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The effect of CPD at different pHs on opacity 
ratio, permeability, compaction and network 
protein concentration 
Opacity ratio Darcy constant Compaction Fibrin cone. 
x10 11 cm2 (%) (mg/ml) 
Control 0.78 + 0.04 68. 1 + 9.5 9.2 + 0.7 3.02 + 0.03 
CPD-pH 6.5 0.69 + 0.05 1046 + 48 32.5 + 1.0 1.19 + 0.02 
CPD-pH 7.4 0.31 + 0.01 3.4+0.1 NA NA 
Networks were formed in fibrinogen solution (3.3 mg/ml) of 
different pHs which contained 1.2 mM CaC1 2 + 0.82 mM 
MgC1 2 . Similar results were obtained in the absence of 
divalent cations. Results are the mean of 3 observations 
+ SD. 
Figure 8. 1 Transmission electron micrographs of fibrin 
networks formed in plasma (above) and in 
purified fibrinogen solution 
The magnification of these micrographs is the same. 

Figure 8.2 Scanning electron microgra2hs of fibrin 
network formed in Rlasma (above) and in 
2urified fibrinogen solution 
Scale is 20pm and the magnification of these micrographs 
are the same. 
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I 
PFP PFP SERR BLOOD SERR 
The µT and µp of networks formed in PFP 
and reconstituted sera 
The µT (open bars) and µP (cross-hatched bars) was 
determined in networks made in PFP or in the sera from PFP 
(PFP Sera) and blood (Blood Sera) which was reconstituted 
with fibrinogen. Results are the mean of data from 5 
observations+ SEM. 
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Networks were formed in PPP prepared with and without 
anticoagulant and clotted with thrombin/CaCl2 
(THR/CA++) or thrombin alone. The native PPP either did 
not contain any additives (CONTROL) or it contained NaCl of 
the same ionic strength as the anticoagulant(+ SALINE). 
Results are the mean of 10 observations+ SEM. 
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The effect of citrate on µT and µp 
Networks were formed in fibrinogen solutions (3.3 mg/ml) 
which either did not contain divalent cations ( D) or which 
contained 1. 2 mM CaC1 2 + 0. 82 mM MgC1 2 ( X). Results 
are the mean of 3 observations+ SD. 
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B . {IT. CTP ~CIT. 
(THR/CA++> <THRICR++> <THRl<:R++> 
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< THR/ CA++> < THR/ CR++> < THR/ CA++> 
The effect of anticoagulants and temperature 
on opacity ratio and compaction 
Networks were formed 1n PFP prepared with buffered citrate 
(BUFF. CIT.), CTP or 3.8% trisodium citrate (NA 3 CIT) at 
room temperature (crosshatched bars) or on ice (open bars) 
and clotted with thrombin/CaC1 2 (THR/CA++) or thrombin 
alone (THR) at room temperature. Results are the mean of 
10 observations+ SEM. 
........ 
Figure 8.7 The effect of CTP constituents on opacity 
ratio and permeability 
Networks were made in fibrinogen solution (3.3 mg/ml) which 
contained 1.2 mM CaC1 2 + 0.82 mM MgC1 2 . Solutions also 
contained 10 mM buffered citrate (Control) and 10 mM 
theophyline (TLN), 0.001% ethanol (ETOH), 0.1 ug PGE 1 
(PGE 1 ), or all these components (CTP). Mass-length ratio 
was not calculated because network protein concentration 
could not be determined as theophylline adsorbed strongly 
at 282 nm. Similar results were obtained for networks 
formed in the absence of divalent cations. Results are the 
mean of 3 observations+ SD . 
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Figure 8.8 The effect of 100 µg/ml of PF 4 , pTG and yTG 
on µT and µp 
Networks were formed in fibrinogen solution ( 1. 5 mg/ml) 
which contained 1.2 mM Cac1 2 + 0.82 mM MgC1 2 . Similar 
results were obtained in the absence of divalent cations. 
The open bars represent uT; the cross-hatched bars 
represent up. Results are the mean of 3 observations+ 
SD. 
CHAPTER 9 
EFFECT OF OPERATION ON FIBRIN NETWORK STRUCTURE 
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9. 1 INTRODUCTION 
The postoperative period is characterized by a number 
of changes in the haemostatic mechanism: the platelet 
count decreases immediately after surgery (Innes and 
Sevitt, 1964), platelet adhesiveness increases (Ardlie et 
al., 1967), whole blood clotting time and recalcified 
plasma clotting time shorten (Blomback et al., 1964), 
fibrinogen concentration increases (Egeberg, 1962) and 
fibrinolytic activity decreases (Innes and Sevitt, 1964). 
It seemed possible that this period is also associated with 
changes in fibrin network structure and this has been 
examined. 
9.2 MATERIALS AND METHODS 
Blood was obtained from 26 patients admitted to the 
Woden Valley Hospital for elective abdominal surgery 
preoperatively, and then on the first, third and fifth days 
following surgery. Informed consent was obtained from all 
patients. Those who had taken aspirin or other drugs known 
to affect platelet reactivity or blood coagulation were 
excluded from the study. 
Blood obtained with minimal stasis with a 19G needle 
was collected in the ratio of 9 1 in 3.8% trisodium 
citrate. It was centrifuged at room temperature for 15 
minutes at 1,300g to obtain platelet-poor plasma (PPP). 
Plastic or siliconized glassware was used for handling 
blood and plasma. 
16 3 . 
900 µl of PPP was clotted with 100 pl of 2.5 U/ml 
thrombin and 30 minutes later, the turbidity at 350 and 608 
nm was recorded using plasma as the blank. Turbidities 
were used to calculate opacity ratio and PT (Chapter 2). 
PPP was also diluted 1 in 3 volumes with 0.895% NaCl. 900 
pl of this diluted PPP was clotted with 100 µl of 2.5 U/ml 
thrombin and the compaction, opacity ratio and PT were 
determined as fully described in Chapter 2. The fibrinogen 
concentration of plasma was determined gravimetrically 
(Hickman, 1971 ). The refractive index of plasma in healthy 
subjects (Appendix 1) was used to calculate µT from 
turbidity and fibrin concentration. 
Fibrinogen to fibrin conversion data in healthy 
subjects was used to calculate µT. The amount of 
fibrinogen converted into fibrin in diluted and undiluted 
PPP samples from 10 donors was determined by adding 1251 
fibrinogen to the plasma before clotting. Plasma was 
clotted as described above and centrifuged at 30 minutes to 
obtain serum. Radioactivity of the serum was measured and 
the percentage conversion calculated. 
9.3 RESULTS 
Fibrinogen concentration, compaction (Figure 9.1), 
opacity ratio and PT (Figure 9.2) in fibrin network 
increase significantly after operation. There is a further 
increase on the third postoperative day in all values with 
the exception of µT. This is followed by a return 
1 6 4 . 
towards preoperative values on the fifth postoperative day. 
The PT returned towards preoperative value after the 
first postoperative day and remained at preoperative levels 
on the third and fifth postoperative days. In other words, 
fibrinogen concentration, compaction and opacity ratio in 
fibrin network increase substantially following major 
surgery, but over the same period the mass-length ratio 
changes relatively little. 
Dilution of plasma always resulted in an increase in 
Pr, which in diluted PPP was linearly related to that in 
undiluted PPP (Table 9. 1). Whereas less than half of the 
fibrinogen in undiluted PPP (42.4 + 4.2%) was converted to 
fibrin, nearly all the fibrinogen in diluted PPP (95.3 
+0.6%) was converted to network. The final fibrin 
concentration in both diluted and undiluted plasma clots 
did not interfere with the calculation of µT. 
As shown in Table 9.1 the PT and the opacity ratio 
were linearly correlated with the fibrinogen concentration. 
Mass-length ratio was not found to be directly related to 
opacity ratio but when opacity ratio was divided by 
fibrinogen concentration to allow for changes in the 
latter, then that value correlated linearly with the mass-
length ratio. Neither the fibrinogen concentration nor the 
mass-length ratio correlated with network compaction. 
I 
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9.4 DISCUSSION 
In this Chapter it has been shown that surgery is 
followed by consistent changes in fibrin network 
characteristics. On the first three days after surgery 
there is a substantial increase in the fibrin mass of the 
network, that is, in the density of fibres in the network. 
This is associated with an increase in the ease with which 
the network may be compacted (Figure 9.1). These parameters 
begin to return to preoperative values after the third 
postoperative day. Immediately following surgery PT 
increases and then rapidly returns to preoperative value by 
the third postoperative day. These findings show that the 
number as well as thickness of individual fibrin fibres 
increase following surgery. 
The consistency of the postoperative response of fibrin 
network suggests that it is subject to a regulatory 
control. But the precise mechanism which underlies the 
changes described in this Chapter remains unknown. From a 
comparison of findings in plasma and in vitro experiments 
in purified fibrinogen solutions described earlier in this 
thesis a tentative understanding of some determinants of 
fibrin network structure in the postoperative period may be 
reached. 
Firstly it seems likely that compaction in fibrin 
networks in plasma is not influenced by the postoperative 
changes in fibrinogen concentration since the two do not 
< 
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correlate closely (Table 9.1). Furthermore, while 
compaction increases in parallel with fibrinogen 
concentration in post-operative plasma (Figure 9.1), in a 
purified fibrin network compaction decreases when 
fibrinogen concentration increases (Chapter 6). 
Secondly, compaction in networks in plasma does not 
seem to be influenced by the changes in mass-length ratio 
because network compaction in plasma did not correlate 
linearly with PT (Table 9.1). This is contrary to 
findings in purified fibrinogen (Chapter 5). 
It seems likely that changes in the tensile properties 
of fibrin and to a lesser extent, changes in the 
distribution of fibres in the major and minor networks 
underlies the observations made on compaction of fibrin 
networks in plasma in the postoperative period. 
Thirdly, while the mechanism underlying the initial 
increase in PT on the first postoperative day is not 
clear the decrease towards preoperative values on the third 
and fifth postoperative days may be related to the increase 
in the fibrinogen concentration. It is known that an 
increase in fibrinogen concentration above physiological 
levels decreases PT (Chapter 6). Indeed, µTwas 
inversely related to fibrinogen concentration in the post-
operative period (Table 9.1). 
Fourthly, it would seem that the changes 1n opacity 
1 67. 
ratio result from an increase in the plasma fibrinogen 
after operation. The statistical correlation between 
opacity ratio and fibrinogen concentration is highly 
significant (Table 9.1). Furthermore, a strong influence 
of fibrinogen concentration on opacity ratio is revealed in 
the linear correlation between PT and opacity ratio 
divided by fibrin concentration (Table 9.1). This supports 
earlier findings (Chapter 5) which show that opacity ratio 
is influenced by both µT and the density of network 
fibres. 
9.5 CONCLUSIONS 
(1) The structure and properties of fibrin networks in 
plasma changes consistently after an operation. Following 
surgery, network compaction and fibrinogen content increase 
substantially whereas PT increases only transiently. 
(2) Unlike compaction in networks made in purified 
fibrinogen solutions those in plasma are not directly 
influenced by changes in fibrinogen concentration or by 
fibre thickness. 
(3) Results suggest that fibrinogen concentration is a 
major factor affecting post-operative changes in PT in 
plasma clots. 
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Table 9.1 The linear correlations between sets of data 
expressed as correlation coefficient and level 
of significance. 
PLOT OF: 
PT 
1 VS u 2 T 
PT 
1 VS opacity ratio 
PT 
1 vs fibrinogen (mg/ml) 
opacity ratio vs 
fibrinogen (mg/ml) 
PT 1 vs opacity ratio/(mg/ml) 
PT 2 vs compaction 
CORRELATION COEFFICIENT (r) 
0.737*** 
-0.063 NS 
-0.480*** 
0.801*** 
compaction vs fibrinogen (mg/ml) 
0.649*** 
0.187 NS 
0.134 NS 
D a ta a r e fr om a 11 2 6 p a t i en t s on 4 days ( n = 1 0 4 ) . * * * 
indicates significance at greater than p(F) < 0.0001 while 
NS indicate p(F) > 0.05. Superscript 1 and 2 refer to data 
from undiluted and diluted plasma, respectively. 
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PRE-DP 3 
DRYS FDLLDWING SURGERY 
The changes in com2action and fibrinogen 
concentration following surgery. 
Compaction data are from networks formed in diluted plasma. 
Results are the means+ SEM of 26 patients. ***and*** 
' 
represents results significantly different from data from 
the preceding study day at the 0.05, 0.005 and 0.001 level 
(paired t test). +, ++and+++ represents results 
significantly different from the preoperative values at 
0.05, 0.005 and 0.001 level (paired t test). 
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Figure 9.2 The changes in µT and opacity ratio 
following surgery. 
Data are from networks formed in undiluted plasma. 
caption details as in Figure 9.1. 
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10.1 GENERAL DISCUSSION 
It seems surprising that although a great deal of 
attention has been focused on the dynamics of the 
coagulation of blood in particular on the clotting time, 
the end product of the coagulation cascade, the fibrin 
network, has not been as critically examined. Recent 
technological advances have allowed development of 
automated turbidimetric techniques for determining the 
clotting end point. Routine clinical use of such 
techniques has demonstrated that in plasma clots turbidity 
can vary considerably. Turbidity reflects network 
structure. The general assumption that in any clot formed 
under physiological conditions the network of fibrin fibres 
is much the same is not true. The general aim of the 
investigation described in this thesis was to examine the 
variation in fibrin network characteristics in clots made 
under physiological conditions. 
As a background to the studies described in this thesis 
it will be recalled that more than three decades ago it was 
shown that fibrin clots of radically different turbidity 
and mechanical properties may be formed by altering the 
composition of the clotting mixture (Ferry and Morrison, 
1947). Furthermore, through in vitro studies it was 
established that the fibrin networks vary continuously 
between two extreme types - fine and coarse and that 
variation in the thickness and number of fibres in a 
network are responsible for the variation in clot 
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characteristics. However, much of the early work of fibrin 
networks as well as a good deal of the more recent studies 
on the mechanism of fibrin polymerization (Carr et al., 
1977; Rosser et al., 1977; Carr and Hermans, 1978; Hantgan 
and Hermans, 1979) concentrated on networks formed under 
non-physiological conditions. The relevance of previous 
observations to the clinical situation has remained 
unclear, a major obstacle being the lack of suitable 
methods applicable to sequential studies in clinical 
settings. 
The several methods available for studying fibrin 
network structure are not only based on independent network 
characteristics but have been developed more or less 
independently of each other for the study of networks 
form ed u n d er non - p h y s i o 1 o g i c a 1 con d it ion s . It i s imp or tan t 
at first to examine the applicability of these methods to 
networks formed under physiological conditions (Chapter 3). 
A methodological study was conducted to determine whether 
changes in network characteristics recorded with one 
methods may be transcribed in terms of another method, that 
is, whether a single method is capable of providing all the 
relevant information about fibrin network structure. 
However, this was found not to be the case. Thus, for 
example, although a mathematical relationship between lag 
time and network permeability had previously been 
postulated (Blomback and Okado, 1982a) it was shown in 
Chapter 5 that this relationship holds only under certain 
conditions. It was concluded that the various methods 
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cannot replace each other. Since the characteristic upon 
which the different methods are based overlap to some 
extent, the various methods complement each other, each 
method providing information unique to itself and extending 
that obtained using the other techniques. Thus, for 
instance, information regarding the three dimensional 
arrangement of fibres in the network is provided by 
scanning electron microscopy; that regarding the 
distribution of fibre sizes by transmission electron 
microscopy. Measurement of pore size and average mass-
length ratio of thinner network fibres may be made with 
permeability technique while the average mass-length ratio 
of thicker fibres may be derived from turbidity methods. 
The opacity ratio technique makes a measurement of fibre 
thickness and fibre density while the compaction technique 
provides information on fibre thickness, density and 
tensile characteristics. Kinetics of network development 
may be analysed from the lag time and ~OD/sec using the 
turbidity technique. Thus, maximal information is obtained 
by using concommittantly a variety of methods so that a 
composite picture of fibrin network may be built up and 
this approach has been adopted in the studies described in 
this thesis. 
It was found that turbidity measurements are sensitive 
predominantly to the thicker fibres in a network whereas 
permeability and compaction are influenced by the size of 
spaces between network fibres, that is, by the more 
numerous thinner network fibres. Since measurement of 
i 
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network permeability and compaction involve physical 
manupulation of the network, they are sensitive to factor 
XIIIa mediated crosslinkages. Not so the turbidity 
method. It should be noted that measurements of 
permeability, compaction and turbidity are all influenced 
by the fibrin content of the network and an allowance 
should be made for fibrin content in opacity ratio and 
compaction. Thus, these methods are sensitive to fibrin 
fibre density in addition to other characteristics of the 
network. These observations described in the earlier part 
of the thesis not only underlie the limitations of the 
various methods but also indicate that network 
characteristics are modified by factor XIIIa mediated 
crosslinking, the fibrin content, the range of fibre sizes 
in the network as well as by the average thickness of the 
network fibres. 
It has previously been generally assumed that fibrin 
networks are composed of fibres of uniform size. This 
assumption has been shown to be untrue. It was shown in 
Chapter 4 that fibrin fibres are, in fact, organized into 
two intimately associated networks, a major and a minor 
network. The major network, which is formed from the bulk 
of the fibrinogen, is composed of the thicker fibres. The 
fibre thickness in the major network, however, is not 
uniform. The minor network is located within the spaces 
between the major network fibres. It is a mesh of very 
thin and numerous fibres which arise from a relatively 
small mass of the total fibrin within the network. When 
--
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fibrin is stabilized by factor XIIIa mediated 
crosslinkages the minor network is anchored within the 
major and this alters the properties of the network as a 
whole. 
The bimodality of fibre distribution accounts, in part, 
for the differences in network structure recorded with 
different methods. As has been shown theoretically 
(Appendix 5) and experimentally (Blomback and Okada, 
1982b) that minimum pore size in fibrin networks is much 
smaller than the average pore size calculated using 
permeability. The average pore size and hence µp, is 
reduced in crosslinked fibrin networks as the minor network 
offers a greater resistance to perfusion. In non-
crosslinked networks, however, the minor network does not 
offer similar resistance to flow and therefore the average 
pore size and Pp represents that of the major network. 
Turbidity measurements and PT do not depend upon the 
minor network nor on whether the fibres of this network are 
crosslinked or not. Because turbidity and permeability 
measuremments are sensitive to opposite ends of the fibre 
size spectrum the PT provides a measure of the average 
mass-length ratio of the thicker network fibres of the 
maJor network whereas µP provides the average mass-length 
ratio of the thinner network fibres. 
Crosslinking by factor XIIIa stabilizes the minor 
network. This results in a reduction in network 
permeability and compaction but not at the expense of the 
1 7 7 . 
elastic modulus of the network which in fact increases 
(Kamykowski et al., 1981). In contrast, the elastic 
modulus decreases with permeability and compaction if these 
are lowered by reducing the average mass-length ratio of 
the network (Kamykowski et al., 1981). Since the 
mechanical characteristics of fibrin networks are 
undoubtedly important in haemostasis it seems likely that 
factor XIIIa plays a vital role in stabilizing the minor 
network and hence in modifying the mechanical 
characteristics of the fibrin network. 
The studies in Section I of this thesis make it clear 
that the proportion of fibrin in the major and minor 
networks and the distribution of fibre sizes in these 
networks is as important to the complete description of 
fibrin network structure as is the average fibre thickness 
and fibre density (and perhaps the density of network fibre 
branch points - Mueller and Birchard, 1978). At present 
little is known about the regulation of fibrin distribution 
in the major and minor networks and this is clearly an area 
for further research. 
Although the distribution of fibre sizes and the 
proportion of fibrin in the major and minor networks is 
important to a complete description of fibrin network 
structure, some evidence obtained in Section II of this 
thesis supports the use of a less detailed description. 
The shape of the distribution of fibre sizes in the network 
might not alter greatly as Pp and Pr, which are 
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sensitive to opposite ends of the fibre size distribution, 
generally changed in parallel. Furthermore, the proportion 
of fibrin in the major and minor networks also might not 
vary greatly as the Pp of crosslinked networks (which is 
sensitive to the minor network) generally changed in 
parallel with the µP of non-crosslinked networks (which 
is apparently insensitive to the minor network). For these 
reasons, a generalized model of fibrin network structure 
varying in fibrin content and average mass-length ratio may 
be used to examine the mechanism underlying changes in 
physiological fibrin network structure. 
It is clear that fibrinogen concentration is an 
important determinant of the density of fibres in the 
network and hence network properties and structure. In 
Section II it is shown that an increase or decrease in 
fibrin concentration causes a parallel change in fibre 
density. However, these two are only directly related when 
fibre thickness does not change. When fibre thickness 
changes even at a fixed fibrinogen concentration, the fibre 
density must change proportionally. It is, thus, clear 
that an understanding of how fibre thickness is altered is 
of paramount importance in understanding the regulation of 
network structure and properties. 
Studies in Section II of this thesis allow some 
understanding of the mechanism underlying changes in 
average fibre density and fibre thickness. It should be 
noted that this area of investigation has been relatively 
1. 
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neglected since Ferry and Morrison (1947) postulated that 
differences in the activity coefficient of fibrinogen cause 
differences in fibrin network structure. More recent work 
has suggested that fibrin networks are metastable 
structures. Fibrils are inhibited from associating 
laterally with each other when the density and 
interpenetrating nature of the fibres in the network is 
such that their rotational diffusion is inhibited (Nelb 
et al., 1976). Until this stage of network development 1s 
reached the diffusion of fibrils enhances the extent of 
lateral aggregation and hence increases the mean network 
fibre thickness. Hantgan and Hermans (1979) used this 
concept to explain the relationship between changes in the 
kinetics of fibrin generation and changes in network 
structure. 
These concepts on the mechanism underlying changes in 
network structure may be unified and extended on the basis 
of observations on physiological fibrin networks. It was 
noted that the kinetics of fibrin generation changes only 
slightly when the mass-length ratio was altered 
substantially by adding substances which strongly affect 
fibrin(ogen) solubility (e.g., heparin, protamine 
sulphate). On the other hand, a substantial change in the 
kinetics of fibrin generation (in terms of lag time) 
affected by slightly modifying thrombin or fibrinogen 
concentration caus e s minor changes only in the mass-length 
ratio. Moreover, although divalent cations increase mass-
length ratio they do not significantly influence changes in 
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network structure caused by other factors. It, therefore, 
appears likely that the solubility of fibrin(ogen) (which 
is related to the activity coefficient) primarily 
determines the rate of lateral association of fibrin 
fibrils while the kinetics of fibrin generation primarily 
influences the extent of lateral association by controlling 
the time available for fibril rearrangement. 
The classification of factors which modify network 
structure in terms of two characteristics (viz factors 
which either predominantly affects fibrin(ogen) solubility 
or factors which predominantly modify kinetics of fibrin 
generation) makes it relatively easy to identify potential 
influences on fibrin network structure. Using these 
criteria we can predict that reduced fibrin generation (as 
in haemophiliac plasma) should result in fibrin networks of 
abnormally high mean fibre thickness and this has been 
found to be the case (Bettingle et al., 1964). Likewise, 
substances which reduce the solubility of fibrin(ogen) 
through steric exclusion effects, such as dextran (Rampling 
et al., 1976) should increase mean fibre thickness. This 
has al so been shown ( Dhall and Bryce, 1970). Furthermore, 
as fibrin network structure and properties in both purified 
fibrinogen solution (Chapters 6 and 7) and in plasma 
(Chapter 8) are sensitive to non-specific changes in 
clotting conditions it would seem that networks formed in 
vivo may also be sensitive to therapeutically induced or 
spontaneous changes in clotting conditions. 
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The importance of sensitivity of network structure in 
vivo would be a moot point if fibrin formed only where 
homeostasis ensured minimum fluctuation in plasma 
composition. But since fibrin serves a reparative function 
it is formed where haemostatic mechanisms may not 
adequately control factors such as ionic strength, pH and 
temperature. In addition, the local variation in 
concentrations of glycosaminoglycans and certain cellular 
components (e.g., histones - Kopec et al., 1974) as well as 
thrombin and fibrinogen may significantly affect final 
network structure. Since certain bleeding disorders are 
associated with the development of fibrin networks of 
abnormal structure and properties (Shaw, 1980) it seems 
likely that variation in network characteristics may be 
important physiologically. 
Although abnormal fibrin network structure and 
properties have been identified clinically through 
comparison of network formed in plasma little was known 
about the factors which influence network structure. 
Indeed, it was not even known how networks in purified 
fibrinogen solution differ from those in plasma. This was 
examined in Section III of this thesis. 
The choice of anticoagulant and the handling procedures 
used in preparing and clotting the plasma were shown to 
affect network structure (Chapter 8). The anticoagulant 
was found to be a major determinant of ionic strength and 
pH of the plasma and henc e it was capable of modifying 
a 
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network structure. Anticoagulants also inhibited fibrin 
formation in plasma but this could be nullified by 
recalcification of the plasma. If the plasma was 
recalcified care had to be taken to remove all platelets to 
prevent significant network retraction. These studies 
indicated that strict standardization of methodology is 
essential for routine clinical studies on fibrin networks 
in plasma. 
Apart from the influences of anticoagulants, networks 
formed in plasma differ from those in purified fibrinogen 
solutions because they are formed in the presence of 
significant amounts of fibronectin and a 2-antiplasmin 
which are incorporated into the network (Mosher, 1980). It 
was shown that networks formed in plasma are more permeable 
and deform more readily than those in purified fibrinogen 
solutions. The reasons for these differences remain 
unclear. However, since networks in reconstituted sera did 
not exhibit the enhanced permeability of networks in plasma 
it seems possible that some plasma component is responsible 
and that it is in some way consumed during network 
development. 
Although platelets are known to contain substances 
which reduce mean network fibre mass-length ratio (Dhall 
et al., 1982), the cellular elements in blood were shown 
not to release stable serum soluble factors which increase 
the mass-length ratio. It thus seems likely that the very 
thick fibrin fibres found associated with platelets in 
a 
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thrombi (Gottlub, 1975; Hattori et al., 1978; Hisano, 1978) 
are not caused by enhanced lateral polymerization due to 
platelet release products, but rather they may represent 
thinner fibres drawn together during platelet mediated clot 
retraction (James et al., 1960; 1962; Szalontai, 1968). 
The final Chapter in this thesis examined fibrin 
networks in a clinical setting . The effect of surgical 
trauma on fibrin network structure was examined using 
sequential measurements (Chapter 9). It was found that 
network structure changes characteristically following an 
operation. The fibre density and the fibre mass-length 
ratio increase immediately after surgery. But while fibre 
density continued to increase until the third postoperative 
day becuase of the increase in plasma fibrinogen levels, 
the mass-length ratio quickly returned to preoperative 
levels. This decrease in mass-length ratio correlated with 
the increase in fibrinogen concentration but the cause of 
the initial increase in mass-length ratio is unknown . It 
was noted that networks compacted more easily following 
surgery. This increase in compaction paralleled the 
increase in fibrinogen level but was not related to either 
changes in mass-length ratio or fibrinogen concentration. 
It, therefore, seems likely that this behaviour, which 1s 
opposite to what might be expected from studies using 
purified fibr inogen ( Chapter 6) , may be the result of 
changes in the tensile characteristics of the network . 
From this clinical study it is clear that network 
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structure and properties are subject to some form of 
physiological control or regulation. Changes in fibrinogen 
level (that is, in the kinetics of fibrin generation) play 
some part in this control. More detailed studies are 
needed to identify other influencing factors. 
10. 2 CONCLUSIONS 
Fibrin networks were formed in plasma or in fibrinogen 
solutions under conditions which simulated those in plasma 
and these networks were examined with a variety of methods. 
A critical examination and comparison of the methods was 
undertaken to establish their suitability to the study of 
physiological fibrin networks. In addition, influences on 
fibrin network structure and properties were investigated 
with the primary aim of deriving information which would 
support study of fibrin networks in a clinical setting. 
It was demonstrated that the measurement of mass-length 
ratio from permeability but not from turbidity is sensitive 
to factor XIIIa mediated crosslinking. This finding led 
to the recognition that crosslinking stabilizes the 
previously undocumented minor network. This network which 
is found within the interstitial spaces between the major 
network fibres reduces network permeability. 
The semi-quantitative methods~ opacity ratio and 
compaction were shown to provide a good measure of changes 
in fibrin thickness but only when the fibrin concentration 
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was not varied. Compaction was shown to also be sensitive 
to crosslinking. Measurement of lag time proved to be 
influenced by changes in network fibre thickness. 
The structure and properties of networks formed in 
fibrinogen solution were shown to be sensitive to small 
changes in clotting conditions and to the presence of a 
variety of clinically and physiologically important 
substances such as heparin, protamine sulphate, glucose and 
glycosaminoglycans. 
Networks formed in plasma were shown to be sensitive to 
anticoagulants, ionic strength and pH but the effects of 
anticoagulant could largely be neutralized by 
recalcification. 
Networks formed in plasma differed from those formed in 
fibrinogen solutions in terms of permeability and ease of 
deformation. The mass-length ratio of networks formed in 
plasma was not increased in the presence of platelet 
release products. 
Network structure and properties changed consistently 
after operation. Fibre density and network compaction 
increased markedly while mass-length ratio initially 
increased and then decreased. Postoperative changes in 
mass-length ratio correlated with changes in fibrinogen 
concentration. 
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APPENDIX I 
REFRACTIVE INDEX MEASUREMENTS 
Aim 
To measure the refractive indicies of fibrinogen 
solution and plasma so as to enable calculation of PT· 
Materials and Methods 
Measurements of the refractive index of solutions wa~ 
made at 22°c using a ABBE - refractometer model A 
calibrated for light of 589.3 nm wavelength. Preliminary 
studies showed that the refractive indicies of solutions 
measured at 615 nm was not significantly different from 
those measured at 589.3 nm and thus, these latter values 
were assumed to be not significantly different from those 
at 608 nm. 
Results and Discussion 
The refractive index of tris-saline was found to be 
1.336. This value increased slightly but significantly 
with fibrinogen concentration. The refractive index of 10 
mg/ml fibrinogen in tris-saline was 1.338. 
The refractive index of plasma from 10 healthy 
individuals was 1.347 + 0.001 (+ SD). The refractive index 
of the serum from t hese individuals was 1.349 + 0.001. 
205. 
The refractive index of plasma from three individuals 
did not change significantly following surgery. The 
refractive index of plasma prepared as in Chapter 8 was not 
significantly different from plasma prepared as in Chapter 
9 . 
The refractive indices used in calculating PT in 
purified fibrin and in plasma clots were 1.336 and 1.347, 
respectively. A difference in refractive index of 0.002 
affects PT by an insignificant 0.2%. 
dn/dc is also used in calculating PT· A value of 
1.001 was used throughout the studies in this thesis. It 
was calculated from data presented by Carr et al. (1977). 
APPENDIX 2 
MEASUREMENT OF uT USING TURBIDITY AT 608 nm AND 
USING TURBIDITIES AT A RANGE OF WAVELENGTHS 
Aim 
206 . 
To establish whether PT can be calculated from the 
turbidity at 608 nm in the presence of physiological level 
of fibrinogen. 
Materials and Methods 
Networks were formed using fibrinogen solution (3.3 
mg/ml or 1.5 mg/ml) which did not contain divalent cations 
or which contained 1.2 mM CaC1 2 + 0.82 mM MgC1 2 . The 
pH and ionic strength were varied as in Chapter 4. The 
turbidities of networks were measured at a range of 
wavelengths from 350 nm to 800 nm and used to determine 
PT (Chapter 2). 
Results and Discussion 
PT can be calculated from the turbidity provided 
turbidity is directly proportional to x-3 (Carr and 
Hermans, 1978). This proportionality was found to hold at 
long wavelengths but to decay substantially at wavelengths 
shorter than 550 nm particularly at higher and 
physiological levels of fibrinogen concentration (Figure 
207. 
A2.1). This finding receives support from Carr and Hermans 
(1978). 
When turbidity is directly related to ,:-3 PT may be 
calculated from turbidity at a range of wavelengths or at a 
single wavelength (Carr and Hermans, 1978). Figure A2.2 
shows that PT calculated from turbidity at 608 nm 
correlated linearly with that calculated from turbidity at 
a range of wavelengths. This relationship holds over a 
wide range of mass-length ratios. These findings indicate 
the turbidity at 608 nm can be used to calculate PT for a 
variety of network types. 
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Figure A2.1 The wavelength de2endence of the turbidity 
of different networks 
Networks were formed in fibrinogen solutions (3.3. mg/ml) 
which did not contain divalent cations. Plots A, B, and C 
were made from fibrinogen solutions of ionic strength 
0.103, 0.153 and 0.203, respectively. PT equalled 29.7, 
12.2 and 1.21 x 10 12 daltons/cm, respectively. Turbidity 
data at 608 nm is marked with an arrow. 
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Figure A2.2 Mass-length ratio from turbidity at 608 nm and 
from turbidities at a range of wavelengths 
Networks were formed in fibrinogen solutions (3.3 or 1.5 
mg/ml) which did not contain divalent cations or which 
contained 1.2 mM Cac1 2 + 0.82 MgC1 2 . The pH and ionic 
strength were varied (Chapter 6). The two mass-length 
ratio values were significantly linearly correlated Cr -
0.991 ; p(F) < 0.0001 ; n = 44). 
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APPENDIX 3 
FLOW RATE AND PERFUSION PRESSURE 
Aim 
To establish whether measurements of flow rate in 
fibrin clot can be used to calculate µp· 
Materials and Methods 
Purified fibrin networks were formed with 1 U/ml 
thrombin in fibrinogen solutions (3.3 mg/ml; pH 7.35; ionic 
strength 0. 103) which contained 1251-fibrinogen and 1.20 
mM CaC1 2 + 0.82 mM MgC1 2 (Chapter 2). 
Plasma clots were formed with 1 U/ml thrombin/CaC1 2 
(Chapter 9) in pooled PFP from 5 health individuals which 
contained 1251- fibrinogen. 
Networks were left to develop fully for 1 hour. The 
clots were then perfused and the flow rates measured 
(Chapter 2) at a variety of different pressures. 
Results and Discussion 
Figure A3. 1 shows that flow rate is directly 
proportional to perfusion pressure in both plasma clots and 
purified fibrin clots. Thus, flow through fibrin networks 
2 1 1 • 
obeys Poiseuille's law. This is supported by previous 
observations (Blomback and Okado, 1982a). Therefore, the 
Darcy constant and Pp may be calculated from flow rate 
through clots made in fibrinogen solution or in plasma. 
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Figures A3.1 The relationship between flow rate and 
perfusion pressure 1n plasma and purified 
fibrin clots 
Networks were formed in PFP ( O) clotted with thrombin/ 
Cac1 2 (Chapter 8) or 1n purified fibrinogen solution (3.3 
mg/ml, pH 7.35, ionic stren g th 0.103) - (>(). Results are 
the mean of 2 determinations. 
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APPENDIX 4 
FACTOR XIII MEDIATED CROSSLI NKING 
Aim 
To establish whether fibrin net works formed in the 
presence and absence of ca++ are crosslinked by Factor 
XIIIa. 
Materials and Method 
SDS polyacrylamide gel electrophoresis (Webber and 
Osborn, 1969) was used to examine whether fibrin was 
crosslinked. Clots were solubilized in 2% P-
mercaptoethanol and run on 10% uniform gel slabs. 
Results and Discussion 
As shown in Figure A4.1, networks made in the presence 
of added 1.2 mM CaC1 2 + 0.82 mM MgC1 2 were crosslinked 
by factor XIIIa. Crosslinking was evidenced by y-
dimerization, absence of individual y chains and a 
polymerization. All purified fibrin networks made without 
Cac1 2 were not crosslinked and all networks made in 
plasma were crosslinked. 
Figure A4. 1 The polyacrylamide gel electrophoresis 
pattern of crosslinked and non-crosslinked 
fibrin 
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APPENDIX 5 
A MATHEMATICAL TREATMENT OF THE EFFECT OF POLYDISPERSION IN 
FIBRE DIAMETER ON up AND uT. 
The fibrin network is composed of two relatively 
distinct networks which have been called major and minor 
networks (Chapter 4). The diameters of the fibrin strands 
in either network are not uniform, but in the major network 
they are many times thicker than those in the minor 
network. The precise distribution of fibres and the 
differences in their diameters vary depending upon the 
average mass-length ratio of network fibres. It has been 
observed that the diameter of fibrin strands in major 
network in a coarse clot may be up to ten times or more 
than that in minor network. The difference remains obvious 
although it is less marked in fine clots. 
If for the following discussion it is assumed that the 
major and minor networks are monodisperse and that diameter 
of strands in minor network is d and diameter of strands in 
major network is 10 times d (i.e., 10d) then, presence of 
the minor network will modify the properties of the clot as 
follows: 
1. Permeation 
The permeability or Darcy constant, T, of a fibrin clot is 
,. 
/, 
given by: 
T - QhT) 
Ft p 
21 6 . 
• • • 1 
where Q is the volume flow through the clot in time t; ~ 
1s the viscosity of the perfusion fluid, his the length 
of the clot; Fits cross-section and pis the applied 
pressure. 
The permeability is related to the mass-length ratio,µ, 
of the fibrin fibres according to the equation: 
T = 4µ/TT k C 
where c 1s the concentration of fibrin and k is the 
packing constant. ( Carr et al., 1977) 
The mass-length ratio, p, is given by: 
µ - TT S r2 
where r is the radius of the fibres and s the fibre 
density. 
In this two network mod el , 
PMajor - TT~ (10r)2 = 100TT~r2 = 100µ -
PMinor - TT~ r2 - µ - -
•.. 2 
... 3 
... 4 
... 5 
Furthermore since the fibrin concentration in the minor 
network is much smaller than that in the major network we 
assume that 
1· 
0.95C 
0.05C 
Then, substituting these values in equation 2 
105.26T 
20.00T 
21 7 . 
. . . 6 
... 7 
•.. 8 
... 9 
The equivalent permeability of a clot composed of more than 
one network may be defined as the permeability of a 
homogeneous clot of the same dimensions that would allow 
equivalent flow rate under identical applied pressure. 
Depending upon whether the major and minor networks are -in 
series or parallel, the equivalent permeability of the clot 
will be given by the harmonic or arithmetic mean, 
respectively (Cardwell and Parsons, 1945). 
Arithmetic mean= 1/2 ( T Maj or + 
Harmonic mean -
1 
TMajor 
2 
+ 1 
T 
Minor 
Substituting values from equations 3 and 4, 
Arithmetic mean - 62.63T 
Harmonic mean - 33.61T 
TMinor) •• 1 0 
••. 1 1 
... 12 
... 1 3 
Since in a clot the two networks are superimposed, the 
equivalent permeability should correspond to the harmonic 
,. 
I: 
2 1 8 . 
mean. However, according to the theory of fluid dynamics 
it cannot exceed the arithmetic mean (Cardwell and Parsons, 
1945). Thus, the permeability of the clot will be markedly 
reduced by the minor network and could approach the 
harmonic mean. Sinceµ is proportional to T , the average 
mass-length ratio of the fibres in the clot will also be 
lower than that for the major network alone. 
2. Turbidity 
According to Carr and Hermans (1978), the turbidity of 
clots made from fibrinogen solutions is given by the 
equation: 
T = 44rr K CA µ/ IS n 
where c is the concentration of fibrin fibres, >. 
• • • 1 5 
wavelength, n is the refractive index of the solution, 
andµ is as before, the mass- length ratio of the fibres. 
The constant K is given by 
K = 2rr2n2(dn/dc)2/N >.4 .•• 1 6 
where dn/dc is the specific refractive index increment of 
the solute in the solvent and N is Avogadro's number. This 
equation is valid in the limit where the diameter of the 
fibrin fibres is small compared with the wavelength. 
Since the turbidity is proportional toµ, and 
Pmajor - 100µminor 
it follows that all other parameters being equal, the 
contribution to turbidity from the minor network will be 
one hundredth that from the major network. Hence, the 
l 
21 9. 
contribution from the minor network to the turbidity of the 
clot may be ignored. 
From this mathematical treatment of the methods of 
measuring Pp and µTit can be seen that the turbidity 
is influenced more strongly by thicker major network fibres 
than by the very thin minor network fibres. On the other 
hand, permeation is especially sensitive to the minor 
network. Although this mathematical treatment assumes only 
two superimposed networks, the major network fibre 
distribution is non- uniform. Thus, even in the absence of 
minor network, turbidity is sensitive to the thicker fiores 
in the major network while permeability is more sensitive 
to its thinner fibre. Consequently, µT and Pp 
represent the average of different populations of fibres in 
the fibrin network. 
a 
APPENDIX 6 
TABULATED DATA OF THE EFFECTS OF CHANGES IN 
CLOTTING CONDITIONS AND THE EFFECTS OF 
VARIOUS SUBSTANCES ON FIBRIN NET WORK 
STRUCTURE AND PROPERTIES 
220 . 
The following tables detail the effect on network 
stucture of : (1) the thrombin concentraion 
(2) fibrinogen concentration 
(3) temperature 
(4) ionic strength 
(5) pH 
(6) glucose 
(7) protamine sulphate 
(8) heparin (1.5 mg/ml fibrinogen) 
(9) heparin (3.3 mg/ml fibrinogen) 
(10) heparin sulphate 
(11) chondroitin-4-sulphate 
(12) chondroitin - 6-sulphate 
(13) citrate 
Networks were made earlier in the absence of divalent 
cations (NOC), in the presence of 2 . 02 mM MgC1 2 (Mg++) 
or in the presence of 1.2 mM CaC1 2 + 0 . 82 mM MgC1 2 
(ca++). ND indicates that the experiment was not done. 
Data is presented as the mean of at least three 
determinations+ SD. 
1. THROMBIN 
0.05 U/ml 
NDC 
ca++ 
0. 10 U /ml 
NDC 
ca++ 
0. 15 U/ml 
NDC 
ca++ 
0.25 U/ml 
NDC 
ca++ 
0.50 U/ml 
NDC 
ca++ 
µ x10 12 
(Daftons/cm) 
37.0 + 0.5 
37.7 + 0.3 
26.5 + 0.8 
-32.9 + 0.7 
23. 3 + 1 . 4 
28.9 + 1.1 
-
17.8 + 0.7 
23.6 + 0.6 
-
13.6 + 0.9 
20. 1 + 1. 7 
-
µTx1012 
(Dalton s/ cm) 
22.9 + 0.8 
24.4 + 0.2 
-
18.6 + 0.5 
22.4 + 0.2 
-
16.8 + 0.4 
-20.5 + 0.2 
-
15.1 + 0.2 
18.6 + 0.2 
-
13.3 + 0.5 
16. 9 + o. 3 
opacity 
ratio 
0.690 + 0.066 
0.722 + 0.017 
-
0.631 + 0.056 
0.706 + 0.015 
-
0.596 + 0.001 
0.678 + 0.014 
-
0.543 + 0.025 
0.638 + 0.022 
0.487 + 0.013 
0.587 + 0.032 
-
compaction 
(%) 
9.8 + 1.0 
-17.0 + 2.2 
6.8 + 0.6 
14.0 + 0.7 
-
6.0 + 0.8 
12.8 + 2.0 
-
4.2 + 1.0 
9.8 + 1.8 
2.8 + 0.8 
6.7 + 1.0 
-
lag time 
(sec) 
183 + 23 
108 + 10 
-
98. 6 + 1 8. 8 
62.0 + 12.0 
-
70.8 + 6.2 
46. 8 + 5. 1 
-
44.5 + 5.8 
29.8 + 3.5 
24. 3 + 1. 1 
17.5 + 1.9 
-
~OD/sec 
x10-4 
5.59 + 0.29 
10.7 + 0.5 
-
11.2 + 0.7 
20.8 + 1.2 
-
16.7+1.4 
28.9 + 1.3 
26. 1 + 0. 9 
47.1 + 1.2 
-
49.3 + 1.8 
85.5 + 2.2 
-
Darcy Const. 
x 10 11 ( cm2 ) 
305 + 4 
-
307 + 3 
190 + 6 
247 + 5 
-
161 + 10 
208 + 8 
-
121 + 5 
164 + 4 
-
92 + 6 
138 + 12 
Fibrin cone. 
(mg/ml) 
2.56 + 0.02 
2.60 + 0.05 
-
2. 95 + 0.01 
2.82 + 0.01 
-
3.06 + 0.02 
2.94 + 0.02 
3. 12 + 0.02 
3.05 + 0.01 
3. 13 + o. 01 
3.08 + 0.01 
N 
N 
t-' 
• 
2. FIBRINOGEN 
1. 0 mg/ml 
NDC 
ca++ 
2.0 mg/ml 
NDC 
ca++ 
3.3 mg/ml 
NDC 
ca++ 
4.0 mg/ml 
NDC 
ca++ 
6.0 mg/ml 
NDC 
ca++ 
8.0 mg/ml 
NDC 
ca++ 
µ x1o 12 
(Da£tons/cm) 
34 . 2 + 2. 1 
28.2+2.1 
-
25.2 + 2.2 
20.7 + 0.6 
23. 1 + 1 . 0 
18.1 + 0.3 
22.7 + 0.4 
28.1 + 1.0 
-
22.0 + 0.5 
13.8 + 0.8 
28.6 + 1.8 
13.7 + 1.6 
µrx1012 
(Dalton s/ cm) 
19.7 + 0.3 
22.9 + 0.8 
20.8 + 0.3 
21.6 + 0.2 
-
19.7 + 0.5 
17.8 + 0.2 
18.4 + 0.3 
16.6 + 0.3 
14.3 + 0.3 
13.8 + 0.3 
12.0 + 0.3 
12.3 + 0.3 
opacity 
ratio 
0.286 + 0.004 
0.306 + 0.007 
o. 436 + o. 050 
0.453 + 0.006 
0.661 + 0.013 
0.615 + 0.013 
-
0.747 + 0.018 
0.685 + 0.031 
-
0.890 + 0.004 
0.860 + 0.004 
-
o. 974 + 0. 004 
0.964 + 0.005 
compaction 
(%) 
13.8 + 0.8 
28.0 + 2.2 
9.6 + 1.9 
14.4 + 1.7 
6.5 + 1.0 
-9.3 + 1.2 
5.5 + 0.5 
8.6 + 1.4 
-
3.5 + 0.5 
6. 7 + o. 6 
3.5 + 0.6 
6.4 + 0.5 
-
lag time 
(sec) 
30. 7 + 3. 1 
21.7 + 0.6 
39.7 + 3.8 
2 8. 7 + o. 6 
-
60.3 + 3.8 
38.0 + 0.6 
62.0 + 4.0 
37.3 + 0.6 
80. 3 + 1. 2 
52.0 + 0.5 
-
103 + 4.4 
68.7 + 1.5 
-
~OD/sec 
x1o-4 
12.2 + 0.9 
21.0 + 0.9 
15.6 + 1.7 
25.8 + 0.4 
-
20. 8 + 1. 1 
32.7 + 1.6 
-
25. 0 + 1. 3 
39.0 + 1.7 
27.3 + 1.2 
43.6 + 1.9 
29.8 + 1.4 
42.6 + 1.2 
-
Darcy Const. 
x 10 11 ( cm2) 
800 + 51 
657 + 50 
299 + 27 
241 + 7 
-
165 + 7 
128 + 2 
-
134 + 3 
-107 + 6 
-
5.7 + 2. 1 
53.8 + 3. 1 
-
4.7 + 5.3 
40.6 + 4.8 
-
Fibrin cone. 
(mg/ml) 
0.91 + 0.01 
0.91 + 0. 01 
1.79+0.02 
1. 82 + 0.01 
-
2. 96 + 0. 02 
3.00 + 0.02 
3.58 + 0.01 
3.59 + 0.03 
5.44 + 0.02 
5.44 + 0.02 
-
7. 16 + 0. 04 
'/.17 + 0.04 
-
N 
N 
N 
3. TEMPERATURE 
15°c 
NDC 
M g:f::f: Ca 
20°c 
NDC 
Mg++ 
ca++ 
22°c 
NDC 
Mg++ 
ca++ 
25°c 
NDC 
Mg++ 
ca++ 
µ x1o 12 
(Daftons/cm) 
19.8 + 1.2 
33.1 + 1.4 
21.6 + 1.9 
ND 
ND 
ND 
23.6 + 0.5 
36.7 + 0.5 
18.7 + 0.8 
ND 
ND 
ND 
µrx1012 
(Dalton s/ cm) 
7.7+0.1 
10.5 + 0.2 
-9.7+0.1 
9.3 + 0.2 
13.6 + 0.2 
10.3+0.1 
10.6 + 0.4 
12.8 + 0.5 
-10.7 + 0.2 
11.5 + 0.2 
14.6 + 0.3 
-11.9+0.1 
opacity 
ratio 
0.340 + 0.003 
0.382 + 0.004 
0.368 + 0.001 
0. 36 1 + 0 . 00 1 
0.438 + 0.006 
0. 385 + o. 004 
0.398 + 0.002 
0.425 + 0.015 
-0.397 + 0.003 
0.411 + 0.004 
0.466 + 0.011 
o. 426 + 0. 003 
compaction 
(%) 
5.6 + 1.1 
14.0 + 1.3 
8.3 + 0.6 
ND 
ND 
ND 
4.6 + 0.9 
14.0 + 1.0 
8.2 + 0.3 
ND 
ND 
ND 
lag time 
(sec) 
66.0 + 1.0 
43.5 + 5.3 
37.8 + 4.8 
52.0 + 5.3 
43.5+2.1 
35. 8 + 4. 1 
54.3 + 2.5 
45.0 + 7.0 
36.4 + 4.5 
44. 0 + 1 . 7 
-35.0 + 2.9 
35. 4 + 1. 9 
~OD/sec 
x10-4 
8.9 + 0.4 
13.7 + 1.9 
14.9 + 1.4 
-
11.3 + 1.5 
15.5 + 0.8 
17.7 + 1.4 
11.5 + 5.5 
14.0 + 2.9 
-
19.0 + 0.9 
16.3 + 0.5 
21.3 + 1.3 
-20. 0 + 1 . 2 
Darcy Const. 
x 10 11 ( cm2) 
141 + 9 
259 + 11 
161 + 14 
-
ND 
ND 
ND 
169 + 4 
290 + 4 
138 + 6 
ND 
ND 
ND 
Fibrin cone. 
(mg/ml) 
2. 97 + 0.01 
2. '"(0 + o.01 
2.84 + 0.03 
2.96 + 0.01 
2.66 + 0.02 
-2.85 + 0.02 
2. 95 + 0. 01 
2.68 + 0.03 
2. 87 + 0. 02 
2.98 + 0.01 
2.73 + 0.01 
2.90 + 0.03 
3. TEMP. Contd. 
30°c 
NDC 
Mg++ 
ca++ 
35°c 
NDC 
Mg++ 
ca ++ 
37°c 
NDC 
Mg++ 
ca++ 
4o0 c 
NDC 
Mg++ 
ca++ 
µ x1o 12 
(Da£ tons/ cm) 
26 . 2 + 3.9 
43.5 + 1.2 
21.4 + 1.5 
-
ND 
ND 
ND 
34. 4 + 1. 6 
56.0 + 1.3 
23 . 7 + 2. 1 
38 .4 + 3.4 
61.2 + 2. 3 
31.0 + 2.8 
µTx1012 
(Dal tons/cm) 
12.8 + 0.1 
16.8 + 0.5 
-12.8 + 0.2 
-
14. 6 + o. 1 
17.9+0.1 
14.1 + 0.3 
15. 1 + 0. 4 
18.2 + 0.2 
-15.7 + 0.3 
18.2 + 0.2 
21. 4 + 0. 3 
17.8 + 0.3 
opacity 
ratio 
0.447 + 0.007 
-0.550 + 0.019 
0. 42 1 + 0 . 01 3 
0.500 + 0.004 
0.572 + 0.008 
0 . 485 + 0.007 
0.520 + 0.016 
0.586 + 0.004 
0.492 + 0.004 
0.614 + 0.001 
0. 653 + 0.010 
0.585 + 0.007 
-
compaction 
(%) 
6.0 + 0.9 
14. 7 + o. 6 
-9.0 + 1.0 
ND 
ND 
ND 
7.8 + 0.6 
16.0 + 1.0 
-9.2 + 1.3 
8.5 + 0.5 
18.0 + 0.5 
-10.0 + 1.0 
-
lag time 
(sec) 
48. 3 + 2. 1 
42.7 + 1.5 
-37.0 + 1.9 
49.3 + 2.3 
36.3 + 1.5 
36. 0 + 1. 7 
54.7 + 3.8 
43.3 + 4.0 
46.3 + 5.0 
72.0 + 4.4 
58.0 + 3.0 
50.5 + 3.5 
~OD/sec 
x10-4 
14. 9 + 0.9 
17.7 + 1.1 
21.6+0.9 
-
14.4 + 0.6 
2 1.6 + 0.5 
23 .7 + 0.6 
12.6 + 0.3 
18.9 + 0.9 
21.2 + 1.8 
-
12.9 + 0.9 
1 8. 4 + 0. 1 
24.4 + 2.2 
-
Darcy Const. 
x 10 11 ( cm2 ) 
186 + 28 
-
331 + 9 
154 + 11 
-
ND 
ND 
ND 
240 + 11 
418 + 10 
167 + 15 
-
271 + 24 
479 + 18 
-222 + 20 
-
Fibrin cone. 
(mg/ml) 
2.99 + 0 . 01 
2. 78 + 0. 03 
2. 94 + 0 . 01 
3. 00 + 0 . 02 
2. 80 + 0. 01 
-
2. 99 + 0 . 01 
3.03 + 0 .01 
2.84 + 0. 02 
-3.01 + 0.01 
3. 00 + 0 . 02 
2. 70 + 0. 06 
2. 96 + 0 . 02 
- N 
N 
.t:::,. . 
• 
4. IONIC STRENGTH 
o. 133 
NDC 
Mg++ 
ca++ 
0. 143 
NDC 
Mg++ 
ca++ 
0. 153 
NDC 
Mg++ 
ca++ 
o. 163 
NDC 
Mg++ 
ca++ 
o. 173 
NDC 
Mg++ 
ca++ 
µPx10 12 
(Dal tons/ cm) 
29.3 + 0.9 
42.3 + 1.7 
13.0 + 0.6 
21.7 + 0.5 
29.4 + 1.9 
-9.2 + 1.2 
-
14.2 + 1.6 
20.7 + 1.9 
6.8 + 1.3 
-
2.72 + 0.6 
12.3 + 1.2 
4.0 + 0.5 
0. 64 + 0. 04 
1. 55 + 0. 02 
-2.11 + 0.2 
µTx1012 
(Dal tons/ cm) 
13.3 + 0.4 
16.1 + 0.6 
14.7 + 0.1 
13.3 + 0.6 
16.5 + 0.6 
14.9 + 0.7 
-
12.3 + 0.4 
15.2 + 0.6 
13.5 + 0.1 
-
11.4 + 0.4 
14.2 + 0.2 
-12.7 + 0.3 
9.7 + 0.2 
12.2 + 0.4 
-10.7 + 0.3 
opacity 
ratio 
0.448 + 0.010 
0.490 + 0.014 
0. 45 1 + 0. 01 4 
0.441 + 0.017 
0.495 + 0.012 
0.467 + 0.020 
-
0.426 + 0.011 
0.463 + 0.009 
0.444 + 0.018 
-
o. 405 + 0. 010 
0.453 + 0.006 
0.422 + 0.007 
0.356 + 0.009 
0.400 + 0.010 
0.365 + 0.009 
compaction 
( % ) 
8.3 + 1.6 
16.0 + 2.4 
-9.9+3.1 
6.5 + 1.3 
11.9 + 1.6 
8.0 + 1.5 
-
4.8 + 0.7 
7.0 + 0.6 
7.5 + 1.4 
-
3.2 + 0.7 
5. 1 + o. 8 
6.5 + 0.8 
2.0 + 0.4 
-3.3 + 0.7 
5.3 + 0.7 
lag time 
(sec) 
103 + 9 
123 + 7 
80 + 7 
-
132 + 10 
127 + 7 
-91 + 4 
120 + 12 
161 + 7 
106 + 8 
-
144 + 14 
144 + 21 
141 + 12 
-
171 + 19.4 
169 + 28 
1'18 + 10 
ti OD/sec 
x10-4 
38. 1 + 2. 1 
46.9 + 4.3 
52.8 + 4.5 
-
34.7 + 2.6 
39.5 + 5.8 
46.0 + 3.0 
30.4 + 2.6 
34.6 + 5.2 
42. 6 + 1. 5 
22. 3 + 2. 1 
28.5 + 3.8 
37.9 + 4.4 
17.7 + 0.4 
20.8 + 1.3 
36.3 + 3.3 
Darcy Const. 
x10 11 (cm2 ) 
228 + 7 
326 + 14 
95 + 4 
-
157 + 4 
216 + 14 
65. 1 + 8.3 
-
99. 3 + 11. 3 
148 + 14 
47.4 + 9.2 
18.8 + 4.2 
870 + 8.8 
-27.0 + 3.3 
-
4.48 + 0.26 
11.1 + 1.5 
-14.3 + 1.8 
Fibrin cone. 
(mg/ml) 
2.90 + 0.02 
2.66 + 0.05 
-2.79 + 0.05 
2.87 + 0.03 
2.64 + 0.02 
2.80 + 0.04 
2.98 + 0.02 
2.70 + 0.02 
2.81 + 0.03 
3.02 + 0.03 
2. 78 + 0. 02 
2.89 + 0.03 
l 
• 
3.02 + 0.05 
-2.79 + 0.02 
-2.89 + 0.03 
5. pH 
7. 15 
NDC 
Mg++ 
ca++ 
7.25 
NDC 
Mg++ 
ca++ 
7.35 
NDC 
Mg++ 
ca++ 
7.45 
NDC 
Mg++ 
ca++ 
7.55 
NDC 
Mg++ 
ca++ 
µ x10 12 
(Daf tons/cm) 
33.7 + 2.0 
58.7 + 4.0 
-
22.3 + 2.6 
30.3 + 2.6 
5 3. 0 + 4. 1 
27. 1 + 0. 6 
-
25. 4 + 1. 2 
42. 9 + 1. 5 
22. 1 + 1 • 4 
-
21.2 + 2.3 
41.1 + 1.9 
18.6 + 0.5 
17.9 + 1.2 
32.9 + 1.8 
15.8+1.7 
µTx 10 12 
(Dal tons/cm) 
11.0+0.4 
15.6 + 0.3 
13.5 + 0.5 
10.7 + 0.2 
1 4. 9 + o. 4 
12.4 + 0.7 
-
9.6 + 0.3 
13.6 + 0.4 
11.7+0.3 
9.2 + 0.2 
12.5 + 0.3 
10.9 + 0.3 
9.2 + 0.3 
11.2+0.4 
11.0 + 0.4 
opacity 
ratio 
0. 42 7 + 0. 011 
0.532 + 0.008 
0.485 + 0.019 
0.417 + 0.009 
0.505 + 0.010 
0.453 + 0.016 
0.391 + 0.009 
0.479 + 0.014 
0.433 + 0.009 
0.385 + 0.007 
0.459 + 0.008 
0.417 + 0.007 
0.380 + 0.010 
0.426 + 0.011 
0.419 + 0.012 
compaction 
(%) 
1.0 + 0.8 
15.5 + 2.9 
11.6 + 2.3 
6.3 + 1.0 
15.1 + 1.7 
9.4 + 1.5 
5.0 + 1.1 
12.5 + 1.4 
8.8 + 1.3 
-
4.0+0.6 
10.7 + 1.8 
-
7.7+1.1 
3.4 + 0.4 
9.1 + 0.2 
6.6 + 1.2 
-
Darc1 Const. x10 1 (cm2 ) 
247 + 14 
466 + 32 
176 + 20 
223 + 19 
424 + 32 
205 + 4 
-
179 + 8 
336 + 14 
166 + 10 
-
148 + 16 
312 + 14 
137 + 4 
125 + 8 
249 + 14 
116 + 13 
Fibrin cone. 
(mg/ml) 
2. 90 + 0. 01 
2.66 + 0.03 
2. 79 + 0. 02 
2. 87 + 0. 04 
2.64 + 0.04 
2. 80 + 0. 04 
2.98 + 0.01 
2.70 + 0.04 
2.81 + 0.03 
3. 02 + 0. 03 
2.78 + 0.04 
2.89 + 0.04 
-
3. 02 + 0. 02 
2.79 + 0.02 
2.89 + 0.05 
N 
N 
(J') 
6. GLUCOSE µ x1o 12 p TX 10 12 opacity 
( Daf tons/ cm) (Dalton s/ cm) ratio 
Control 
NDC 13.3+1.7 18.5 + 0.2 0.617 + 0.035 
ca++ 16.2 + 2.3 25. 7 + o. 4 o. 7 86 + o. 04 9 
10 mM 
NDC 9. 7 + 1. 8 17.6+1.4 0.580 + 0.023 
ca++ 11.0 + 0.5 24. 7 + o. 8 0.745 + 0.015 
-
40 mM 
NDC 4.53 + 0.83 15.3+0.3 0.463 + 0.012 
ca++ 6.92 :- 0.56 21.3 + 0.5 0.702 + 0.048 
70 mM 
NDC o. 80 + 0. 14 10.4 + 0.8 0.355 + 0.013 
ca++ 4.58 + 0.52 14.4 + 0.5 0.699 + 0.057 
- -
100 mM 
NDC 0.41 + 0.03 10.7 + 1.3 0.314 + 0.002 
ca++ 1. 53 + 0. 4 9 13.9 :- 0.4 0.566 :- 0.018 
-
compaction Dar c ~ Const • 
(%) x10 1 (cm2 ) 
2.9 + 0.7 94. 7 + 12. 2 
6.0 + 0.4 114 + 16 
- -
2.0 + 0.6 71.8+13.6 
6.5 + 0.5 80.6 + 4.0 
- -
<2. 0 39.2 + 1.2 
5. 6 + o. 5 56.8 + 4.6 
-
<2. 0 5. 73 + 1. 40 
4.2 + 0.4 4 5. 1 + 5. 2 
-
-
<2. 0 6.0 + 0.5 
2.8 + 0.4 22. 1 + 7.2 
-
Fibrin cone. 
(mg/ml) 
2. 95 + 0. C9 
3.01 + 0.02 
2.85 +0.03 
2. 87 + 0. 05 
-
2.44 + 0.09 
2 . 58 + 0. 01 
-
2 . 13 + 0. 08 
2.15+0.12 
-
1. 40 + 0. 11 
1. 46 :- 0. 1 0 
-
N 
N 
-...J 
7. PROTAMINE 
SULPHATE 
Control 
NDC 
ca++ 
0. 1 µg/ml 
NDC 
ca++ 
0.25 µg/ml 
NDC 
ca++ 
0.5 µg/ml 
NDC 
ca++ 
0.75 pg/ml 
NDC 
ca++ 
1. 0 µg/ml 
NDC 
ca++ 
µ x1o 12 
( Daf tons/ cm) 
22. 5 + 2. 1 
19.0 + 3.9 
31.5 + 1.1 
33.4 + 2.8 
35. 7 + 1. 8 
57.9 + 4.5 
57. 4 + 1 . 9 
68.6 + 5.0 
-
77. 7 + 1. 5 
80. 1 + 3. 6 
105.4 + 11.0 
91.6 + 3.9 
PTX 10 12 
(Dalton s/ cm) 
14. 1 + o. 2 
19.9 + 0.2 
14.2+0.3 
21.7 + 0.6 
-
17.6 + 1.5 
23.2 + 0.4 
21.9+0.7 
30.9 + 0.6 
29.6 + 0.7 
35.3 + 1.0 
31.2 + 3.0 
34.4 + 0.8 
opacity 
ratio 
0.287 + 0.001 
0.348 + 0.008 
0.289 + 0.007 
0.355 + 0.003 
0.316 + 0.008 
0.369 + 0.006 
0. 353 + 0. 008 
o. 465 + 0. 007 
-
0.455 + 0.009 
0.521 + 0.016 
-
0.507 + 0.017 
0.514 + 0.011 
-
compaction 
(%) 
6.8 + 1.3 
1 o. 2 + 1. 9 
9.6 + 0.9 
14.4 + 1.8 
-
10.3+2.1 
17.0 + 2.2 
-
12.6 + 2.3 
25.2 + 3.2 
15.0 + 2.2 
-
29. 7 + 3. 0 
19.6 + 4.4 
40.3 + 5.0 
Dar(ff Con~t. 
x10 (cm) 
349 + 33 
305 + 63 
489 + 17 
536 + 45 
560 + 28 
-912 + 71 
917 + 30 
1086 + 7 9 
222 + 24 
-1271 + 57 
666 + 174 
1422 + 61 
-
Fibrin cone. 
(mg/ml) 
1. 36 + 0. 02 
1. 32 + o. 03 
1.36+0.01 
1. 33 + 0. 02 
1.35+0.01 
1.34 + 0.01 
1. 33 + 0. 02 
1. 34 + o. 01 
1. 34 + 0. 01 
1. 33 + o. 02 
1. 34 + 0. 02 
1.36 + 0.01 • 
8. HE PAR IN µ x1o 12 PTX 10 12 opacity compaction Dar c 1 Const • Fibrin cone. ( Daf tons/ cm) 1 2 (Dalton s/ cm) ratio (%) x10 (cm) (mg/ml) 
Control 
NDC 22. 5 + 2. 1 17.4 + 2.2 0.287 + 0.001 6.8 + 1.3 349 + 33 1. 36 + 0. 02 
C ++ a -19.0 + 3.9 21 .4 + 1.8 0.383 + 0.008 10.2 + 1.9 305 + 63 1. 32 + 0. 03 
-
0. 18 U/ml 
NDC 22.2 + 1.5 12.2 + 0.1 0.263 + 0.003 9. 1 + 2. 1 357 + 24 1. 32 + 0. 02 
ca++ 18.6 + 1.8 1 8. 6 + o. 3 o. 300 + o. 002 9.1 + 1.3 304 + 3 1.29 + 0.03 
-
0.50 U/ml 
NDC ND 9.4 + 4.0 0.268 + 0.005 ND ND 1.28+0.04 
ca++ ND 7.3+0.1 0.288 + 0.002 ND ND 1.29 + 0.04 
-
0.90 U/ml 
NDC 21.9 + 1.0 15.9+0.3 0.281 + 0.003 11.5 + 1.6 371 + 17 1. 25 + 0. 03 
ca++ 19.4 + 2.1 1 8. 8 + 0. 1 0.305 + 0.001 11.2 + 1.4 321 + 35 1.28 + 0.02 
- -
-
1. 8 U/ml 
NDC 29.2 + 1.0 19.0 + 0.6 0.310 + 0.008 13.5 + 2.2 485 + 17 1. 27 + 0. 04 
ca++ 20.6 + 0.7 22.4 + 0.40 0.336 + 0.006 13.3+2.1 347 + 11 1.26 + 0.03 
-
9.0 U/ml 
NDC 39.0 + 2.0 24.2 + 0.3 0.387 + 0.006 24.0 + 1.7 604 + 31 1.36 + 0.01 
ca++ 28.6 + 2.3 27.8 + 0.2 0.419 + 0.006 20.7 + 1.5 449 + 18 1. 35 + o. O 1 
18.0 U/ml • 
NDC 74.6 + 7.7 32. 9 + 0. 1 0.501 + 0.005 29.0 + 2.0 143 + 118 1. 38 + 0. 01 
ca++ 41.9 + 1.3 34.3 + 0.4 0.520 + 0.005 29.2 + 3.5 646 + 20 1.37 + 0.01 
-
-
9. HEPARIN p x1o 12 pyx 10 12 opacity compaction Darc1 Const. Fibrin cone. (3.3 mg/ml) (Daftons/cm) (Dalton s/ cm) ratio (%) x10 1 (cnl) (mg/ml) 
Control 
NDC 18.8+1.4 17.3 + 0.5 0. 60 1 + 0. 01 8 5.5 + 2.3 130 + 10 3. 06 + 0. 01 
ca++ 15.6 + 1.0 19.9 + 0.2 0.740 + 0.008 9.5 + 1.5 109 + 7 3.02 + 0.03 
- - -
0. 18 U/ml 
NDC 19.9 + 1.1 12.6 + 0.5 0.436 + 0.012 5.3 + 1.5 140 + 8 3. 00 + 0. 01 
ca++ 19.2 + 1.5 17.8 + 1.1 0.576 + 0.027 8.9 + 0.9 138 + 11 2.94 + 0.03 
0.50 U/ml 
NDC ND 9.8 + 0.3 0.361 + 0.009 ND ND 2.90+0.03 
ca++ ND 1 6. 1 + o. 4 0.519 + 0.005 ND ND 2.92 + 0.04 
-
0.90 U/ml 
NDC 17.4+0.3 12.5 + 0.1 0.415 + 0.007 6.5 + 1.0 126 + 2 2. 92 + 0. 03 
ca++ -17.0 + 2.9 17.9 + 0.4 0.562 + 0.008 9.0 + 1.2 124 + 21 2.91 + 0.02 
- -
1.8 U/ml 
NDC 19.7 + 2.5 16.6 + 0.3 0.530 + 0.011 11.3 + 3.5 143 + 18 2.91 + 0.01 
ca++ 1 6. 9 + 2. 8 19.3 + 0.2 0.612 + 0.007 10.0 + 2.6 121 + 20 2.95 + 0.02 
- - -
9.0 U/ml 
NDC 38.6 + 2.7 25.4 + 1.2 0.814 + 0.034 19. 8 + 4. 9 273 + 19 2. 99 + 0. 03 
ca++ 30. 1 + 2. 6 2 7. 1 + o. 3 0.876 + 0.006 18.8 + 2.9 212 + 18 3.00 + 0.02 
- -
-
18. 0 U/ml 
NDC 46. 2 + 4. 4 28.4 + 0.2 0.908 + 0.005 26.3 + 2.5 323 + 31 3. 02 + 0. 03 0 
ca++ 32.4 + 2.3 17.6 + 5.0 0.926 + 0.006 22.3 + 4.7 224 + 16 3.06 + 0.02 
- -
10. HEPARIN p x10 12 fl TX 1012 opacity compaction Darc1 Const. Fibrin cone. SULPHATE (Daf tons/cm) (Dalton s/ cm) ratio (%) x10 1 (cm2) (mg/ml) 
Control 
NDC ND ND 0.287 + 0.003 6.8 + 1.3 349 + 33 ND 
ca++ ND ND 0.348 + 0.008 8. 5 + 2. 8 305 + 63 ND 
-
0. 1 mg/ml 
NDC ND ND 0.289 + 0.003 8.9 + 1.9 407 + 30 ND 
ca++ ND ND 0.338 + 0.005 12.3 + 1.6 445 ~ 56 ND 
0. 28 mg/ml 
NDC ND ND 0.300 + 0.007 8. 3 + 1. 9 352 + 18 ND 
ca++ ND ND 0.354 + 0.002 14.0 + 2.0 443 + 28 ND 
-
0. 5 mg/ml 
NDC ND ND 0.318 + 0.003 11.0 + 1.1 401 + 20 ND 
ca++ ND ND 0.372 + 0.003 15.7 + 1.6 447 + 35 ND 
-
1.0 mg/ml 
NDC ND ND 0.348 + 0.005 13.3+1.9 452 + 4 ND 
ca++ ND ND 0.404 + 0.004 18.0 + 3.4 561 + 62 ND 
- -
10 mg/ml 
NDC ND ND 0.437 + 0.005 27. 2 + 1. 7 605 + 15 ND 
ca++ ND ND o. 534 + 0.011 36.5 + 5.2 958 + 4 9 ND 
N 
w 
I-' 
11. CHONDROITIN-4 p x1o 12 12 opacity compaction Dar c 1 Const . Fibrin cone. 11TX 1 0 SULPHATE (Daf tons/cm) (Dalton s/ cm) ratio (%) x10 1 (cm2 ) (mg/ml) 
Control 
NDC 13.3+0.8 20.3 + 1.5 0.325+0.003 6.4 + 0.8 227 + 13 3. 04 + 0. 04 
ca++ 16.1 + 1.5 26.9 + 0.5 0.389 + 0.010 14.0 + 1.3 265 + 25 S.08 + 0.02 
-
-
35 pg/ml 
NDC 18.9+0.4 26.6 + 0.8 o. 341.1 + o. 007 7.8 + 0.9 318 + 7 3. 05 + 0. 02 
ca++ 1 9. 6 + o. 9 27.4 + 1.1 0.403 + 0.002 13.7 + 1.5 317 + 15 3.11 + 0.02 
- -
70 µg/ml 
NDC 19.7 + 0.8 26.1 + 1.2 0.375 + 0.005 8.5 + 1.0 328 + 14 3.07 + 0.04 
ca++ 20.3 + 0.4 29.6 + 1.4 0.436 + 0.009 14.0 + 1.0 327 + 6 3. 11 + o. 01 
- -
350 pg/ml 
NDC 26. 2 + 1. 1 33 .6 + 1.2 0.481 + 0.002 13.3 + 0.7 425 + 18 3. 10 + o. 01 
-
ca++ -25.3 + 0.5 36.8 + 1.2 0.538 + 0.004 17.3 + 1.8 399 + 8 3.14 + 0.01 
-
700 µg/ml 
NDC 34 .3 + 2.6 41.3 + 1.6 0.583 + 0.008 18.2 + 4.8 557 + 43 3. 10 + 0. 03 
-
ca++ 41.6 + 1.3 0.608 + 0.006 411 + 12 26.3 + 0.8 25.7 + 1.2 3. 15 + 0.02 
- -
-
12. CHONDROITIN-6 p x1o 12 J-l TX 1012 opacity compaction Darc1 Const. Fibrin cone. SULPHATE ( Daf tons/ cm) (Dalton s/ cm) ratio (%) x10 1 (cm2 ) (mg/ml) 
Control 
NDC 13.3 + 0.8 20. 3 + 1. 5 0.325 + 0.003 6.4 + 0.8 227 + 13 3.04 + 0.04 
ca++ 16.1: 1.5 26.9 + 0.5 0.398 + 0.004 14.0 + 1.3 265 + 25 3.08 + 0.04 
-
- -
35 µg/ml 
NDC 18. 9 + 2. 1 26.5 + 1.0 o. 376 + o. 001 9. 0 + 1. 2 317 + 35 3.06 + 0.05 
-
-
ca++ 18.6 + 0.7 27.5 + 1.0 0.398 + 0.001 12.7 + 1.2 306 + 12 3. 09 + o. 03 
- - -
70 pg/ml 
27.2 + 1.0 0. 397 + o. 009 8.4 + 0.6 368 + 28 3. 08 + 0. 04 NDC 22. 3 + 1 . 7 
ca++ 19.6 + 0.6 29.8 + 1.5 0.430 + 0."006 14.3 + 1.1 320 + 9 3.10 + o. 01 
350 pg/ml 
NDC 35. 2 + 0. 9 39.0 + 1.0 0.558 + 0.013 16.1 + 1.4 571 + 1 4 3. 10 + 0. 04 
ca++ 29.6 + 1.8 39.0 + 0.6 0.575 + 0.010 17.7 + 1.2 4 64 -:;- 2 8 3.15 + 0.01 
- - -
700 pg/ml 
45.5 + 1.2 0.658 + 0.003 24.8 + 1.3 821 + 59 3. 12 + 0. 01 NDC 51.4+3.7 
ca++ 36.3-:;- 3.6 42.9 + 0.8 0.622: 0.002 23.0 + 2.8 574 + 57 3. 14 -:;- 0. 02 
-
-
13. CITRATE p x1o 12 PTX 10 12 opacity compaction Dar c 1 Const . Fibrin cone. ( Daf tons/ cm) (Dalton s/ cm) ratio (%) x10 1 (cm2 ) (mg/ml) 
Control 
NDC 13.6 + 1.8 18.2 + 1.4 0.617 + 0.035 2.9+0.7 94. 7 + 12. 2 3. 04 + 0. 02 
ca++ 8. 7 + o. 5 20.2 + 1.2 o. 6 93 + 0. 040 6. 0 + 0. 4 59. 3 + 3.2 3. 10 + o. 02 
-
-
2. 5 mM 
NDC 13.3+2.6 18.9 + 1.0 0.640 + 0.031 3. 2 + O. 3 92.7+18.0 3. 03 + 0. 01 
ca++ 9.4 + 0.4 21.4 + 2.4 0. 71 0 + 0. 02 9 6.6+1.1 65. 5 + 2.'"( 3. 05 + o. 02 
-
- -
5.0 mM 
NDC 15.0+1.3 23.0 + 0.4 o. 729 + o. 061 4.0 + 1.0 105 + 9 3 03 + 0. 01 
ca++ 13.8 + 1.7 23.1 + 0.8 0.776 + 0.017 7. 0 + 0. 5 95.8 + 12.0 3.04 + 0.02 
-
7.5 mM 
NDC 19.3+3.3 22.9 + 1.2 0.760 + 0.032 5.8 + 0.8 135 + 23 3. 02 + 0. 02 
ca++ 20.8 + 2.2 24.3 + 1.2 
-
o. 812 + 0. 038 7.0 + 0.4 133 + 15 3.06 + 0.03 
10.0 mM ' 
NDC 24.5 + 4.2 23.6 + 1.1 0. 795 + o. 041 6.7 + 0.5 170 + 2 9 3.04 + 0.01 
ca++ 21.8 + 2.0 24. 9 + 0. 7 o. 827 + o. 033 7. 4 + o. 6 152 + 28 3.03 + 0.03 
- - - -
12. 9 mM 
NDC 23.5 + 3.4 24.6 + 1.2 0.794 + 0.034 9.8 + 1.8 166 + 24 2. 99 + 0. 03 
ca++ 23.5 + 3.9 25.2 + 1.2 0.843 + 0.031 9.3 + 1.5 163 + 27 3.04 + 0.01 
-
